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Summary

Resumen
La VGF es una proteina neurosecretora de ~68 kDa que pertenece a la familia de las
graninas. VGF no es un acrónimo, sino que hace referencia a un clon de cADN derivado
de un ARN mensajero cuya expresión se indujo en células PC12 mediante tratamiento
con la neurotrofina "Nerve Growth Factor (NFG)". Levi y colaboradores designaron este
clon como procedente de la placa V de la biblioteca de cADN inducida por el Growth
Factor (Levi et al., 1985; Possenti et al., 1989).
La proteína VGF se expresa fundamentalmente en neuronas, como consecuencia de la
inducción mediada por NGF y otras neurotrofinas como BDNF.  Como se detallará, la
VGF es a su vez una neurotrofina, y puesto que el género asignado a BDNF y NGF es el
masculino (de "factors"), se utilizará arbitrariamente este mismo género para el VGF,
aunque como se ha indicado, VGF no signifique “Growh Factor V”.
La secuencia aminoacídica del VGF incluye varios pares de amino acidos básicos
(arginina y lisina) consecutivos, lo que lo convierte en una diana de endoproteasas que lo
cortan generando un gran número de péptidos de secreción biológicamente activos.
Dichos péptidos se almacenan en vesículas densas hasta el momento de su secreción,
que tiene lugar de una forma regulada. Varios de estos péptidos han sido caracterizados
y algunas de sus funciones, identificadas. Estas incluyen importantes papeles en la
regulación del equilibrio energético, la función reproductiva, la modulación del dolor, el
mantenimiento de células neuronales, y la modulación del estado de ánimo.
Uno de los neuropéptidos derivados del VGF major caracterizados y estudiados hasta la
fecha es el TLQP-21. El nombre de este péptido, siguiendo la pauta utilizada para otros
también derivados del VGF, hace referencia al número de aminoácidos que lo componen
y a sus cuatro residuos aminoacídicos aminoterminales. Las secuencias de los TLQP-21
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humano y murino son relativamente parecidas, aunque con diferencias no desdeñables.
Concretamente: TLQPPSALRRRHYHHALPPSR (humana) y
TLQPPASSRRRHFHHALPPAR (murina). Como puede apreciarse, la diferencia es de 5
aminoácidos sobre 21, es decir, de aproximadamente un 20%. Esta diferencia se hará
particularmente relevante en la discusión sobre las posibles diferencias en la actividad y,
sobre todo, los posibles receptores de estos péptidos (ver más adelante).
Se han demostrado efectos del TLQP-21 en los siguientes procesos fisiológicos, entre
otros: gasto energético (Possenti et al., 2012; Jethwa et al., 2007; Bartolomucci et al.,
2006), metabolismo en general (Bartolomucci et al., 2008), lipolisis (Possenti et al.,
2012), secreción de insulina estimulada por la glucosa (Stephens et al., 2012),
nociocepción (Fairbanks et al., 2014; Chen et al., 2013; Rizzi et al., 2008; Severini et al.,
2008), regulación de la presión sanguínea y control de la hipertensión (Fargali et al.,
2014),  contractilidad gástrica (Severini et al., 2009; Bartolomucci et al., 2008),
regulacion de la secreción ácida gástrica (Sibilia et al., 2012; Sibilia et al., 2010a;
2010b), función reproductora (Aguilar et al., 2013; Pinilla et al., 2011) y respuesta al
estrés (Razzoli et al., 2012, Bartolomucci et al., 2011).
De entre todos estos efectos, aunque todos importantes, merece la pena destacar la
regulación del gasto energético. A grandes rasgos se puede afirmar que el TLQP-21
tiene como efecto un aumento del gasto energético en modelos animales. Este efecto se
produce sin que haya una elevación de los niveles séricos de las hormonas tiroideas T3 y
T4, y sin un aumento de la actividad locomotora (Bartolomucci et al., 2006; 2009). Sí
se acompaña de una elevación de la temperatura rectal. Por otra parte, el tratamiento con
TLQP-21 tuvo como consecuencia un aumento de expresión en el tejido adiposo blanco
(WAT) de RNA de marcadores catabólicos tales como las isoformas δ y β del
"peroxisome proliferator-activated receptor" (PPAR), el receptor adrenérgico y la
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"uncoupling protein 1" (UCP1,  Bartolomucci et al., 2006; 2007). Además, el TLQP-21
produce un aumento de la razón entre ácidos grasos libres y triglicéridos (FFA/TG ratio,
según la terminología anglosajona habitual, Bartolomucci et al., 2007). En resumen, el
TLQP-21 tiene un efecto catabólico neto, dando lugar a un aumento del gasto
metabólico y una disminución de la masa corporal y de grasa (Bartolomucci et al.,
2007).
En vista de esta extensa lista de efectos, la identificación del (los) receptor(es) de TLQP-
21 se ha convertido, obviamente, en un objetivo de gran interés, por una parte, para
poder comprender mejor los mecanismos moleculares de las diversas acciones del
péptido, pero por otra, como posible(s) diana(s) terapéutica(s). Recientemente se han
publicado dos trabajos en los que se describe la identificaron de los receptores de
factores del complemento C3AR1 y gC1qR  como receptores de el TLQP-21 murino
(Hannedouche  et al., 2013; Chen et al., 2013). Sin embargo, el TLQP-21 humano
muestra una afinidad mucho menor tanto por las versiones murinas como las humanas
de estos receptores (Hannedouche  et al., 2013; Chen et al., 2013; Cero et al., 2014).
Esto sugiere la existencia de otro(s) receptor(es) para el péptido humano.
El C3AR1 es un receptor acoplado a proteína G que se une a dos componentes del
sistema de complemento, C3a y C4a (Klos et al., 2013). Hannedouche y cols. partieron
del hecho conocido de que en células CHO-K1 la aplicación de TLQP-21 da lugar a un
aumento del calcio intracelular (Cassina et al., 2013). Puesto que dicho efecto es
inhibido por la toxina pertussis, esos investigadores razonaron que el receptor del TLQP-
21 murino (cabe señalar en este punto que las secuencias de la TLQP-21 de diversos
roedores como ratón, rata o hámster son idénticas) sería un receptor acoplado a G0. De
acuerdo con esta premisa, realizaron un estudio genómico y concluyeron que el receptor
era C3AR1, lo que fue posteriormente confirmado mediante diversos estudios
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bioquímicos y moleculares (Hannedouche et al., 2013). Sin embargo, tal y como ya se ha
indicado, la unión del TLQP-21 humano a la C3AR1 humana es mucho más débil que la
unión del TLQP-21 murino a esa misma proteína. Así, Cero y cols. comprobaron,
mediante un ensayo de reclutamiento de arrestina, que si bien la EC50 del péptido murino
es, en células con sobreexpresión de C3AR1 humana, 3 veces menor que la del agonista
por antonomasia de C3AR1, a saber, C3A, la EC50 del péptido humano es 22 veces
inferior (Cero et al., 2014).
En cuanto al receptor gC1qR, fue identificado por Chen y cols. como un receptor de
TLQP-21 murino mediante un estudio de cromatografía de afinidad (Chen et al., 2013).
Se trata del receptor de la cabeza globular del componente del complemento C1q
("globular head of the complement component C1q receptor"). Pero ya antes de su
identificación como receptor del TLQP-21 murino se sabía que también se une a otros
diversos ligandos of origen celular, bacteriano y vírico (Peerschke et al., 2006;
Ghebrehiwet et al., 1996; Xu et al., 1999). Es de destacar que el gC1qR tiene una
localización en la superficie celular pero también en el citosol, el retículo endoplásmico
o las mitocondrias (Peterson et al., 1997), lo que resulta de gran interés en el contexto
del presente trabajo (ver más adelante).
En este contexto, la identificación de posibles receptores específicos del TLQP-21
humano es de gran interés. En el presente trabajo se describe la identificación de la
proteína “heat shock cognate 71 kDa protein A8 (HSPA8)”, como un receptor del
TLQP-21 humano. Para ello se utilizó cromatografía de afinidad. Se acopló TLQP-21
humano derivatizado con biotina a una columna de agarosa-avidina. Posteriormente se
preparó un homogenado de células de neuroblastoma SH-SY5Y y se pasó por la
columna. Las células SH-SY5Y expresan una considerable cantidad de VGF (Ramos et
al. 2014), por lo que se supuso que probablemente expresarían también una cantidad
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apreciable de receptores de los péptidos derivados de VGF, incluído el TLQP-21, siendo
además fáciles de cultivar. Se decidió utilizar inicialmente un homogenado completo, en
vez de una fracción de membrana, para evitar pérdidas, maximizando las posibilidades
de aislar e identificar proteínas capaces de interaccionar con TLQP-21.
La columna se eluyó con biotina, recogiéndose varias fracciones que fueron sometidas a
electroforesis en gel de poliacrilamida en SDS (SDS-PAGE). Los geles fueron
posteriormente teñidos con Sypro Ruby, un colorante de gran sensibilidad. La tinción
puso de manifiesto la presencia de una banda correspondiente a una proteína o proteínas
con una masa molecular aparente de algo menos de 75 kDa, ausente en fracciones
similares eluídas de una columna control no cargada con el péptido TLQP-21
biotinilado. A continuación se cortó la banda, se sometió a reducción, alquilación y
digestión con tripsina “en gel” (Shevchenko, 2006), y tras su elución del gel los péptidos
trípticos resultantes fueron analizados mediante especrometría de masas (MS/MS)
utilizando un equipo de nanoHPLC (EASY-nLC, Proxeon, Bruker Daltonik GmbH,
Alemania)  equipado con una nanocolumna de fase reversa (Easy column SC200 C18
3μm 120A 360 μm OD/75μm ID, L=10cm, Proxeon-Thermo Scientific, Estados Unidos)
cuyo efluente se dirigió a un espectrómetro de masas Bruker Amazon ETD con
electrospray y detector de trampa iónica. El análisis automatizado de datos se realizó
mediante los programas Data Analysis 4.0 y BioTools 3.2 de Bruker Daltonik GmbH. El
análisis mediante el motor de búsqueda Mascot v2.3 (Matrix Science, Reino Unido)
utilizando la base de datos SwissProt (release 57.15) reveló la presencia de HSPA8 con
una puntuación ("score") de 735.0, una cobertura del 19.8% y 12 péptidos detectados.
Dos proteínas adicionales fueron detectadas, Stress-70 protein (HSPA9/mortalin), y 78
kDa glucose-regulated protein (HSPA5), aunque con puntuaciones, coberturas y número
de péptidos detectados sensiblemente menores. La identidad de la HSPA8, en la que se
han concentrado todos los esfuerzos ulteriores (ver más adelante) fue confirmada
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mediante un anticuerpo específico que reaccionó con la banda de  75 kDa detectada en
el gel mediante Sypro Ruby.
La proteína HSPA8 se localiza en diversas fracciones celulares, incluyendo la
membrana. No obstante, dado que se habían utilizado homogenados totales de las células
SH-SY5Y, y a pesar de que precisamente en estas células se ha descrito la presencia de
HSPA8 en la membrana celular, cabía la posibilidad de que la interacción entre la
HSPA8 y el TLQP-21 fuese artefactual. Por ello se realizó un experimento para
comprobar la unión de TLQP-21 HSPA8 situado en la superficie celular.
Concretamente, se suministró TLQP-21 biotinilado con un residuo extra de cisteína
(Biotina-TLQPPSALRRRHYHHALPPSRC al medio de células SH-SY5Y vivas en
presencia del reactivo de entrecruzamiento bifuncional Sulfo-N-[ε-
maleimidocaproyloxy]succinimide ester (sulfo-EMCS). El reactivo entrecruzó el péptido
y HSPA8 presente en la superficie de las células, como pudo comprobarse tras
homogenizar las mismas, someter el homogenado a cromatrografía de afinidad en una
columna de avidina y finalmente identificar las proteínas adsorbidas mediante
inmunodetección con un anticuerpo específico para HSPA8.
Como prueba adicional de que el TLQP-21 se une a un receptor (HSPA8) situado en la
membrana de las células HSPA8, se realizó un estudio mediante citometría de flujo
(FACS). Se trataron células SH-SY5Y con TLQP-21 humano biotinilado, se utilizó a
continuación avidina conjugada con fluoresceína, y se procedió a analizar las células
mediante un equipo de citometría de flujo FACScalibur (Becton Dickinson, Estados
Unidos). Se observó una fracción creciente de células “decoradas” con fluoresceína,
mayor cuanto mayor fue la concentración de TLQP-21 utilizado.
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Los resultados anteriores dieron lugar a una colaboración con Sandipan Chakraborty,
investigador del departamento de Microbiología la Universidad de Calcuta experto en
modelización molecular. Éste realizó un estudio de modelización de la unión y encaje
(“docking”) del TLQP-21 humano a HSPA8, utilizando el programa GROMACS 4.5.,
cuyos resultados sugieren que el péptido encaja muy bien en la cavidad de esta proteína
que sirve, precisamente, para unirse a péptidos. La modelización también predice que el
péptido, que muestra una estructura desordenada en solución, según otro estudio de
modelización previo (Chakraborty et al. 2015) adopta una estructura de hélice .
Igualmente, siempre según la modelización, se produce un elevado número de
interacciones iónicas entre el péptido y la cavidad, siendo particularmente reseñables
aquellas en las que participan los residuos R10R11 del péptido. La presencia de pares
residuos consecutivos de arginina es una conocida característica de otros péptidos que se
unen a HSPA8.
La HSPA8 pertenece a la familia de las proteínas de choque térmico (“heat shock
proteins, HSPs”), si bien presenta características y particularidades que la hace un
miembro muy especial de este grupo. Así, si bien realiza, como otras HSPs, funciones de
chaperona, esto es, de asistencia al correcto plegamiento de determinadas proteínas y del
mantenimiento del mismo (He et al., 2010), cada vez se van conociendo otras funciones
específicas de esta proteína. Además, una característica fundamental de la HSPA8 es que
se expresa de manera constitutiva, en contraste con la expresión inducible,
particularmente por situaciones de estrés, de sus compañeras de grupo. Además, la
HSPA8 es a menudo secretada en vesículas y exosomas (Clayton et al., 2005). Otras
funciones importantes de la HSPA8 se relacionan con procesos de inmunidad,
antigenicidad, hematopoyesis y autofagia (Stricher  et al., 2013; Meimaridou et al.,
2009).
Resumen
Sin embargo, las funciones más interesantes de HSPA8, en el contexto de este trabajo,
son aquellas en las que actúa, precisamente, como un receptor. Así, por ejemplo, su
actuación como receptor del péptido P140. El P140 es un fosfopéptido artificial (análogo
a otro natural) que se une a HSPA8, y que tiene un significativo efecto protector frente al
lupus eritematoso (Page et al., 2009; Stricher et al., 2013). De hecho, dicho péptido está
siendo sometido a un ensayo clínico de fase III como un posible agente terapéutico para
esta enfermedad (Muller et al., 2008; Zimmer  et al., 2013; Stricher et al., 2013).
Experimentalmente, la unión del P140 a HSPA8 afecta el procesamiento de
autoantígenos por parte de células presentadoras de antígenos del sistema inmunitario en
el modelo murino de lupus eritematoso MLR/lpr (Page et al., 2011), induciendo una
disminución de la señalización asociada a los mecanismos lisosomales. Por otra parte, el
HSPA8 también actúa como receptor del virus HTLV-1, con la consiguiente formación
de sincitios  (Sagara et al., 1998). Por consiguiente, el papel del HSPA8 como receptor
de superficie no es una novedad. Más específicamente, su papel como receptor del
péptido P140 es de particular relevancia.
El HSPA8 contiene, de hecho, de un dominio de unón a peptidos (Wang, 1993), una
característica que comparte con otros miembros de la familia de las HSPs, y más
concretamente con la sub-familia  HSP70, aunque cada miembro de la familia exhibe
propiedades exclusivas y diversificadas de unión (Fourie et al., 1994). En este sentido, se
ha visto que la afinidad del dominio de unión a péptidos del HSPA8 aumenta
dramáticamente para péptidos que contienen las secuencias KK, KR, o RR (Takenaka et
al., 1995). Cabe resaltar que el TLQP-21 humano contiene la secuencia R9- R10- R11.
En una fase posterior del presente trabajo de investigación se llevaron a cabo dos
estudios proteómicos preliminares cuyo objetivo fue comprobar que en nuestro sistema
experimental (células SH-SY5Y), el péptido TLQP-21 humano no sólo se une a su
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receptor (HSPA8) sino que además esta unión pone en marcha mecanismos moleculares
que dan lugar a un efecto biológico; y por otro. Por otro lado, la identificación de alguno
de estos efectos (en forma de cambios en la expresión de proteínas o fosfoproteínas)
debería abrir la puerta a futuras investigaciones encaminadas a elucidar las rutas de
señalización y los mecanismos moleculares mediante los que el TLQP-21 humano
realiza sus funciones fisiológicas.
Así, se realizó un estudio proteómico comparativo de extractos de células SH-SY5Y
tratadas y sin tratar con TLQP-21. Se separaron las proteínas mediante electroforesis 2D
y se cuantificaron las intensidades de las docenas de manchas obtenidas tras teñirse los
geles con Sypro Ruby. Mediante el programa Ludesi RedFin, se procedió a comparar las
intensidades de 4 geles de muestra tratada con las de 4 geles de muestra control. Se
identificaron varias manchas con intensidades diferentes. La identidad de las proteínas
correspondientes a estas manchas fue desvelada mediante espectrometría de masas
(MS/MS), tal y como se ha descrito para las bandas obtenidas tras SDS-PAGE de las
fracciones eluídas de la columna de afinidad con TLQP-21, tras cortarse las areas de los
geles correspondientes a las mismas, y someter dichas muestras a reducción, alquilación
y digestión trípticas “en gel”. El análisis reveló una expresión diferencial de las
proteínas: "Mediator of RNA polymerase II transcription, subunit 24";
"Adenylosuccinate synthetase isozyme 2"; "Spindle and kinetochore-associated protein
2"; "1-phosphatidylinositol 3-phosphate 5-kinase (type III PIP kinase)"; "Heat shock
protein beta-1" y "Endothelial differentiation-related factor 1" (se indican los nombres
en inglés por ser los habituales en la literatura).
En paralelo, y teniendo en cuenta la importancia de los procesos de fosforilación en las
rutas de señalización, y aunque HSPA8 no es una quinasa o fosfatasa, se realizó un
estudio fosfoproteómico elemental basado en la separación en una dimensión mediante
SDS-PAGE de las proteínas correspondientes a muestras de células tratadas y no
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tratadas con TLQP-21. Los geles fueron a continuación teñidos con el colorante
Diamond Pro-Q, específico de proteínas fosforiladas. Se apreció la disminución de
intensidad de 2 bandas correspondientes a proteínas con pesos moleculares aparentes de
aproximadamente 55 y 220 kDa. Es intrigante que 220 kDa es precisamente, de forma
aproximada, la masa molecular de la "type III PIP kinase", de modo que resulta tentador
especular que la mancha de intensidad disminuida correspondiente a dicha quinasa
detectada en el análisis proteómico podría quizá corresponder a una isoforma
fosforilada, si bien de momento no hay datos experimentales suficientes que permitan
llevar esto más allá de la mera especulación. En cualquier caso, será interesante realizar
estudios adicionales para investigar esta posibilidad.
En resumen, se ha identificado la proteína de la familia de las chaperonas HSPA8 como
un receptor del neuropéptido activo TLQP-21 y se ha comprobado, con células SH-
SY5Y, que éste se une a aquella en el contexto de la superficie celular, y que esta unión
da lugar a cambios sutiles en la expresión proteica y la fosforilación de determinadas
proteínas. Estos estudios abren la posibilidad de buscar agonistas farmacológicos del
HSPA8 que pudiesen tener efectos similares a los del TLQP-21, que podrían ser de gran
utilidad como agentes para la prevención de la obesidad, entre otros muchos posibles
efectos farmacológicos.
(Nota: Las referencias citadas pueden encontrarse en forma completa en la sección
"References" de esta tesis).
Summary
VGF (non-acronymic) is a ~68 kDa neurosecretory protein, belongs to the extended
granin family of proteins, initially identified as a nerve growth factor (NGF) inducible
gene product, is selectively synthesised mostly in neuronal and neuroendocrine cells.
Due to the presence of paired basic amino acid residues (R – Arginine, and K – Lysine),
the VGF sequence undergoes endoproteolytic cleavage to produce several smaller
peptides, released upon stimulation via the regulated secretory pathway both in vitro and
in vivo. There are data suggesting that the VGF-derived peptides are the biologically
active, stored in dense core vesicles and secreted in order to play a role in inter cellular
communication, and responsible for the diverse range of  biological functions associated
with VGF. Several of these VGF-derived peptides have been characterised and are
involved in energy balance, reproductive behaviour, pain modulation and mood order.
Till now, the best characterized VGF derived peptide is designated as TLQP-21. As
growing data is accumulating on the several significant biological effects of TLQP-21
like energy balance, pain modulation, gastric, reproduction, stress, diabetes;
identification of its receptor(s) is of particular relevance. In light of this extensive array
of effects, the very limited knowledge about its molecular mechanisms of TLQP-21 is
remarkable. Recently, C3AR1 and gC1qR have been reported as receptors of murine
TLQP-21. However, human TLQP-21 whose sequence shows differences with respect to
murine TLQP-21, exhibits at best very weak binding to these receptors, suggesting the
existence of different receptors for human vs rodent TLQP-21.
Here using affinity chromatography and mass spectrometry-based protein identification,
the heat shock cognate 71 kDa protein A8 (HSPA8) has been identified as a receptor of
human TLQP-21. Binding of TLQP-21 to membrane associated HSPA8 in live SH-
SY5Y cells was confirmed by cross-linking and FACS studies. Furthermore, molecular
modeling studies show that TLQP-21 can be docked into the peptide binding pocket of
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HSPA8. The major task moving forward is to elucidate the signaling pathways of the
ligand TLQP-21 and its receptor HSPA8. Identification of HSPA8 as a receptor of
human TLQP-21 could open new approaches for diagnostics and therapeutics for a wide
range of human diseases related with VGF, in particular those in which TLQP-21 has
been shown to have an effect.
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VGF (a non-acronymic name) gene was originally identified as a nerve growth factor
(NGF) responsive gene and should not be confused with VEGF (vascular endothelial
growth factor). NGF33.1, a nervous system-specific mRNA was cloned by treatment of
PC12 cells with NGF. After elucidating the nucleic acid as well as amino acid sequences
of the NGF33.1 cDNA clone, Levi et al. (1985) designated this clone corresponding to
the NGF-inducible mRNA as VGF. The term ‘VGF’ derived from the selection of this
clone from plate V of the nerve Growth Factor induced PC12 cell cDNA library (Levi et
al., 1985; Possenti et al., 1989). Indeed, in response to NGF treatment, VGF was
independently identified by several groups using differential hybridization techniques
(Cho et al., 1989; Levi et al., 1985; Salton et al., 1991).
Structure of VGF:
The human and mouse VGF genes are located on chromosome 7q22.1 and 5 (Hahm et
al., 1999; Canu et al., 1997a; Canu et al., 1997b) and encode a 615 amino acid (human)
and 617 amino acid (rat), respectively (Levi et al, 1985). VGF is a single copy gene
(Canu et al., 1997a) and is simply organized as depicted in Figure 1 and 2. It is
composed of 3 exons but the complete VGF protein is encoded by exon 3 only while two
introns interrupt the region encoding the 5’ untranslated sequence of VGF (Hahm et al.,
1999). C-terminal peptide regions encode a number of bioactive peptides. As depicted in
Table 1, VGF is a proline, and glycine rich and acidic polypeptide. Although there are
evolutionary conservation of  other invertebrate granins (a family of proteins comprising
chromogranins, secretogranins and some other related proteins (Bartolomucci et al.,
2011) found in the secretory granules of endocrine, neuroendocrine cells and neurons
(Deftos et al., 1986; Fischer-Colbrie et al., 1987), that function to control the  supply of
neurotransmitters, hormones, growth factors and peptides (Bartolomucci et al., 2011);
no invertebrate VGF proteins have been identified so far. And several regions of high
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sequence conservation were found in both lower and higher vertebrate VGF proteins
(Figure 3).
Table 1: Introductory informations on VGF, at a glance. (Number of amino acids
(AA) and calculated molecular mass (MM) of the preprotein, number of amino acids and
calculated molecular mass of the mature protein, observed molecular mass of the mature
protein, number of dibasic sites, number/content of proline, number/content of
glutamate, calculated (calc) and observed (obs) pI, and secondary structure (percent α-
helix) are shown for human (h), ND, not determined. From Bartolomucci et al., 2011).
VGF derived peptides:
In human, rat, mouse and chimpanzee (Hahm et al., 1999; Canu et al., 1997a; Possenti et
al., 1989), VGF protein possesses ten (Levi et al., 2004) paired basic amino acid residues
(as illustrated in the Figure 3) having potential cleavage sites for the best characterized
mammalian prohormone processing enzymes, prohormone convertases (PCs), members
of the family of subtilisin/kexin-like serine proteinases (Seidah and Chretien, 1999;
Steiner, 1998). For example, TLQP-62 is produced by PC1/3, while NAPP-129 has been
produced by the action of either PC1/3 or PC2 (Trani et al., 2002). N-terminal VGF
peptides (human) are not compatible with known motifs required for PCs. So some VGF
peptides must be generated by other yet unidentified endoproteases. As mentioned
earlier, in rat, mouse and human VGF protein comprises at least 10 basic amino acid
residues susceptible to potential PC cleavage. Hence the number of known VGF derived
peptidesis likely to increase further. To understand the contributions of ‘such a variety of
VGF peptides’ individually as well as their mode of action has now become a big
challenge.
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Figure 1:  Schematic diagram of the VGF gene and its derived peptides (mouse).
The numbers correspond to the positions of amino acid residues in mouse VGF protein.
The closed black boxes represent neuroendocrine regulatory peptides (NERPs): NERP-1
and NERP-2 and the rest of the boxes represent other peptides: TLQP-62, TLQP-21,
AQEE-30 and LQEQ-19. (From Toshinai and Nakazato, 2009).
VGF in PC12 cells appears as a doublet of 80–90 kDa when analysed by Western Blot
though its calculated molecular weight is 68 kDa. The lower band was confirmed to be
generated from the upper, probably due to limited proteolysis, providing that no post-
translational modification occurred (Levi et al., 1985). Finally it was concluded that the
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very high proline content accounts for the lower than expected electrophoretic mobility
of the protein. In addition to a doublet of 80–90 kDa, several smaller peptides were
identified in rat brain homogenates, neuronal, endocrine and pancreatic beta cell lines, in
extracts of primary cultures of cerebellar granule cells in response to the antibodies
raised against the C-terminal nonapeptide of rat VGF protein (Possenti et al., 1999;
Trani et al., 1995). Several VGF peptides were revealed out in rat brain homogenates by
mass spectroscopy followed by affinity purification with C-terminal antiserum, in
addition to more lower molecular-weight peptides detected by Western Blot Analysis
(Trani et al., 2002).
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Figure 2: Schematic diagram of the VGF gene and its derived peptides (mouse).
VGF gene with its simple structure encodes a 617-amino acid protein in rats, and a 615-
amino acid protein in humans, subjected to cleavage into several peptides. Two introns
interrupt the region encoding the 5’ untranslated sequence of VGF, and the entire VGF
protein is encoded by exon 3. Most of the fragments are capable to show biological
activity, indicated in Table 2 (From Jethwa and Ebling, 2008).
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Table 2: A listing of VGF derived peptides. Nomenclature of the peptides was
simplified by the first four amino acids and by its length, such as: TLQP-21 and TLQP-
62 are two peptides with TLQP (Thr-Leu-Gln-Pro, respectively) sequences at N-
terminus with total length 21 and 62 amino acids, respectively except the
neuroendocrine regulatory peptides, NERPs (an acronym for neuroendocrine regulatory
peptides) and VGF 20 (20 kDa, based on the apparent molecular weights observed by
Western blot analysis). (Adapted from Jethwa and Ebling, 2008).
Peptide names Amino acid position
on VGF precursor
Length Biological
activity
known?
APPG-40 23-62 40 No
APPG-37 23-59 37 No
GRPE-37 26-62 37 No
NERP-1 302-309 8 Yes
NERP-2 341-350 10 Yes
NAPP-129 (VGF 20) 417-617 201 No
VGF 18 Unknown --- No
TLQP-62 (VGF 10) 556-617 62 Yes
HFHH-51 (VGF 6) 567-617 51 No
HHPD-41 576-617 41 No
AQEE-30 (Peptide V) 588-617 30 Yes
LQEQ-19 599-617 19 Yes
TLQP-21 556-576 21 Yes
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Figure 3: Evolutionary conservation of VGF. Each of the three highly conserved
regions of VGF: NERP-2, TLQP and AQEE peptides, are conserved in both higher and
lower vertebrates (From Bartolomucci et al., 2011).
Tissue distribution of VGF:
VGF mRNA is expressed in the main and accessory olfactory bulbs, hippocampus,
cortex, basal ganglia, thalamus, amygdala, midbrain and the brainstem, with the highest
expression in neurons in the hypothalamus and in the granular layer of the cerebellum
(van den Pol et al., 1989; 1994; Snyder et al., 1997; 1998). After birth, rats express VGF
throughout brain (in neurons exclusively), and in peripheral endocrine and
neuroendocrine tissues (Snyder et al., 1998). Later on in the adult rat brain, VGF mRNA
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becomes widely distributed in the spinal cord, olfactory system, cerebral cortex,
hypothalamus, and hippocampus, and also in thalamic, septal, amygdaloid, and brain
stem nuclei (Snyder et al., 1998; van den Pol et al., 1989; 1994). Before birth, rats
express VGF at first on embryonic day 11.5 in the dorsal root and sympathetic ganglia,
neural crest cells migrating to enteric ganglia and in primordia of the vagal (X) complex
(Snyder et al., 1998). VGF mRNA continues to be expressed in the ventral spinal cord,
cranial nuclei, basal forebrain, adrenal and pituitary in between of embryonic day 13.5 to
15.5. Later in embryogenesis,  VGF expression starts to additional CNS sites as well as
becomes prevalent in the esophagus, stomach (both in endocrine cells and myenteric
plexus), and pancreas in between of embryonic day 17.5 to 19.5). High expression of
VGF mRNA was evident in oligodentrocyte precursors though it was found to disappear
following differentiation (Dugas et al., 2006; Cheishvili et al., 2007). VGF derived
peptides were also found to be expressed in peripheral leukocytes (Cattaneo et al., 2010)
and glial fibrillary acidic (GFA) protein-expressing astrocytes of the spinal cord in
transgenic mutant SOD1G93A mice. In the spinal cords of sporadic amyotrophic lateral
sclerosis (ALS) patients, VGF expression was found low in comparison to control
patients. A small molecule, SUN N8075 was capable to slow down disease progression
in  SOD1 mouse and rat models of ALS, resisting the lowering of VGF level in the
spinal cords of ALS mice (Shimazawa et al., 2010). However, further investigation
regarding the unexpected localization of VGF may point out towards unexpected
functional roles. To summarize, VGF is synthesized by neurons in the CNS and PNS, as
well as in the adult pituitary, adrenal medulla, endocrine cells of the stomach and
pancreatic beta cells, moreover, VGF mRNA is obvious at embryonic day 11·5 in the rat
dorsal root and sympathetic ganglia (Snyder et al., 2003).
All these informations regarding tissue specific expression and distribution of VGF
suggest that VGF has different roles in the concerned tissues.
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Functions of VGF:
Regulation of energy homeostasis:
Studies on VGF knockout mice demonstrated that they were hyperactive,
hypermetabolic, lean, and small with less abdominal fat (Hahm et al., 1999). VGF
derived peptide, TLQP-21 was found to decrease food intake and to rise energy
expenditure in Siberian hamsters (Jethwa et al., 2007). Also in mice fed high-fat diet
(HFD) for 14 days, TLQP-21 decreased body weight and white adipose tissue (WAT)
blocking hormonal changes associated with HFD and provoking the autonomic
activation of the adrenal medulla and adipose tissue. Furthermore,
intracerebroventricular (icv) administration of TLQP-21 reduced early phase diet
induced obesity (Bartolomucci, et al., 2006). Thus, VGF derived peptide TLQP-21
shows catabolic activity (Jethwa et al., 2007; Bartolomucci et al., 2006) whereas VGF
knockout mice demonstrated the opposite trend (Hahm et al., 1999). The hyphothesis to
explain this inconsistency could be: one or more VGF derived peptides possess opposite
biological roles with respect to TLQP-21. There are evidences that upkeep the
hyphothesis: administration of TLQP-62, HHPD-41 increased food intake in fasting
mice (Bartolomucci et al., 2007). While, NERP-2 icv administration to rats and mice
increased food intake, body temperature, O2 consumption, locomotor activity promptly
(Yamaguchi et al., 2007; Toshinai and Nakazato, 2009; Toshinai et al., 2010).
Regulation of gastrointestinal function:
There are evidences suggestive of the central role of TLQP-21 in intermediating
gastroenteric functions by the initiation of prostaglandin (PG) synthesis. Icv, but not
intraperitoneal (ip), or intravenous (iv) injection of TLQP-21 inhibited gastric emptying
almost ~40% in a time (Severini et al., 2009) as well as dose dependent manner and
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reduced ethanol induced gastric lesions in rats through nitric oxide synthase and PG E2.
It also reduced gastric acid secretion through somatostatin and PG (Sibilia et al., 2010a;
2010b).  The peptide also induced contraction of gastric fundic strips ex vivo by PG
mucosal release (Severini, et al., 2009).
Regulation of hormone, neurotrophin, and/or neurotransmitter release:
TLQP-62, in hippocampal slices, provoked electrical potentiation that was found to be
blocked by the brain-derived neurotrophic factor (BDNF) scavenger TrkB-Fc, Trk
tyrosine kinase inhibitor K252a, and tissue plasminogen activator STOP (Bozdagi et al.,
2008), pointing out the probable role of TLQP-62 in inducing release of  BDNF in the
hippocampus and other regions of CNS. The BDNF-receptor, TrkB, is progressively
activated in vitro by TLQP-62 to initiate the TLQP-62 induced proliferation of neural
progenitor cells (NPCs) (Thakker-Varia et al., 2014) in consistent with the upregulation
of VGF protein by BDNF treatment (Alder et al., 2003). Accordingly, AQEE-30 and
LQEQ-19 upregulate phosphorylation of MAPK p38 in microglia (Riedl et al., 2009) in
nociceptive signaling with the probable induction of BDNF (Coull et al., 2005). Another
VGF derived peptide,  neuroendocrine regulatory peptide (NERP) increased food intake
in mice through the activation of an orexin dependent mechanism  indicating that NERP
induces the release of neuropeptide orexin in hypothalamus (Toshinai K et al., 2010).
Regulation of pain:
In the first study highlighting the role of TLQP-21 in pain modulation , the forepaw-
injected formalin test confirmed the induction of analgesic effect by TLQP-21,
additionally it was established that the inflammatory modulatory effects of TLQP-21
depend on the route of administration : being pronociceptive at the periphery and
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antinociceptive at the central level (Rizzi et al., 2008). TLQP-21 has been found to
provoke a hyperalgesic response when it was subcutaneously injected into the hind paw
of mice. Mechanical hypersensitivity was apparent in rat following inoculation of
TLQP-21-stimulated macrophages into rat hind paw and intracellular Ca2+ levels in
macrophages was lessened via siRNA suggesting that TLQP-21 plays an important role
in inducing heperglesia/hepersensitivity/chronic pain through activation of macrophages
(Chen et al., 2013). Moreover, in vivo, long-lasting mechanical and cold behavioural
allodynia (pain produced by stimuli which usually do not  provoke pain (Merskey and
Bogduk, 1994) like temperature, cold or physical stimuli (Hooshmand and  Hooshang,
1993) was persuaded by TLQP-62 (Moss et al., 2008). AQEE-30 and LQEQ-19 caused
hyperalgesia via microglial p38 MAPK activation (Riedl et al., 2009). To sum up, both
the short and long VGF derived peptides like LQEQ-19 (Riedl et al., 2009), TLQP-21
(Fairbanks et al., 2014; Chen et al, 2013; Rizzi et al., 2008), AQEE-30 (Riedl et al.,
2009), TLQP-62 (Moss et al., 2008) were found to be responsible for the consistent
induction of  analgesia/hyperalgesia/hepersensitivity/chronic pain in diverse models of
pain.
Regulation of emotion/psychiatric disease:
Probably out of the granin family members, VGF has been the most explored for its role
as well as mechanism in emotional behavior and psychiatric disease (Bartolomucci et al.,
2011), while there are very few data suggesting the role of other granin family members
like secrotogranin II (SgII)-derived peptides GE19, GAIPIRR and SN (secretoneurin) in
emotional behavior (Wakonigg et al., 2002). Since the time period when VGF mRNA
was found in the hippocampal areas, VGF was thought to play a crucial role in this area
(Snyder and Salton, 1998) which was later confirmed.
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VGF has antidepressant-like actions in rodents (Hunsberger et al., 2007, Thakker-Varia
et al., 2007; 2010). For the last two decades, this VGF peptide is getting more
importance due to the unveiling of its role as an anti-depressant. VGF +/− mice exhibit
deficits in experimental paradigms of depression (Hunsberger et al., 2007). VGF mRNA
extensively co-localizes throughout the central nervous system (CNS) with mRNA
encoding brain derived neurotrophic factor (BDNF) and the BDNF receptor, TrkB
(Snyder et al., 1997),  suggesting that VGF could potentially mediate some of the
behavioral and electrophysiological actions ascribed to BDNF signalling. BDNF is a
central player in the “adult neurogenesis theory of depression” (Gilhooley et al., 2010).
Recently, using a proteomic approach, VGF was found to be one of the proteins whose
expression more conspicuously decreased as a result of ShRNA-based DISC1
(Disrupted-in-schizophrenia 1, one of the very few genes directly correlated with
psychiatric illness and was co-segregated with schizophrenia, bipolar disorder and major
depression in a large Scottish pedigree (Chubb et al.,  2008) silencing in human SH-
SY5Y neuroblastoma cells. Subsequently, this result was confirmed by means of
Western blot analysis in the same cells and in ShRNA-silenced murine primary neurons
(Ramos et al., 2014).  In this context, the finding that silencing of DISC1 causes a
marked decrease of expression of VGF, a protein that is so critically involved in
depression, bipolar disorder, and schizophrenia, is of particular relevance. Further, a
recent study found that NPAS3, a transcription factor that is a replicated genetic risk
factor for psychiatric disorders, regulates VGF (Sha et al., 2012). Therefore, three
independent proteins with strong associations with mental disease, DISC1, NPAS3 and
BDNF, seem to have VGF as a downstream effector, making VGF, and more
specifically, the putative receptor of VGF-derived peptides, a very attractive target of
pharmacological intervention to develop new drugs effective in the treatment of mental
diseases. Though till to date, VGF derived peptide TLQP-62 (Lin et al., 2014; Bozdagi
et al., 2008) has been found to be linked up with mental depression, etc., not TLQP-21.
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Regulation of sexual function:
In consistent with both male and female infertility observed in VGF knockout mice
(Hahm et al., 1999; 2002), following repeated administration of TLQP-21 on adolescent
males with chronic food deprivation the gonadotrophin response of hypothalamic-
pituitary-gonadal axis was reduced. However, in case of properly nourishley fed mice,
only puberty onset was late (Pinilla et al., 2011). Other VGF derived peptides namely
AQEE-11, LQEQ-19, AQEE-30 and HHPD-41were found to facilitate penile erection
capability in rats via the mechanism of nitric oxide production in the paraventricular
nucleus (PVN) followed by the activation of PVN oxytocinergic neurons (Succu et al.,
2004; 2005).
Regulation of body fluid homeostasis:
With the aid of immunogold electron microscopy, neuroendocrine regulatory peptides
(NERPs) colocalization was confirmed with vasopressin in storage granules (Toshinai
and Nakazato, 2009). VGF mRNA in rats was found to be upregulated as a consequence
of water deprivation, in consistent with the upregulation of the vasopressin mRNA. VGF
mRNA was also increased with vasopressin mRNA level following salt inoculation into
the brain of rats (Mahata, et al., 1993).  Icv inoculation of hypertonic NaCl stimulated
vasopressin release while inoculation with NERP-1 and 2 inhibited the NaCl induced
vasopressin release. Moreover, NERP antibodies were found to reduce plasma
vasopressin following water loading (Yamaguchi et al., 2007). All these data including
in vivo and immunocytochemical observations suggest the possible roles of VGF
derived peptides, NERPs in modulation of the central body fluid balance.
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Role of VGF as neuroprotective agent:
TLQP-21 was found to protect the cerebellar granule cells (CGCs) dose-dependently in
rats which (CGCs) were supposed to go through cell death due the serum and potassium
deprivation via the  modulation of extracellular signal-regulated kinase1/2, ERK1/2 and
by the enhancement of intracellular  Ca2+ release (Severini, C. et al, 2008). SUN N8075,
an inducer of VGF mRNA, protected cells from ER stress induced cell death. But its
protective mechanism was entirely diminished by VGF knockdown with siRNA
validating that the protective effect of SUN N8075 is mediated by VGF.  VGF level was
found to be lower in the spinal cords of sporadic ALS patients. This inducer was also
found to slow the disease progress in the mutant SOD1 animal models of familial ALS
and thus elongating the survival of the animals (Shimazawa et al., 2010). From all these
findings, the involvement of SUN N8075/ VGF, either unconnectedly or concurrently, in
progression of ALS can be speculated, and either or both of them may become a
potential therapeutic candidate for treatment of ALS.
VGF derived peptides as diagnostic tools and/or targets in drug discovery:
It has already become evident that VGF derived peptides are produced at altered levels
in different disease conditions. VGF expression is down regulated in the brains of
rodents subjected to animal depression paradigms (Thakker-Varia et al., 2007). VGF is
also reduced in postmortem brain of patients with bipolar disorder and contributes to
some of the behavioral and molecular effects of lithium, the canonical drug used to treat
this disorder (Thakker-Varia et al., 2010).
Data referring to expression of VGF in schizophrenia are conflicting: one study reported
increased VGF expression in prefrontal cortex of four brains from schizophrenic
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patients, and an increased concentration of in CSF of a 40-amino acid VGF-derived
peptide, VGF 23–62, in CSF of first-onset, drug-naive schizophrenia patients and, to a
lesser degree, in patients with depression. Interestingly, a VGF 26–62 peptide with an
identical sequence to the VGF 23–62 peptide, except for the first three amino amino-
terminal amino acids, did not appear to be differentially expressed in CSF from
schizophrenia or depression patients compared to healthy volunteers, in the same study
(Huang et al. 2006). On the other hand, results from the Stanley Medical Research
Institute Genomics Database showed decreased VGF in prefrontal cortices of
schizophrenia and bipolar disorder patients (Thakker-Varia et al., 2010). More recently,
a reduced density of hypothalamic VGF-immunoreactive neurons was detected in post-
mortem brains from patients with schizophrenia as compared to control subjects (Busse
et al., 2012). All these strongly suggest that VGF does play an important role in the
development of schizophrenia.
Like schizophrenia, VGF derived peptides are also related to some other diseases as
summarized in Table 3.
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Table 3: VGF derived peptides linked to diseases in humans and animals, at a
glance. (Bartolomucci et al., 2010).
The number of diseases for which VGF-derived peptides have already been proved or
are being investigated to act as disease biomarkers are increasing day by day. Some of
them are namely  breast cancer, gastroenteric tumors, insulinoma, lung tumors,
medullary thyroid carcinoma, neuroblastoma, ganglioneuroma, parathyroid adenoma,
pheochromocytoma, pituitary carcinoma, fronto-temporal dementia (FTD),
schizophrenia (SCZ), major depressive disorder (MDD), alzheimer’s disease (AD),
Amyotrophic lateral sclerosis (ALS) (Bartolomucci et al., 2011). Though the number of
experimental proofs are increasing day by day to recommend VGF derived peptides for
widespread clinical use, not yet enough data confirmed the clinical utility of the VGF
derived peptides as ‘surrogate endpoints’ for diseases, especially for life threatening,
extensively prevalent neurological, psychriatic disorders (Bartolomucci et al., 2010). It
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should be noted that it took forty five years for the first granin protein, chromogranin A
(CgA) to be used as a biomarker for neuroendocrine tumors (Harsha et al., 2009).
Future perspective:
Biological activities of a number of VGF derived peptides as well as their diverse tissue
specific distribution and their corresponding multi-functional roles have already been
elucidated with experimental evidences, as described earlier. What is now left and of
upmost important in the field of VGF is complete elucidation of physiologically
important receptors/binding proteins/partners with further characterization of receptor-
dependent and/or receptor-independent signaling pathways.
Significance of TLQP-21 as a bioactive VGF derived peptide:
Out of several bioactive peptides derived from VGF, TLQP-21 is of great importance
because of its many physiological roles, some of which have already been mentioned in
the previous sections in which a general overview of VGF was provided. In the
following sections, the specific significance of TLQP-21 will be discussed. Thus, TLQP-
21 plays a key role  in energy expenditure (Possenti et al., 2012; Jethwa et al., 2007;
Bartolomucci et al., 2006), metabolic functions (Bartolomucci et al., 2008), lipolysis
(Possenti et al., 2012), glucose-stimulated insulin secretion (GSIS) ( Stephens et al.,
2012), nociception (Fairbanks et al., 2014; Chen et al., 2013; Rizzi et al., 2008), blood
pressure/hypertension regulation  (Fargali et al., 2014), gastric contractility (Severini et
al., 2009; Bartolomucci et al., 2008),  regulation of gastric acid secretion ( Sibilia et al.,
2012; Sibilia et al., 2010a; 2010b) reproduction (Aguilar et al., 2013; Pinilla et al.,
2011), stress (Razzoli  et al., 2012, Bartolomucci et al., 2011), neuroprotective agent
(Severini et al., 2008), anorexia ( Bartolomucci et al., 2006; Jethwa et al., 2007).
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TLQP-21 was the first identified VGF-derived peptide involved in energy homeostasis
(though the first identified VGF-derived peptide was AQEE-30 (Liu et al., 1994) which
added a new aspect to the study of energy homeostasis and nutrigenomics (Kaput et al,
2006; Bartolomucci et al., 2007) as previously several findings identified some other
different genes contributing in energy homeostasis (Cederberg et al., 2001; Obici et al.,
2003; Riu et al., 2003; Zhang et al., 2005; Netea et al., 2006).
Growing biological significant effects of TLQP-21 has reached momentum:
TLQP-21: Feeding, energy balance, obesity and lypolysis:
TLQP-21 increased energy expenditure (as mentioned earlier) along with elevation of
rectal temperature, serum epinephrine but with decrease of norepinephrine levels
accompanied by no fluctuation in the level of free T3 and free T4 serum levels , in
addition, no change was evident in locomotor activity (Bartolomucci et al., 2006; 2009).
Moreover, catabolic markers like peroxisome proliferator-activated receptor δ, β-3
adrenergic receptor and uncoupling protein 1 (UCP1) mRNA in white adipose tissue
(WAT) were upregulated by TLQP-21 while hypothalamic mRNA encoded
metabolically active hypothalamic  peptides and hematological biomarkers were
unchanged (Bartolomucci et al., 2006; 2007). TLQP-21 was found to increase FFA/TG
(free fatty acids/ triglycerides) ratio as TLQP-21 down regulated the level of TG keeping
FFA consistent. Glucose level after TLQP-21 treatment was found unaffected while
there was non-significant reduction of leptin level and WAT (Bartolomucci et al., 2007).
Jethwa et al., 2007 also validated the similiar findings like Bartolomucci et al., 2006;
2007; 2009 confirming that TLQP-21 confers catabolic effects decreasing bodyweight
and adipose fat mass. To sum up, the effects of TLQP-21 on energy balance has been
characterized but receptor mediated TLQP-21 effects have not yet been well
characterized, and findings on the mechanism of action of TLQP-21 in this regard is yet
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to be clarified (Cassina et al., 2013). However, it has been validated that TLQP-21
induced energy expenditure  follows the same mechanism of action of CNS constitutive
COX-2 (cyclooxygenase-2) stimulation and gastric PG (prostaglandin) production
(Sibilia et al., 2010b) : the effect of TLQP-21 induced gastric fundus strips contraction
was prevented by COX inhibitors, indomethacine and naproxen and by PG receptor
antagonists, PGF2 dimethyl-amide and SC-19220.  Presence of PGs (PGF2α, PGD2 and
PG E2) were additionally confirmed in the medium after incubation of rat fundus
dissections and TLQP-21. PGs, specially, PG E2 has been found to induce energy
expenditure (Amir and Schiavetto, 1990; Heleniak and Aston, 1989; Konsman et al.,
2002). β-adrenergic (AR) stimulation also controls energy expenditure (Jimenez et al.,
2002; Larsen et al., 2002; Bachman  et al., 2002). In consistent with the β-adrenergic
(AR)  controlled energy expenditure,  β-2 AR expression in brown adipose tissue (BAT)
and  β-3 AR in white adipose tissue (WAT) were increased by  TLQP-21 (Bartolomucci
et al., 2007).  TLQP-21 induced upregulation of PPAR-δ expression (Bartolomucci et
al., 2007) also contributes in energy expenditure by fatty acid oxidation and energy
uncoupling in WAT (Wang et al., 2003; Evans et al., 2004; Cannon and Nedegaard.,
2004). Overall, TLQP-21 increses energy expenditure through the induction of central
PG, peripheral adrenomedullary activities and catabolic activities of adipose tissue.
Accordingly, by virtue of these effects of the peptide (as mentioned above), it also
controls weight gain, obesity and lipolysis (see below), given that all the effects relating
to energy balance and obesity were found in rodents using TLQP-21 of rodent version.
Due to the increasing spread of obesity problem, especially in industrialized countries
(Cassina et al., 2013), the role of  TLQP-21 in preventing obesity (Jethwa et al., 2007;
Bartolomucci et al., 2006) and decreasing adipocyte diameter (Possenti et al., 2012) is
getting utmost importance.  In highly fed TLQP-21 mice, serum leptin increased while
ghrelin was found to decrease along with keeping endocrine biomarkers steady
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(Bartolomucci et al., 2007).  TLQP-21-induced increase of energy expenditure,
temperature and adipose tissue catabolic mediators is compatible with the preventing of
obesity and adiposity (Lowell and Spiegelman, 2000; Lowell and Flier, 1997; Schwartz
et al., 2000). TLQP-21 induced upregulation of β AR stimulation and PPAR-δ
expression (Bartolomucci et al., 2007) contributes in preventing obesity and fatty acid
oxidation (Wang et al., 2003; Evans et al., 2004; Cannon and Nedegaard, 2004). It has
been validated that TLQP-21 plays role in lypolysis (Hannedouche et al., 2013) , later
on, confirming it in 2014 by Cero et al. though the mechanism is yet to be more
clarified. To sum up, TLQP-21 confers its role in energy expenditure, obesity and
adiposity through the stimulation of autonomic nervous system by central PG induction,
peripheral adrenomedullary actions and catabolism of adipose tissue (Bartolomucci et
al., 2007).
Due to the identification of TLQP-21 as the first metabolically active VGF peptide
(Bartolomucci, et al., 2006), this peptide is now being considered as a key regulator of
energy balance, obesity and lypolysis. Key challenge is now ahead to clarify its
mechanisms of action in details targeting to develop metabolically active drugs.
TLQP-21: To modulate pain:
TLQP-21 is a modulatory peptide for pain (Fairbanks et al., 2014; Chen et al., 2013,
Rizzi et al., 2008). The role of this peptide in pain modulation was confirmed by
formalin tests in two phases: in the first phase, there is local response because of direct
chemical stimulation of nociceptors that lasts for 5-10 minutes following the formalin
injection. This early phase results in nociceptor activation suggesting that formalin
prompts actions in C-fibers, not in Aδ afferents (Porro and Cavazzuti 1993; Tjolsen et
al., 1992; Heapy et al., 1987). Later on, it has been shown that formalin provokes
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primary afferent sensory neurons through TRPA1 channels (McNamara et al., 2007).
The last phase continues for 30-60 minutes which starts after 15-20 minutes following
the injection of formalin. This phase is characterized by the inflammatory reaction in the
peripheral tissue and functional changes in the dorsal horn of the spinal cord.  The
functional changes seem to be initiated by the C-fiber activity of the early phase,
provoking the activity-dependent sensitization of the CNS neurons in the dorsal horn
(Tjolsen et al., 1992). As an effect of peripheral injection of TLQP-21, a remarkable
increase of pain-related licking response was observed while there was an analgesic
effect without pain following the icv injection of the peptide (Rizzi et al., 2008). All
these studies suggest that this peptide is involved in inflammatory pain in vivo and acts
differently at the peripheral and central levels of the nociceptive pathways : being
pronociceptive at the periphery and antinociceptive at the central level.
Other VGF derived peptides like LQEQ-19 induces hyperalgesia dose dependently
mediating by p38 MAPK phosphorylation in microglia cells in the spinal cord while SB
202190, the p38 MAPK phosphorylation inhibitor, was found to inhibit the induction of
hyperalgesia (Riedl et al., 2009). In addition, another VGF derived long peptide, TLQP-
62 also showed its role in pain modulation (Moss et al., 2008). Interestingly, TLQP-62 is
composed of both TLQP-21 and LQEQ-19 suggesting that  VGF derived these peptides
have direct effects as well as may interact each other to induce more (synergistic) or less
(antagonistic) effect simultaneously or when undergo differential proteolytic cleavage
(Trani et al., 2002; Seidah and Chretien, 1999).
Macrophages have been shown to be involved in neuropathic pain maintenance after
stimulation by TLQP-21, additionally downstream signaling following the TLQP-21
treatment may control chronic pain (Chen et al., 2013). Chen et al., 2013 also confirmed
TLQP-21 stimulated upregulation of intracellular Ca2+ in macrophages inducing nitric
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oxide and TNF-α synthesis (Brown et al., 2004; Korhonen et al., 2001). Xiao et al., 2001
showed IL-8 (interleukin-8) expression through MAP kinase pathways. Following nerve
injury, plenty of macrophages (Mueller et al., 2001) and monocytes flow at the injured
site (Abbadie et al., 2003) that was already evident while reduction of macrophages was
shown to  result in the reduction of mechanical hypersensitivity following  nerve  injury
(Liu et al., 2000) and delayed onset of pain in diabetic condition (Mert et al., 2009).
Pap/Reg2, the macrophage chemoattractants were found to increase in the rat models of
neuropathic pain (Maratou et al., 2009). All these data suggest that TLQP-21 induced
macrophage stimulation may influence the process of synthesis and secretion of some
cytokines possibly following MAP kinase pathway, in order to modulate pain.
Recently, Fairbanks et al., 2014 illustrated the effects of the peptide TLQP-21 in spinal
mechanisms of continuous pain: TLQP-21 induced dose-dependent thermal hyperalgesia
was inhibited by a p38 mitogen-activated protein kinase inhibitor, as well as inhibitors of
cyclooxygenase (COX) and lipoxygenase. Moreover, intradermal injection with
complete Freund adjuvant, intrathecal treatment with anti-TLQP-21 immediately prior to
or 5 hours after induction of inflammation inhibited tactile hypersensitivity and thermal
hyperalgesia in a dose dependent manner. These results provide credence that TLQP-21
peptide contributes to the mode of action of spinal neuroplasticity after inflammation
and nerve injury (Fairbanks et al., 2014).
Overall, in vivo data suggest that TLQP-21 is a modulator in pain that acts at the
peripheral and central levels of the nociceptive pathways (Rizzi et al., 2008), possibly
via the interaction of TLQP-21 with microglia: either by direct actions of TLQP-21-
activated microglia on neurons or microglia mediate activity of other cells like glia,
including astrocytes, as well as other immune cells. However, there is a possibility that
the mechanisms of action of TLQP-21 for pain modulation is yet to be unveiled (Ayub,
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2012). But till now, there is growing data confirming the involvement of TLQP-21 in
pain modulation, now urge to further elucidate the molecular mechanisms of action of
the peptide on different cells, specially dorsal root ganglion (DRG) neurons and
microglia, in the PNS and CNS that are involved in the pathway of pain modulation in
order to confirm the target of TLQP-21 as a drug/novel analgesics/hyperalgesics for the
treatment of pain.
TLQP-21: Gastrointestinal function:
TLQP-21 confers potential roles in gastroenteric function of rat (Bartolomucci et al.,
2008).  In vivo and ex vivo experiments confirmed that TLQP-21 treatment provoked
the contraction of gastric fundus strips, though it failed to induce contraction of stomach
antrum or more distal gut portions like jejunum and ileum. PG E2 and PG F2α were
synthesized and secreted from the mucosal layer while  due to the pretreatment with PG
antagonists and  the COX (cyclooxygenase) inhibitors : indomethacin and naproxen, the
fundus strip contraction was diminished (Severini et al., 2009;  Sibilia et al., 2010b). In
support of the involvement of TLQP-21 in the outflow pathway from CNS to
gastrointestinal tract, acute icv, not ip or iv, administration of the peptide reduced
ethanol-induced gastric lesions (Sibilia et al., 2010a) and repressed gastric emptying in a
time and dose dependent manner (Severini et al., 2009).  A significant upregulation in
the expression of gastric PG E2 and COX1 was found as the resultant effect of the
TLQP-21 induced gastroprotective effect. Treatment with NG-nitro-L-arginine methyl
ester (nitric oxide synthase inhibitor) and indomethacin (COX inhibitor) diminished the
activity of TLQP-21 induced gastroprotection, gastric emptying (Severini et al., 2009),
gastric acid secretion (Sibilia 2010b). To sum up, both in vivo and in vitro, the peptide
exerts its gastrointestinal effect via PG-dependent mechanism: in vivo, the peptide
showed a central inhibitory role on gastric emptying, involving PG release while in
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vitro, TLQP-21 stimulated contraction of the rat longitudinal forestomach (RLF) strip
through the discharge of PGs within the mucosal layer of the cells. Further studies are
now required to validate the downstream effectors contributing to the biological activity
of TLQP-21 regarding gastrointestinal functions in vivo.
TLQP-21: Its role in reproduction:
Upon injection of several VGF derived peptides including TLQP-21 into the
hypothalamic Paraventricular Nucleus (PVN), the male erectile behavior was modulated
(Pinilla  et al., 2011)  via nitric oxide mediated excitation of an oxytocynergic pathway
(Succu et al., 2004; 2005). The nitric oxide synthase inhibitor, L-NG-nitro-L-arginine
methyl ester, the oxytocin receptor antagonist d-[CH (2)](5) Tyr(Me)-Orn(8)-vasotocin,
morphine and muscimol inhibited TLQP-21 induced penile erection partially (Succu et
al., 2004; 2005). TLQP-21 administration showed : acute gonadotrophin response
through stimulation of Gonadotrophin releasing hormone (GnRH), Leutinizing hormone
(LH) secretion from pubertal, not adult, male rat pituitary, human chorionic
gonadotrophin (hCG) induced testosterone secretion by adult testicular tissue. TLQP-21
administration on pubertal chronic undernourished males ameliorated the
hypogonadotrophic condition whereas in properly fed males it delayed the onset of
puberty. Thus Pinilla et al., 2011 for the first time by both in vivo and in vitro analyses
documented complex and multifaceted mechanisms of accomplishment of TLQP-21 at
different levels of the male hypothalamic-pituitary-gonadal (HPG) axis with
predominant stimulatory consequences, establishing a reasonable concrete base for the
direct reproductive function of TLQP-21.
All these findings are consistent with the reproductive phenotypes of VGF knockout
mice, characterized by delayed puberty, reduced fertility, decreased ovarian and uterus
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weights, and low mRNA levels and protein contents of LH and FSH (follicle-stimulating
hormone) β-subunits at the pituitary, strongly suggesting that the products of VGF,
including TLQP-21 are directly or indirectly involved in the control of the reproductive
events (Hahm et al., 2002; 1999).  Hence, VGF derived peptides like TLQP-21 could be
a target to be used in the stimulation/modulation of reproductive phenomena.
TLQP-21: Glucose metabolism and diabetes:
Stephens et al., 2012 showed that TLQP-21 is capable to potentiate glucose-stimulated
insulin secretion (GSIS) in isolated rat and human pancreatic islets. Consistently,
administration of TLQP-21 to Wistar rats upregulated the circulating insulin in response
to a glucose challenge, confirming the increase glucose tolerance. TLQP-21 induced
insulin secretion occurs in concert with an upregulation of cAMP, indicating that the
effect of TLQP-21 is mediated by downstream targets of activated PKA, as with other
cAMP-raising agents such as glucagon-like peptide-1 (GLP-1), glucose-dependent
insulinotropic polypeptide (GIP), and vasoactive intestinal peptide (VIP). A role for
PKA (protein kinase A) in the TLQP-21 signaling pathway is supported by the finding
that inhibition of PKA blocks the ability of TLQP-21 to suppress thapsigargin-induced
islet cell death. Unlike GLP-1, TLQP-21 does not hamper gastric emptying or boost up
heart rate. Taken together all these findings, TLQP-21 is a targeted agent for uplifting of
islet β-cell survival period of time and functionality, ultimately for the
treatment/improvement of diabetes (Stephens et al., 2012).
Receptor(s) for human vs rodent TLQP-21:
For the last two decades the effects of TLQP-21 have been demonstrated and
characterized but till now, not enough has been elucidated about its molecular
mechanism in physiological system. Being one of the bioactive peptides of VGF, the
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elucidation of the biological activity of the peptide is under investigation but there is
lacking of the informations on the receptor-dependent or receptor independent signaling
pathways.
TLQP-21 was found to bind to adipocyte membranes, expressing stimulatory pro-
lypolytic effect (Possenti et al., 2012) and unique binding sites of TLQP-21 were
revealed on living Chinese hamster ovary (CHO) cell lines with the aid of atomic force
microcopy (AFM) (Cassina et al., 2013) but there was little information about the
mechanisms of action of the peptide as well as about putative receptor that mediate the
TLQP-21 effects, as mentioned earlier. Very recently, complement component-3a
receptor 1 (C3AR1) (Cero et al., 2014; Hannedouche et al., 2013), and globular head of
the complement component C1q receptor (gC1qR) (Chen et al., 2013) have been
identified as receptors of murine TLQP-21.
C3AR1 as a receptor of rodent TLQP-21:
C3AR1 is a G protein-coupled receptor protein that binds both C3a (complement
component-3a) and C4a (complement component-4a) though its official name implies
that it only binds C3a (Klos et al., 2013).  Before discovery of its role as a receptor of
rodent TLQP-21, its activity was thought to be involved in innate immune system
showing roles in the complement system. But its roles are not limited only to
complement system, its roles also found in neurogenesis (Klos et al., 2013), cancer
(Opstal-van Winden et al., 2012) and hormone release from pituitary gland (Francis et
al., 2003).  Moreover, C3AR1 knockout mice were found to be resistant to diet-induced
obesity and high fat diet induced insulin suggesting its role in metabolism (Mamane et
al., 2009).
Hannedouche et al. 2013 conducted studies on signaling activity in rodent cell lines,
CHO-K1 and O-342, that led to the discovery of its cognate receptor C3AR1. CHO-K1
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cells responded to TLQP-21 showing increase in intracellular calcium (Cassina et al.,
2013) though ATP priming was necessary to get a vigorous signal suggesting that the
expected TLQP-21 receptor is not Gq- coupled GPCR (G-protein coupled receptor).
cAMP or Inositol phosphates accumulation was not found in TLQP-21-induced
signaling events in CHO-K1 cell line. Moreover, increase in intracellular calcium influx
induced by TLQP-21 treatment was blocked by pertussis toxin (PTX).  The authors
therefore concluded that it was highly likely that the G-protein mediated effects were to
be G0 due to all the findings regarding PTX sensitivity and lack of cAMP modulation.
Subsequently, RNA sequencing was carried on both TLQP-21 responsive, CHO-K1 and
TLQP-21 non-responsive, CCL39 cell line in order to have more informations on the
molecular mechanisms of TLQP-21 induced actions. A total of 21 GPCRs were
identified after unbiased genome-wide sequencing of the transcriptome that were
speculated to bring about TLQP-21 mediated biological activity, considering that
GPCRs expression would be more in CHO-K1 than CCL39 cell line.
To confirm the identity of GPCR of TLQP-21, a panel of antagonists were used to
inhibit the peptide response in CHO-K1 cell line. Out of the well characterized
antagonists, SB290157 was proved as the most potential antagonist which was a C3AR1
antagonist (Ames et al., 2001). In another TLQP-21 responsive cell line O-342, the
antagonist SB290157 was tested to confirm that this cell line would express the
homologous receptor like CHO-K1 that was further confirmed by qRT-PCR showing
that O-342 cells express the C3AR1.
To further validate C3AR1 as a receptor of TLQP-21, siRNA screening was performed.
A total 63 siRNAs were tested against all the 21 genes that were confirmed by the
transcriptomic analysis earlier. The only gene knockdown was found to reduce the
TLQP-21 mediated response consistently was siRNAs against C3AR1. Thus, C3AR1
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was confirmed as a potential receptor for TLQP-21 in rodents using defined receptor
antagonist and siRNA techniques.
However, this finding was not translatable to the human receptor. For example, the
authors tried to show the TLQP-21 signaling in HEK293 cells expressing the human
C3AR1 but failed whereas in hamster and rat C3AR1, it was successful. This might be
due to the fact that human TLQP-21 is remarkably different than rodent version
(Hannedouche et al. 2013) (see below, in details, about the difference between human
and rodent version of the peptide).  All these studies led the authors to conclude that
there might be a receptor other than C3AR1 for human TLQP-21.
Later on, Cero et al., 2014 confirmed C3AR1 as a receptor of TLQP-21. By
photoactivated crosslinking, the peptide was found to bind to a ~56 kDa (equivalent to
molecular weight of C3AR1) protein in 3T3L1 and CHO cell lines. The same binding
experiment was performed using SB290157, a C3AR1 antagonist (Ames et al., 2001)
and the binding was found reduced in presence of the antagonist suggesting that
SB290157 competes with C3AR1 for binding with TLQP-21. Furthermore, β-arrestin
recruitment assay in HTLA cells transfected with human C3AR1 (Lin et al., 2013) added
more credence to the interaction of TLQP-21 and C3AR1 as it demonstrated that TLQP-
21 acts as an agonist for the human C3AR1: half maximal effective concentration (EC50)
for mouse TLQP-21 was about 3 times lower than that of C3A while the EC50 for human
TLQP-21 was about 22 times lower than that of C3A, suggesting that human and mouse
version of the peptide show activity toward human C3AR1 with different potency.
Further experiments were targeted to find out the hot spots for biological function in the
sequence of the peptide based on the bioassay for the peptide function of the contraction
of the stomach fundus strips (Severini et al., 2009).  The peptide showed ~69%
contraction promoted by acetylcholine at a dose of 3 µM of the peptide. Two truncated
TLQP-21 peptide fragments were used, TLQP-11 (the C-terminus sequences with the
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first 11 amino acids) and HFHH-10 (the N-terminus sequences with the latter 11 amino
acids) showing that TLQP-11 is completely inactive whereas HFHH-10 is modestly
active demonstrating 2.6 %, 62%, 75% response at a dose of the peptide 3, 6, 10 µM,
respectively while TLQP-11 showed zero response even at the dose of 10 µM). This
suggests that hot spots in the peptide responsible for biological activity lies in the C
termini, not in the N-termini. Accordingly, Ala scanning mutagenesis in the C-terminal
of the peptide was performed to observe the biological effect of the mutated peptide. It
was found that this mutation had no significant effects excepts P18A mutant, P19A and
R21A that showed biological activity 65%, 19%, nil, respectively. Amidation of the
capping of the C-terminal resulted in the complete loss of biological activity. Notably, in
this experiment human TlQP-21 showed 20% response while rodent version of the
peptide showed 100% activity as expected suggesting that human peptide shows five
times less biological activity to the rodent receptor compared to the rodent version of the
peptide (Cero et al., 2014). Moreover, C3AR1 has been confirmed as a receptor of
TLQP-21 pointing out the folding-upon-binding Mechanism : TLQP-21 is intrinsically
disordered but upon binding with its receptor C3AR1, it goes from disordered to ordered
shift adopting α- helical conformations (Cero et al., 2014) in consistent with a molecular
dynamics study exploring that the peptide is not absolutely random coil but it also
possesses stretches of distinct structural region that adopts a very much compact
globular structure stabilized by π-cationic interactions and  several hydrogen bonding
interactions, finally validating that the peptide exhibits very flexibility in solution and
that three C-terminal residues, P19-R21, and the region A7-R9 shows  strong helical
tendency (Chakraborty et al., 2015).
In fact, the study by Cero et al., 2014 supplemented the finding of Hannedouche et al.
2013 that there is possibly a receptor other than C3AR1 in humans, as human TLQP-21
is different from its rodent version sequence by four amino acids (Bartolomucci et al.,
2011), highlighting the dissimilar biological function of human and rodent TLQP-
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21(Cero et al., 2014), as described earlier.  Cero et al. 2014 suggested that this finding
might be connected with  the human susceptibility to obesity due to less potency of
human TLQP-21 toward receptor C3AR1 resulting in less lipolysis of adipocytes
(Possenti et al., 2012). This could be one of the reasons of being more susceptible to
obesity by human than other species (Cero et al., 2014).
All in all, considering all potential functions of TLQP-21 (as illustrated earlier), there
should be another receptor in humans to which human version of the peptide will bind
and potentiate 100% biological activity.
gC1qR as a receptor of rodent TLQP-21:
The globular head of the complement component C1q receptor, gC1qR,  also known as
C1QBP, TAP, HABP1, p33 and p32, is a multiligand binding and ubiquitously expressed
protein. It is found in mitochondria (Dedio et al., 1998), nuleaus, endoplasmic
reticulum(ER)( Petersen-Mahrt et al., 1999), cytosol(Peterson et al., 1997) and cell
surface(Peerschke and Ghebrehiwet, 2007): interacting with a variety of ligands of
cellular, bacterial and viral origin (Peerschke et al., 2006; Ghebrehiwet et al., 1996; Xu
et al., 1999). It has been observed to play important role in carcinogenesis (Ghebrehiwet
et al., 2001), bacterial and viral infections (Ghebrehiwet and Peerschke, 2004), immune
cell modulation and complement activation (Peerschke et al., 2006), adipogenesis (Kim
et al., 2009) and pain modulation (Chen et al., 2013). Recently, it has been validated as a
receptor of murine TLQP-21 highlighting its role in pain modulation (Chen et al., 2013).
In order to search for the receptor, Chen et al., 2013 used chemical cross-linking, affinity
chromatography followed by mass spectrometry analysis: a heterobifunctional
crosslinker, Sulfo-EMCS was conjugated with biotinylated TLQP-21 followed by cross-
linking reaction between  this peptide and membrane proteins obtained from whole brain
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and spinal cord of  6 weeks old female Wistar rat.  A ~30 kDa protein was detected by
Western blot, probing with HRP-conjugated Streptavidin, from the sample obtained after
cross-linking reaction. Further experiment was performed by attaching the peptide to
avidin monomeric column followed by incubation with three types of membrane protein
fractions of post-natal day 4 rat forebrain: whole cell lysate, cytosolic and membrane &
associated protein fractions. The elutants were analysed by silver-staining showing ~30
kDa protein which was identified as gC1qR after nanoLC-MS/MS analysis.
Further experiments showed that electroporation of siRNAs against gC1qR remarkably
lowered the gC1qR level in macrophages. The siRNAs also reduced the quantity of
macrophages responding to the peptide observed in live cell Ca2+ imaging. A
considerable reduction of the response to the peptide was evident after incubation of
macrophages with neutralizing gC1qR monoclonal antibodies. Furthermore, to elucidate
the role of gC1qR in pain modulation, the following experiment was performed using
gC1qR antibody :  the gC1qR antibody was applied to the site of  the nerve ligation of
partial sciatic nerve ligation (PSNL) model rats that resulted in the drop of punctuate
mechanical threshold. Again, the gC1qR antibody application caused delay of the
inception of the hypersensitivity linked with PSNL (Chen et al., 2013). All these results
validate the gC1qR as a receptor that activates macrophages in response to TLQP-21,
playing a crucial role in pain modulation.
It was proposed by Chen et al., 2013 that both receptors, gC1qR and C3AR1 functions in
response to TLQP-21, either simultaneously or sequentially as it has not yet been
disclosed that whether the receptors interact each other or not, in response to the peptide.
However, the functional and structural similarity between gC1qR and the peptide TLQP-
21 is apparently absent (Gaboriaud et al., 2003).  Moreover, the possibility of the
existence of the second receptor, in addition to C3AR1, in CHO or 3T3L1 cells is not
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supported by the recent and previous works (Cero et al., 2014; Hannedouche et al., 2013;
Cassina et al., 2013; Possenti et al., 2012).
All these studies confirm the existence of cell surface membrane receptor of TLQP-21 in
rodents. It is noteworthy that almost all of these works with TLQP-21 were performed
with rat/mouse TLQP-21, except, so far it has been known, very few works that were
performed by Hannedouche et al., 2013 and Cero, et al., 2014 with human TLQP-21;
provided that due to the difference in biological activities between human and rodent
TLQP-21 (as discussed earlier) (Cero et al., 2014) as well as due to the difference in
respect of the sequences between human (TLQPPSALRRRHYHHALPPSR) and rodent
version (TLQPPASSRRRHFHHALPPAR) of the peptide,  it is highly expected that
there is different receptor(s) for human as mentioned by Hannedouche et al., 2013.  No
doubt left, identification of the receptor of VGF-derived human peptide TLQP-21 will
offer a very interesting pharmacological target to develop drugs for the treatment not
only of obesity related disorders but also for improving the treatment for hypertension,
stress, reproduction and diabetes. In addition, it should help understand the molecular
mechanisms in human underlying these ailments.
Objective
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The objective of this study:
-To identify and characterize the receptor of VGF derived peptide human TLQP-
21.

Materials and methods
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TLQP-21:
TLQP-21(human,  molecular weight 2490.88 Da) and biotinlyted TLQP-21(human)
containing an extra cysteine residue at the C-terminus with total molecular weight
2820.32 Da, were purchased from ChinaPeptides Co. Ltd., Shanghai; peptide purity
>95%, confirmed by HPLC and MS analysis (Figure 24 and 25, respectively, Appendix
I). It was in the form of white lyophilized powder and stored at -21˚C immediately
upon arrival for short time storage and at -80 ˚C for long term storage, as per
instruction of the supplier. The peptide sequence is –
Biotin-TLQPPSALRRRHYHHALPPSR-C
Biotin-Thr - Leu - Gln - Pro - Pro - Ser - Ala - Leu - Arg - Arg - Arg - His - Tyr -
His - His - Ala - Leu - Pro - Pro - Ser – Arg- Cys
To prepare solutions of TLQP-21 and Biotin-TLQP-21-C, the lyophilized powder was
dissolved in filtered (0.22 µm, Millex, Merck Millipore Ltd.) PBS, used instantly or
was kept at -80 ˚C for long term storage. It should be noted here that in all the
experiments Biotin-TLQP-21-Cys was used except phosphoprotein gel staining and
proteomic study, where TLQP-21 was used.
SH-SY5Y cell culture:
SH-SY5Y (European Collection of Cell Cultures, ECACC; catalog number-94030304)
is a thrice cloned (SK-N-SH → SH-SY → SH-SY5 → SH-SY5Y) subline of the
neuroblastoma cell line SK-N-SH which was established in 1970 from a metastatic
bone tumor of a four year-old female with neuroblastoma (Biedler et al, 1973; 1978).
The cells were grown at 37 ˚C in a 5% CO2-humidified incubator on a culture medium
composed of 1:1 Earle’s Balanced Salt Solution (EBSS) (Sigma Aldrich) and F12
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HAM (Sigma Aldrich) supplemented with 15% fetal bovine serum (FBS) (Gibco), 1%
Glutamine (Gln) (Sigma Aldrich), 1% Non-Essential Amino Acids (NEAA) (Sigma
Aldrich), and 1% Penicilin-Streptomicin (P/S) (Invitrogen) in 100×20 mm Falcon Petri
dishes (Life Sciences). The cells were always used at less than 20 passages.
Petri dishes with confluent SH-SY5Y cells were washed twice with cold PBS, followed
by solubilization in lysis buffer, composed of 20 mM HEPES, 2mM EGTA, 1mM DTT,
1mM sodium orthovanadate, 1% Triton X-100, 10% Glycerol, 2µM leupeptin, 400 µM
PMSF, 50 µM β-glycerophosphate, 100 µg/ml trasylol. The cells were scrapped on ice
for 10 minutes and were incubated on ice for 30 minutes with periodic vortexing at each
5 minutes interval, followed by centrifugation for 20 minutes at 14000g at 4 ˚C. The
supernatant was saved for further use. Protein concentration was quantified using the
BCA protein assay kit (Pierce Chemical).
Detection of a TLQP-21 receptor in SH-SY5Y cells using biotinylated TLQP-21 as
a probe:
Peptide conjugation:
Sulfo-N-[ε-maleimidocaproyloxy]succinimide ester (sulfo-EMCS) cross-linkers are
moisture-sensitive. So, to avoid moisture condensation inside the container the vial was
equilibrated to room temperature. Dissolving in Conjugation buffer (PBS,0.1M sodium
phosphate, 0.15M NaCl, pH 7.2, Thermo Scientific), 1 mMSulfo-EMCS (Thermo
Scientific) solution was freshly prepared, to which 0.1 mMBiotin-TLQP-21 peptide
was added, making final volume 1 ml and incubation continued on ice for 2 hours. The
resultant conjugated peptide was then checked byMatrix Assisted Laser Desorption
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Ionization Time-of-Flight (MALDI-TOF) mass spectrometry (MS) and subsequently
was used for the crosslinking step.
MALDI-TOF mass spectrometry:
Sulfo-ECMS-conjugated peptides were identified using a 4800 MALDI-TOF/TOF
analyzer (Applied Biosystems).  Peptides were dissolved in 4 μL of 0.5% formic acid.
The same volumes (0.5 μL) of peptide and matrix solution, composed of 3 mg alpha-
cyano-4-hydroxycinnamic acid (α-CHCA) were dissolved in 1ml of 50% acetonitrile in
0.1% trifluoroacetic acid (TFA), then deposited using the thin layer method, onto a 384
Opti-TOF MALDI plate (Applied Biosystems). Mass spectrometric data were obtained
in an automated analysis loop. MS spectra were attained in reflectron positive-ion mode
with aNd:YAG, 355 nm wavelength laser, averaging 1000 laser shots and using at least
three trypsin autolysis peaks as internal calibration.
Crosslinking:
Followed by confirmation of the peptide conjugation, the cross linking reactions were
accomplished. For the crosslinking reaction, the resulting activated peptide solution (5
µl) was mixed with 5 µl of SH-SY5Y cell homogenate, equivalent to 10 µg of protein
(final activated peptide concentration, 10 µM) and allowed the reaction for 2 hours on
ice. To optimize the conditions, the cross linking reaction was also performed with
higher amount (50 and100 µg) of cell homogenate protein as well as with higher
amount (20 and 100 µM) of conjugated peptide. Finally, the reaction was terminated
adding 50 mMTris buffer (pH 8.0), containing primary amines reacting with
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unconjugated crosslinker, if any. As a control, cell homogenate, unconjugated Sulfo-
EMCS and conjugation buffer, without conjugated peptide were incubated. Then the
samples were subjected to SDS-PAGE and Western blot analysis.
SDS-PAGE and Western blot analysis:
All the samples obtained from crosslinking were boiled in 2xLaemmli sample buffer
(Bio-Rad)  for 10 minutes at 100 ˚C, spun, loaded and subjected to SDS-PAGE in a
12% gel. After electrophoresis (200V, 01h), proteins were transferred onto PVDF
(Polyvinylidene fluoride) membranes (Millipore, Bedford) in the condition of 0.8
mA/cm2 for 90 minutes using semi-dry method (Trans-blot SD semi-dry transfer cell,
Biorad). The PVDF membranes were then blocked with 5% BSA in TBS-T solution
(Tris-buffered saline with 0.1% Tween - 20) for 1 hour at room temperature, followed
by three washes with TBS-T solution each for 10 minutes. The membrane was then
probed by Pierce high sensitivity streptavidin- HRP (Thermo Scientific) at 1:20000
dilution in TBS-T. Then the PVDF membranes were washed 3 times with TBS-T for
10 minutes each wash, followed by incubation for 5 minutes with the
chemiluminescence solution Luminata Forte Western HRP substrate (Merck Millipore)
wrapping the PVDF membrane containing container to shield it from light, and finally
developed using, Hypercassette and Amershamhyperfilm (GE Healthcare).
Avidin agarose affinity chromatography:
The Pierce Monomeric Avidin Kit (Thermo) was used. It contains a monomeric avidin
column (2 ml prepacked column containing  monomeric avidin immobilized to 4%
beaded agarose, supplied as a 50% slurry (i.e., 4 ml of slurry equals 2 ml of settled
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resin); binding capacity is ≥1.2 mg biotinylated BSA/ml settled resin), Wash buffer-
BupHTMphosphate buffered saline (PBS) pack (equivalent to 0.1 M sodium phosphate,
0.15M NaCl, pH 7.2 when reconstituted with 500 ml of ultrapure water; to store buffer
for >1 week, preservative 0.02% sodium azide was added.), biotin blocking & elution
buffer (having 2 mM D -biotin in PBS),  regeneration buffer (contains 0.1M  glycine, pH
2.8).
The column has 2 porous discs: to produce a stop-flow action preventing resin from
drying when left unattended for short period and to stop automatically the solution flow
applied to column when the liquid level reaches the top disc. The monomeric avidin
resin can be regenerated at least 10 times with negligible loss in binding capability.
Upon receipt, all of the kit components were stored at 4˚C.
After equilibration of the necessary kit components to room temperature, the storage
solution of the column was drained out. The column was washed with 8 ml PBS
followed by addition of 6 ml biotin blocking & elution buffer (2 mM D-biotin in PBS) to
block any non-reversible biotin binding sites. Regeneration buffer (0.1M glycine, pH
2.8, 12 ml) was added to remove biotin from the reversible binding sites followed by
addition of 8 ml of PBS to wash the column again. The column was then ready to add
protein or peptide samples. Air bubbles introduced into column resin beds may impede
the flow of solutions column, so extra care was taken to prevent air bubbles to enter into
the resin by removal top column cap before bottom cap all the time.
To attach biotin-TLQP-21 to the column, 2 ml of solution consisting of 1 ml of 0.1 mM
biotin-TLQP-21, 900 µl of wash buffer and 100 µl of 1mM TCEP (to prevent biotin-
TLQP-21 peptides to form disulphide bonds due to the extra cysteine residues at their C-
termini) were applied to the column, which was incubated for an hour at room
temperature. The column was subsequently washed by 12 ml wash buffer, then the
column was ready to add SH-SY5Y cell homogenate.
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A 700 µl SH-SY5Y cell homogenates with a protein concentration of 10 µg/µl were
diluted into 1.3 ml wash buffer to make the total volume 2 ml, then applied to the
column already supposed to be attached with the biotin-TLQP21. The column was then
washed with 12 ml washing buffer followed by addition of 10 ml of elution buffer.
Fractions of 500 µl were collected and stored on ice until further use for analysis by
SYPRO® Ruby Protein Gel Stain (Lonza), and Western blot. As control, cell lysate
solution was added under the same conditions to a column without biotin-TLQP-21
attached, and processed under the described conditions.
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Box 1: Avidin affinity chromatography, at a glance.
To regenerate column after use, it was washed two times with 4 ml of regeneration
buffer to strip the column of residual bound biotin without losing the ability to bind
another biotinylated sample. For storage, column was washed with 5 ml of PBS
containing the preservative 0.01% sodium azide. A supplied white tip was placed on the
column and additional preservative-containing PBS was added above the top disc before
replacing the top cap. Finally, it was stored at 4°C for use next time.
The immobilized monomeric avidin protein bound biotin with
high specificity and moderate affinity, allowed non-biotin
molecules to be washed away and then the bound biotin-labeled
molecules were competitively eluted using 2mM biotin in
phosphate buffered saline (PBS) (biotin blocking and elution
buffer) and thus provided the gentlest elution conditions for
biotinylated protein purification, in more details : avidin with
strong binding features was immobilized in monomeric avidin
immobilization. These high affinity biotin-binding binding sites
were first blocked with biotin-containing buffer (biotin blocking
and elution buffer). Biotin molecules were eluted from
monomers with the glycine solution (regeneration buffer, pH
2.8) revealing the reversible binding sites. The biotinylated
specimens of interests were then applied for purification,
followed by elution through ligand competition using the biotin-
containing solution (biotin blocking and elution buffer)
(Strachan, et al, 2004). Thus, the monomeric avidin agarose
resin resulted in the high-binding capability with least
nonspecific binding and last of all, excellent recovery of
biotinylated molecules was performed.
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SDS-PAGE and SYPRO® Ruby Protein Gel Stain:
Samples (25 µl) from the different fractions eluted from Pierce monomeric avidin
agarose affinity chromatography were boiled in 2X Laemmli buffer (Bio-Rad) for 10
minutes at 100 ˚C, spun, and loaded to SDS-PAGE gel. After electrophoresis (200V,
01h), the gel was washed in dH2O for 10 minutes. Then the gel was incubated with
fixing solution (10% methanol, 7% acetic acid) for 1 hour at room temperature in an
orbital shaker step at 50 rpm, followed by overnight incubation with SYPRO® Ruby
Protein Gel Stain at room temperature with shaking.
The gel was then placed into a staining container covering with a lid to protect it from
the light, in addition, the container was wrapped in aluminium foil to further shield the
stain from light during the staining process, as per instruction of the supplier. After
overnight staining, the gel was transferred to a clean staining dish, washed with the
fixing solution in the same condition of staining followed by 5 minutes washing in
dH2O. Finally, the gel was taken from the container to take the image in a Molecular
Imager® Gel DocTM system (Bio Rad, Hercules) using the highest sensitivity of the CCD
camera at a resolution of 1392 x 1040 pixels with 12 bit gray scale levels per pixel.
Protein identification:
Following Pierce monomeric avidin agarose affinity chromatography, SDS-PAGE gel
run and SYPRO® Ruby Protein Gel Staining, the protein bands found (but not in the
control lane) were carefully excised from the gel using a clean, sterile razor blade in a
laminar flow hood to avoid dust and keratin contamination and, subjected to in-gel
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reduction, alkylation and trypsin digestion, according to the method of Shevchenko et
al., (2006). Extracted peptides were analysed by LC-MS/MS.
Digested peptide mixtures were dried in a centrifugal evaporator (Speedvac, Savant) and
dissolved in 0.1% formic acid followed by separation in an EASY-nLC (Proxeon,
Bruker Daltonik GmbH) with a reverse phase nanocolumn (Easy column SC200 C18
3μm 120A 360 μm OD/75μm ID, L=10cm) from Proxeon. Peptides were ionized and
examined in a Bruker Amazon ETD ion trap. Automated analysis of mass data was
performed by Data Analysis 4.0 and BioTools 3.2 from Bruker Daltonik GmbH.
Database search was done with the Mascotv2.3 search tool (Matrix Science, London,
UK) screening SwissProt (release 57.15). Searches were limited to human taxonomy
permitting carbamidomethyl cysteine as a fixed modification and oxidized methionine as
potential variable modification.  Both the precursor mass tolerance and the MS/MS
tolerance were fixed at 0.3 and 0.4 Da, respectively, with 1 missed tryptic cleavage site.
All spectra and database results were scrutinized manually in details using the above
software, especially in the case of identifications based on one peptide hit. Positive
identification by MS was only accepted when more than 50% y-ions were obtained for a
peptide comprising at least eight amino acids long and no missed tryptic cleavage site.
Positive hits corresponded to Mascot scores > 40 plus the fulfillment of the above
criteria.
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Western blot analysis of the samples obtained from monomeric avidin experiment:
As per standard protocol for Western blot analysis, samples (25 µl) obtained from
monomeric avidin experiment were boiled in 2X Laemmli sample buffer (Bio-Rad) for
10 minutes at 100 ˚C, loaded to SDS-PAGE gel. After electrophoresis (200V, 01h),
proteins were transferred onto Polyvinylidene fluoride (PVDF) membrane (Millipore,
Bedford, MA) in the condition of 0.8 mA/cm2 for 90 minutes using semi-dry method
(Trans-blot SD semi-dry transfer cell, Biorad). The  PVDF membrane was then
blocked by 5% BSA (Bovine Serum Albumin) in TBS-T solution (Tris-buffered saline
with 0.1% tween 20) for 01 hour at room temperature, followed by three washes by
TBS-T each for 10 minutes and then, the membranes were probed by Anti-Hsc
70/HSPA8 (Abcam) antibody at 1:500 dilution in TBS-T. Then the PVDF membrane
was washed 3 times with TBS-T for 10 minutes each wash, followed by incubation
with the secondary Anti-rabbit antibody (Dako) at 1 : 2000 dilution in TBS-T. The
membrane was washed 3 times with TBS-T for 10 minutes each wash.  Subsequently,
the membrane was incubated with chemiluminescence solution Luminata Forte
Western HRP substrate (Merck Millipore) for 5 minutes covering the membrane
containing container to protect it from light and was developed using Hypercassette
and Amershamhyperfilm (GE Healthcare).
Additionally, the same PVDF membrane was stripped by incubation in Restore Plus
Western Blot Stripping Buffer (Thermo Scientific) as per instruction of the supplier
and finally was probed with Anti-C3AR1 antibody(Sigma-Aldrich) at a 1:200 dilution,
followed by incubation with anti-mouse secondary antibody (GE Healthcare, UK) at a
1:5000 dilution. But it could not recognize any protein in the membrane, concluding
that it is not C3AR1 protein.
Materials and methods
79
Crosslinking of biotinylated TLQP-21 to SH-SY5Y surface membrane proteins:
SH-SY5Y cells were grown as described above. Culture medium from the Petri dishes
with confluent SH-SY5Y cells were removed followed by washing three times with
PBS. Subsequently, the dishes were incubated with 10 ml of PBS containing 1 mM
Sulfo-EMCS and 0.1 mM biotin-TLQP-21 for 30 minutes at room temperature. The
cross-linking reaction was stopped adding Tris-HCl, pH 7.8 to a final concentration
50mM. Cells were then harvested as described above. Briefly, Petri dishes were
washed twice with cold PBS, then solubilization in lysis buffer( 20 mM HEPES, 2mM
EGTA, 1mM DTT, 1mM sodium orthovanadate, 1% Triton X-100, 10% Glycerol,
2µM leupectine, 400 µM PMSF, 50 µM β-glycerophosphate, 100 µg/ml trasylol). The
cells were scrapped on ice for 10 minutes and were incubated on ice for 30 minutes
with vortexing at each 5 minutes interval, finally centrifuged for 20 minutes at 14000 g
at 4 ˚C. The supernatant was collected for the next step use and the pellet was
discarded.
The Pierce monomeric avidin agarose affinity chromatography kit components were
equilibrated to room temperature. The column was extensively washed with 8 ml PBS,
then added 6 ml biotin blocking & elution buffer to block any non-reversible biotin
binding sites. Regeneration buffer (12 ml) was added to remove biotin from the
reversible binding sites followed by washing again with 8 ml of PBS. Thus the column
was prepared to add solubilized biotinylated SH-SY5Y membrane protein samples.
Two ml of solubilized biotinylated SH-SY5Y membrane proteins were applied to the
Pierce avidin-agarose affinity column. The column was then washed with 12 ml washing
buffer and eluted with 10 ml of elution buffer.  Fractions of 500 µl were collected and
stored on ice and subsequently subjected to SDS-PAGE and Western blotting as
described above.
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Fluorescence-activated cell sorting (FACS) analysis:
To further confirm binding of TLQP-21 to the surface of viable SH-SY5Y cells, FACS
analysis was performed. Adherently growing SH-SY5Y cells were washed with room
temperature PBS. Then for detachment from the bottom of the Petri dish, cells were
incubated with 1.5 ml of 0.05% Trypsin/EDTA solution (1×Gibco, Life Technologies) at
37 ˚C with 5% CO2 for 2-5 minutes and finally cell detachment was empirically assessed
by visual inspection.  Subsequently, 1.5 ml of SH-SY5Y culture medium was added and
mixed gently by pipetting. Cells were taken in a Falcon tube and spun down at 1500 rpm
for 10 minutes. Cells were resuspended in PBS containing 1% BSA at a concentration of
0.5-2 × 106 cells/ml, as determined by counting using a FACSCalibur™ (Becton
Dickinson; San Jose).
Biotin-TLQP-21 (28, 10 or 5 µl of a 0.1 mM solution in filtered PBS, corresponding to
2.8, 1.0 and 0.5 mmoles of biotin-TLQP-21) was added to resuspended cells, and the
mixture incubated at 4 ˚C for 30 minutes. The cells were then washed twice with PBS
supplemented with 1% BSA (wash buffer), followed by centrifugation at 1500 rpm for 7
minutes. After the second wash, the supernatant was discarded gently, followed by
vortexing to resuspend the pellet. Fluorescein-conjugated avidin (Thermo Scientific) was
added at 10 or 20 µg/ml as per instructions of the supplier, and the mixture incubated at
4 ˚C for 30 minutes in the dark. Then after washing two times as before, the cells were
measured with a FACSCalibur™ (Becton Dickinson; San Jose). When necessary,
propidium iodine was added before analysis to exclude nonviable cells, using 10000
cells per treatment. Gates were set by forward and side scatter. For analysis, cells were
calculated using Cell Quest Software (Becton Dickinson). As control, cells were treated
with fluorescein-conjugated avidin (Thermo Scientific) only.
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Effect of Oxymatrine (OMTR), an inhibitor of HSPA8 expression, on binding of
Biotin-TLQP-21 to the surface of intact, live SH-SY5Y cells:
OMTR, an inhibitor of HSPA8 protein expression, with purity >97% was purchased
from the Selleck Chemicals, USA.
SH-SY5Y cells treated with OMTR (0.4 mg/ml; 1.51 mM) and untreated control cells
were collected. The cell suspension was further processed for flow cytometry analysis,
as described before.
Box 2: Oxymatrine (OMTR), at a glance.
Over 70 candidate compounds were screened by Wang et al.,
2010 to find out HSPA8 inhibitor. Among the compounds
examined, Oxymatrine (OMTR), molecular weight (MW) 264.31
(Figure 15) an alkaloid extract from Sophera flavescens (Ling et
al., 2007) (popularly known as ku shen plant, Figure 16),
showed significant activity to down regulate the expression of
HSPA8 in HepG2 liver cells without showing any toxicity to the
cells. Additionally, Western blotting confirmed the reducing
effect at the protein level showing reduction of HSPA8 protein in
the OMTR treated cells (Wang et al., 2010).
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Phosphoprotein gel staining:
Petri dishes with confluent SH-SY5Y cells were incubated for 6 hours with the peptide
TLQP-21 at a concentration of 1µg/ml. Then the cell homogenates were prepared as
discussed above. As control, cells without peptide incubation were grown, then
homogenized under the same conditions as treated cells.
Cell homogenate samples (20 µl) were boiled in 2X Laemmli buffer (Bio-Rad) for 10
minutes at 100 ˚C, spun, and loaded to SDS-PAGE gel. After electrophoresis (200V,
01h), the gels were washed in dH2O for 10 minutes. Then the gels were incubated with
fixing solution (50% methanol and 10% acetic acid) for 30 minutes at room temperature
in an orbital shaker step at 50 rpm. The fixation step was repeated once. Followed by
washing the gel with water three times each for ten minutes, the gels were incubated for
one and half hour with Pro-QR Diamond (Invitrogen) gel stain in the dark with agitation
at 50 rpm.  The gels were then destained with Pro-QR Diamond phosphoprotein gel
destaining solution (20 % acetonitrile, 50 mM sodium acetate, pH 4) for 30 minutes with
shaking. The destaining procedure was repeated two times more, followed by washing
the gels two times with water, each for 5 minutes. Finally, the gel was imaged using a
Typhoon FLA9500 scanner at a 100µm resolution at 532nm green laser.
Proteomic study:
Protein preparation and processing:
SH-SY5Y cells were grown as described earlier in the SH-SY5Y cell culture section.
Petri dishes with confluent SH-SY5Y cells were incubated for 6 hours with the TLQP-
21 peptide at a concentration of 1µg/ml. Then the cell homogenates were prepared as
discussed above. As control, cells without peptide incubation were grown, then
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homogenized under the same conditions as treated cells. Both the cell homogenates
treated with peptide and control (without peptide treatment) were precipitated with 60%
trichloroacetic acid in acetone as follows:
Frozen extracts were resuspended in half of their volume with a 60% TCA/acetone
solution and kept during 45 minutes on ice. The samples were then centrifuged at 10000
g during 1 minute at 4ºC and the supernatant was discarded. The pellet was resuspended
in 500 μl of cold acetone and sonicated with 3-4 pulses in the ultrasonic cell disruptor
Sonifier 150 (Branson) until it was broken up. The sample had to be maintained cold, so
for this purpose it was kept on ice. The samples were then centrifuged at 10000 g during
1 minute at 4ºC. Precipitation and resuspension steps were repeated twice. The last
supernatant was discarded and the last pellet was left to air dry.
The dry pellet was finally resuspended in a minimum volume of 2D sample buffer (5 M
urea, 2 M thiourea, 2 mMtributyl-phosphine, 65 mM DTT, 65 mM CHAPS, 0.15 M
NDSB-256, 1 mM sodium vanadate, 0.1 mM sodium fluoride, and 1 mMbenzamidine).
Thus the sample was ready to quantify.
Protein quantitation:
Protein quantitation was performed with the Coomassie Plus proteinreagent (Thermo
Scientific) that is a compatible method with the 2D buffer used to solubilize the samples.
Samples in 2-DE buffer, 50 mL of Coomassie Plus and BSA (2 mg/mL) solution (BSA
was reuspended in PBS) were allowed to reach room temperature. A standard curve was
constructed as follows: six different points were obtained with consecutive dilutions 1:2
of a BSA solution (1mg/ml), using as solvent the buffer in which the sample was diluted,
i.e. 2-DE buffer. For the first data point 20 μL of 2-DE buffer and 20 μL of BSA
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solution (2mg/ml) were mixed. The six points of the standard curve had the following
concentrations of BSA: 1000; 500; 250; 125; 62,5; 31,25 μg/mL. Two ul of each sample
were analyzed. The Coomassie reagent was allowed to stand at room temperature, and
then 600 μl were added to each sample. They were mixed and let stand at RT during 5
minutes. Absorbance at 595 nm was them measured in a Genesis 20 spectrophotometer
(Thermo Scientific). A blank was prepared with the solvent (20 μL) and Coomassie (600
μL) for the samples of the standard curve and 2 μl of the solvent and 600 μl of
Coomassie for the samples of unknown concentration. Each sample was measured twice;
in case both measurements diverged more than 10%, the sample was prepared and
measured again. With all the measurements, a standard curve was constructed with the
Excel program (Microsoft).
Bi-dimensional (2-D) gel electrophoresis:
Cell homogenates treated with peptide and control (without peptide treatment) were
subjected to two dimensional gel electrophoresis-based proteome analysis.
Rehydration of IPG strips:
Rehydration of the IPG strips is a passive rehydration that takes place during 14-16
hours. The strips used had a pH gradient of pH 4-7 and 24 cm (GE Healthcare) and the
final volume of rehydration buffer was 500 μl. 600 μg of the sample was mixed with
1,6% (v/v) of ampholytes (pH 4-7) (SERVA Electrophoresis GmbH). 2-DE buffer (see
previous section) was added to a final volume of 500 μl. The mixture was vortexed and
centrifuged during 5 min at 10000g to avoid any type of impurities. The sample was
pipetted in a lane of the rehydration tray (Immobiline Dry Strip Reswelling Tray, GE
Healthcare). The gel of the strip was in contact with the sample. The strip was covered
with mineral oil Dry Strip Cover Fluid (GE Healthcare) to avoid evaporations and it was
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left in rehydration overnight. The following day the strip was blotted on a filter paper to
remove oil. Finally, the strips were placed in a Multiphor II electrophoresis unit (GE
Healthcare) to perform the first dimension separation.
Isoelectrofocusing (first dimension):
The IPG strips were placed in the Multiphor II electrophoresis unit with the gel up.
Small pieces of electrode paper were humidified with milliQ water and placed in the
ends of the strips to absorb the remaining salts. The IPG strips were covered with
mineral oil. The electrodes were set in place and the programme was set as described in
Table 4. The first dimension was carried out at 17ºC.
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Table 4: Conditions of the isoelectrofocusing performed in the first dimension.
Equilibration:
After the first dimension the strips were equilibrated, reduced and alkylated: First the
strips were treated 15 minutes at room temperature and in agitation with the reducing
buffer (50 mMTris, pH 8,8; 4M urea; 2% (v/v) SDS; 30%(v/v) glycerol; 2% (w/v) DTT
and traces of bromophenol blue).After this, the strips were gently washed with milliQ
water and incubated this time in an alkylating buffer (same composition as the reducing
buffer but without DTT and with 2.5% (w/v) iodoacetamide  Alkylation with
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iodoacetamide after cysteine reduction results in the covalent addition of a
carbamidomethyl group (57.07 Da) and prevents the regeneration of disulfide bonds.
The strips were incubated in this buffer during 15 minutes at RT and in agitation. Finally
the strips were washed gently with milliQ water.
SDS-PAGE (second dimension):
The second dimension was performed on 10% large polyacrylamide gels. The DALT six
Gel Caster system (GE Healthcare) was used to polymerize the gels. With this system it
is possible to prepare 6 gels at the same time, therefore, the reproducibility of the system
is higher. Bis-acrylamide (37.5:1, 30% w/v) was used in the presence of N,N,N’,N’-
tetrametil-etilendiamine (TEMED) and ammonium persulfate, (APS) (Table 5). The gels
were prepared the day before their use and they were allowed to polymeryze during 5
hours at room temperature. After this, the gels were kept at 4ºC overnight protected with
a storage solution (0.1% SDS, 375mM Tris pH 8.8) to avoid dehydration. The
equilibrated strips were placed onto the gel with a 0.5% (w/v) agarose solution avoiding
bubbles between the strip and the gel.
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Table 5: Reagents used for the preparation of the gels.
The second dimension was carried out in the EttanDALT six system (GE Healthcare),
with electrophoresis buffer (0.25 M Tris BASE, 1.92 M Glycine, 1% (w/v SDS) for 5
hours at 10ºC with the program detailed in Table 6.
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Table 6: Program for the second dimension (25x20 cm gels).
Staining and scanning:
The gels were stained with Sypro Ruby fluorescent dye (Lonza). When the second
dimension was finished, the gels were extracted carefully from the glasses and they were
washed with water during 10 min. Gels were washed for 1 hour in 10% methanol/7%
acetic acid, followed by stained overnight with Sypro Ruby solution. Gels had to be
protected from the light. For this purpose the boxes that contained the gels were covered
with a black plastic bag. After staining, gels were washed with 10% methanol/7% acetic
acid during 1 hour, and subsequently in milliQ water for 10 minutes. All these steps
were carried out with enough volume of solutions (300 ml) and in constant agitation.
Finally the gels were scanned in a Typhoon 9410 scanner (GE Healthcare). The
programme used to scan the images was Typhoon Scanner Control, version 5.0 and the
following parameters were chosen: resolution 200 μm, blue laser with an excitation
wavelength of 488nm, filter 610 nm, medium sensitivity, and photomultiplier 600V.
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After scanning the images were converted to a high resolution TIF format to be imported
to the image analysis software: Ludesi REDFIN 3 (Ludesi, Malmö, Sweden) The gels
were kept in plastic bags in vacuum and they were stored at 4ºC until spot excision.
Differential image analysis:
Images were processed using Ludesi REDFIN 3 Software. Four gels from each sample
were analyzed. Images were analyzed using the LudesiRedfin Solo protocol. In this
approach, spot detection and image segmentation takes place in a composite image (see
below) and the same spot positions and borders are then applied to all images, after
compensation for geometric distortions. The advantages of this protocol are its
simplicity and that every detected protein spot will be assigned a volume in each image.
A disadvantage is that some spots may be assigned misshaped/misaligned borders,
leading to an incorrectly measured spot volume. The results may later be quality
controlled by inspection of the individual images and errors can be manually corrected.
The steps performed in this process were:
1) Image registration and alignment: The first step is to register matching points in the
gel images, based on features or patterns that can be seen in the image. Using this
information the images can be aligned and geometrically transformed (warped) so that
matching protein spots appear at the same position in the warped images. The spots
should overlap when the warped imaged are stacked on top of each other. LudesiRedfin
Solo uses a semi-automatic approach, where a human indicates matching points in the
images, which are subsequently improved by computer algorithms. One gel is selected
as the reference gel, and all other gels are aligned/warped to it.
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2) Composite image: A composite image (consensus image or fusion image) is created
by merging all the gel images into a single representative image. This image will then
contain all the spots from the individual gels. In order to avoid artifacts, such as cracks
or large stains, from being included in the composite image, it is possible to choose to
exclude some images, or image regions, when creating the fusion image.
3) Spot detection: Spot detection involves using algorithms to detect all real protein
spots in the images, while avoiding falsely detecting anything in the images that does not
represent a true spot. The sensitivity of the spot detection algorithm is adjusted to work
well with the specific images. The detected spot positions should be checked for both
falsely detected spots and undetected spots.
4) Segmentation: The image segmentation step determines which region in the images
contains each protein spot. The region outline (spot border) should encompass all of the
stained area belonging to the spot and nothing from nearby spots. In the Redfin Solo
protocol, spot borders are determined in the composite image and are then applied, after
warping, to all the individual images. After this, verification and adjustment of spot
positions and borders can be done in each individual image.
5) Quantitation: Quantitation is the process of measuring the cumulative staining
intensity contained within a spot which in turn corresponds to the relative protein
volume. This involves calculating the local background level around a spot, and
subtracting this background level from the staining level contained within the spot as
defined by the spot border. The result is a calculation of the total, background corrected,
and staining level of the spot.
6) Normalization: Normalization is the process of making these spot volumes
comparable between gel images in the face of technical differences in staining, scanning,
sample volume, and so on.Ludesi uses a method of normalization that works with gel
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pairs. The algorithm computes a normalization factor for each gel and uses it to
normalize the spot volumes in that gel:
• For each gel pair that has been matched, all matches between the two gels are
extracted. The top 50% matches, based on the spot volumes, are kept.
• A spot volume ratio is calculated between each kept spot pair match. A pair-wise
normalization factor between the gels is computed by taking the median of these ratios.
This ensures robustness and accuracy even if the project contains up to 50% regulated
spot volumes.
• Each gel normalization factor is computed by optimizing an over-determined equation
system, resulting from the pairwise normalization factors.
• Finally, the spot volumes in each gel are multiplied with the corresponding gel
normalization factor.
Statistical analysis:
To help determine statistically significant differences between groups of samples One-
way ANOVA ("Analysis Of Variance") method for statistical hypothesis testing was
employed. For each spot ID, ANOVA p-value was calculated using the quantified and
normalized volumes for the matched spot in each of the images. ANOVA is a parametric
method that assumes independency and normal distribution of all values and is capable
of comparing multiple groups. For comparisons between two groups only, the ANOVA
becomes equivalent to the two-sided Student's t-test.In this study differential expression
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of proteins was defined on the basis of >1.5-fold change between group averages and
p<0.05.
Protein identification using mass spectrometric analysis:
Spots chosen for mass spectrometric analysis were excised from the gels with a pipette
tip and manually in-gel digested with trypsin following the protocol described by
Shevchenko et al., 2006.The excised spots were washed three times with 100 μl of
ammonium bicarbonate 50 mM in 50% methanol (grade HPLC Scharlau) and reduced
with 10 mM DTT (SERVA Electrophoresis GmbH). After this, the gel pieces were
washed three times with ammonium bicarbonate, dried in a SpeedVac (Thermo
Scientific) and alkylated with 55 mMiodoacetamide (IAA) (Sigma- Aldrich). The gel
pieces were washed again with ammonium bicarbonate, dehydrated with acetonitrile and
dried again in a SpeedVac (Thermo Scientific). Porcine modified trypsin (Promega) was
added to a final concentration of 20 ng/mL in 20 mM ammonium bicarbonate and
digestion let proceed overnight at 37ºC.
Peptide extraction from the gel pieces was carried out three times with 40 μL of 60%
acetonitrile in 0.5% of formic acid. Extracts were pooled, dried in the SpeedVac
(Thermo Scientific) and stored at -20ºC.After digestion the spots were identified using a
model 4800 MALDITOF/TOF mass spectrometer (ABSciex, Framingham, MA, EEUU)
at the Proteomics Lab of the Foundation IDICHUS (Hospital Clínic, University of
Santiago de Compostela), as per protocol described above. All MS/MS spectra were
performed by selecting the precursor ions with a relative resolution of 300 (FWHM) and
metastable suppression. Automated analysis of mass data was achieved by using the
4000 Series.
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Explorer Software V3.5. MS and MS/MS spectra data were combined through the GPS
Explorer Software v3.6. Database search was performed with the Mascot v2.1 search
tool (Matrix Science, London, UK) screening SwissProt (release 56.0). Searches were
restricted to human taxonomy, setting carbamidomethyl cysteine as a fixed modification
and oxidized methionine as potential variable modification. Both the precursor mass
tolerance and the MS/MS tolerance were set at 30 ppm and 0.35 Da, respectively,
allowing 1 missed tryptic cleavage site. All spectra and database results were manually
inspected in detail using the above software.
Results
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Maleimide group
NHS ester group
Crosslinking and detection of a TLQP-21 binding protein in SH-SY5Y cell
homogenate:
In order to confirm the presence of a TLQP-21 receptor or receptors in SH-SY5Y cell
homogenates, a modified version of the approach described by Ayub (2012) was used.
Such approach relies on probing a cell homogenate with biotinylated TLQP-21; after
chemical cross-linking with the hetero-bifunctional reagent Sulfo-ECMS (Figure 4) to
stabilize any putative receptor: peptide complex, the reaction mixture is subjected to
SDS-PAGE, transferred to a PVDF membrane and probed with HRP-avidin, so as to
detect any protein bound to the biotinylated peptide.
Figure 4: Chemical structure of Sulfo-EMCS crosslinking reagent highlighting
NHS ester and maleimide group.
The cross-linking reaction is carried out in two steps: first, the maleimide moiety in
sulfo-EMCS reacts with the extra C residue in the specially designed biotinyl-TLQP-21;
then, this “activated” biotinyl-TLQP-21 is mixed with the cell homogenate and the
Results
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Free amino
groupNH2
\
\
\
sulfo-NHS-ester “traps” any free amino group that is within reach, i.e., that is part of a
protein bound to the activated, biotinylated TLQP-21 (Figure 5).
While the two steps of the reaction are carried out one immediately after the other,
following the steps of Ayub (2012), the correct activation of the biotinylated peptide was
checked by MALDI-TOF mass spectrometry (MS) to be sure that the peptide TLQP-21
was conjugated correctly to Sulfo-EMCS under the conditions used.
Biotin
Cysteine
Figure 5: The structure of the conjugated TLQP-21 with Sulfo-EMCS that traps
free amino group.
\ Sulfo-EMCS
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B.
Figure 6: MALDI-TOF MS confirmation of formation of a stable thioether linkage
between Sulfo-EMCS and Biotin-TLQP-21. Biotin-TLQP-21 was conjugated to
Sulfo-EMCS, followed by sample clean up using C18 resin Zip Tips (Millipore) and
MALDI-TOF MS analysis. A: full spectrum; (1)The peak at m/z 3223.52 corresponds to
TLQP-21 conjugated to Sulfo-EMCS. (2) The peak at m/z 2819.38 corresponds to
unconjugated TLQP-21. (3) The peak at m/z 1612.73 corresponds to doubly charged
Sulfo-EMCS conjugated to the peptide. (4) The peak at m/z 1410.19 corresponds to
doubly charged, unconjugated TLQP-21. B: zoom on the m/z range where the peaks of
interest appear; (1)The peak at m/z 3223.52 corresponds to TLQP-21 conjugated to
Sulfo-EMCS. (2)The peak at m/z 2819.38 corresponds to unconjugated TLQP-21.See
text for additional details.
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MALDI-TOF spectra of reaction products showed generation of the expected thioether
adduct (Figure 6): the theoretical MW of the peptide + Sulfo-EMCS thioetheraduct is
3208 Da (with Na+ being replaced by H+ as a consequence of protonation of the sulfo
group under the strongly acidic conditions of sample preparation for MALDI). A peak
with an m/z of 3223.52 was detected; the ~17 kDa difference agrees with the
characteristic -OH addition and rearrangement of the maleimide moiety during MALDI
(Borges & Watson, 2003, Figure 7). Additional peaks in the spectrum correspond to
doubly charged products.
Figure 7: Rearrangement of cysteine maleimide adducts during MALDI (From
Borges & Watson, 2003).
Once it was ascertained that the reaction conditions were adequate for generation of a
stable activated peptide, the crosslinking reaction was carried out by conjugation of
Sulfo-EMCS to TLQP-21 and then immediate reaction of the activated peptide with an
SH-SY5Y cell homogenate on ice for 2 hours, terminated by 50 mM Tris buffer (pH
8.0), which contains primary amines reacting with unconjugated crosslinker, if any;
followed by separation by SDS-PAGE and Western blotting using high sensitivity
streptavidin-HRP, as the peptide had biotin tagged at N-terminal end.
Results
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Figure 8: The crosslinking reaction of Sulfo-EMCS conjugated VGF-derived
peptide TLQP -21 to SH-SY5Y cell homogenate traps a ≤75 kDa TLQP-21-binding
protein. The Sulfo-EMCS conjugated peptide biotin-TLQP-21 was incubated with SH-
SY5Y cell homogenates followed by resolving by SDS-PAGE, and probed with HRP-
avidin. A ≤ 75 kDa protein band is visible in the reaction mixture containing TLQP-21
(T1 and T2), whereas in the control sample (C, homogenate incubated with
unconjugated Sulfo-EMCS crosslinker and conjugation buffer, without any conjugated
peptide) no band was detected. T2 lane corresponds to the double amount of sample
loaded as compared to T1.
As shown in Figure 8, a ≤ 75 kDa protein band is visible in T1 and T2 lanes. In T1 lane,
the band was less prominent as the amount of loaded protein sample was doubled in T2
MW
(kDa) Con.     T1       T2
250----
75-----
50-----
20-----
15-----
10-----
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lane whereas in control lane no protein band was found there. All these indicate that the
intensity of the ≤ 75 kDa band in the sample is enormous greater than the control lane.
To optimize the conditions, the crosslinking reaction was also performed with higher
amount (50 and 100 µg) of cell lysate protein as well as with higher amount (20 and 100
µM) of conjugated peptide. But the best result was obtained using 10 µg of protein
added to 10 µM conjugated peptide (data not shown).
Identification of a receptor of human TLQP-21:
Once the presence of a TLQP-21-binding protein in SH-SY5Y cell homogenates was
confirmed, cell homogenates were subjected to affinity chromatography on a biotinyl-
TLQP-21-loaded avidin column to adsorb and isolate the ≤ 75 kDa binding protein that
was cross-linked to TLQP-21. Following affinity chromatography, SDS-PAGE of eluted
fractions and SYPRO® Ruby protein staining, a protein band of ≤ 75  kDa was detected
that was not present in the elution fractions of the control sample applied to an avidin
agarose column lacking the biotinyl-TLQP-21 peptide (Figure 9). This band was excised
and analyzed by nanoHPLC-electrospray MS/MS. MASCOT analysis of the spectra
(Table 7) identified total 3 proteins, considering exclusion parameters (Nesvizhskii et al.,
2007): Heat shock cognate 71 kDa protein (HSPA8/HSC70), Stress-70 protein
(HSPA9/mortalin), and 78 kDa glucose-regulated protein (HSPA5). Sequence coverages
and scores varied from highest for HSPA8 (19.8, 735), middle for HSPA9 (12.5, 431), to
lowest for HSPA5 (5.4, 216) (Table 7, Figure 10). For this latter protein, only 3 peptides
were identified, at the borderline of exclusion parameters; therefore, we concentrated our
attention on HSPA8 and HSPA9.  Given the predominantly mitochondrial localization of
HSPA9/mortalin (Deocaris et al., 2008; Kaul, 2002; 2006; Bhattacharyya et al., 1995)
compared to the known presence of HSPA8 in the cell membrane (Shin, et al., 2002;
Liao and Tang, 2014; Mambula et al., 2006; Kettner  et al., 2007; Powers et al., 2008),
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we further narrowed our interest on HSPA8 as the most promising candidate to be a
receptor of VGF-derived peptide TLQP-21, which was further validated afterwards (see
below).
Figure 9: Biotin-TLQP-21 interacts with a ≤ 75 kDa protein in SH-SY5Y cell
homogenate. SH-SY5Y cell homogenates were applied to the monomeric avidin
column loaded with biotin-TLQP-21. The eluted fractions were resolved by SDS-PAGE
and analysed by Sypro ruby staining. A ≤ 75 kDa protein band was apparent in (fractions
eluted from the TLQP-21 column, TF 4-5) but not in the corresponding elution fractions
obtained from column without TLQP-21 attached (control fraction, CF4-5).
MW CF2 CF3     CF4     CF5   CF6    TF2    TF3 TF4 TF5 TF6
(kDa)
250---
150---
100---
75---
50---
37---
25---
20---
15---
10---
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Table 7: MASCOT analysis of tryptic peptides extracted from the ≤ 75 kDaband.
Protein Score MW(kDa) Sequence
coverage
Number
of
unique
peptides
Heat shock
cognate 71 kDa
protein(HSPA8)
735.0 70.9 19.8 12
Stress-70 protein
(HSPA9/mortalin)
430.0 73.6 12.5 07
78 kDa glucose-
regulated protein
(HSPA5)
216.0 72.3 5.4 03
A.
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B.
C.
Figure 10: Comparative peptide coverage of tryptic peptides extracted from the ≤
75 kDaband. A. ForHSPA8, there were 12 unique peptides identified, in red, with
score: 735.0, MW [kDa]: 70.9, sequence coverage [%]: 19.8 B. For HSPA9/mortalin,
there were 7 unique peptides identified, in red, with score: 430.9, MW [kDa]: 73.6,
sequence Coverage [%]: 12.5 C. For HSPA5, there were 3 unique peptides identified, in
red, with score: 216.0, MW [kDa]: 72.3, sequence coverage [%]: 5.4
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Immunochemical validation of HSPA8:
The  samples corresponding to fractions 4 and 5 (Figure 9) in which the ≤ 75 kDa band
was detected by Sypro® ruby staining, were pooled together subjected to Western blot
analysis with an anti-Hsc70 (HSPA8) antibody. As seen in Figure 11, the antibody
reacted positively with the protein but not in the corresponding control fractions.
Figure 11: Immunochemical validation of HSA8 as a TLQP-21 binding protein. The
HSPA8 was confirmed at ~71 kDa by Western blot analysis of the fractions eluted from
the column loaded with biotin-TLQP-21 (“TF”, T-21 column), but not in the equivalent
fractions eluted from a control column not loaded with biotin-TLQP-21(C column).
250---
100---
75---
50---
37---
25---
20---
15---
10---
Fractions from T-21 column
Fractions from C column
MW
(kDa) 1           2          3            4 5          6
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Binding of biotinylated TLQP-21 to HSPA8 on the SH-SY5Y membrane:
Since we used, for practical reasons, whole cell homogenates in the experiments that led
to identification of HSPA8 as a putative human TLQP-21 receptor, and considering that
a considerable fraction of HSPA8 is localized in the cytoplasm, there was the possibility
that its interaction with TLQP-21 might be artifactual, and it was imperative to
demonstrate that TLQP-21 actually binds HSPA8 on the cell membrane. For this,
biotinylated TLQP-21 was added to intact, live SH-SY5Y cells and cross-linked to
putative membrane receptors with the bi-functional crosslinking reagent Sulfo-EMCS.
Subsequently, the cells were homogenized and the homogenate subjected to affinity
chromatography using a monomeric avidin column. Eluted fractions were resolved by
SDS-PAGE, blotted, and membranes probed with anti-HSPA8 antibody. A positive ~71
kDa band corresponding to HSPA8 was detected in fractions 3, 4 and 5 (Figure 12),
though in the previous monomeric avidin column purification fractions used for Sypro
ruby staining, it was  visible in 4 and 5 fractions, not in fraction 3 (Figure 9). The small
mass increment added by biotin-TLQP-C (2820 Da) to HSPA8 is not sufficient to be
detected in our SDS-PAGE system.
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Figure 12: Binding of biotinylated TLQP-21 to HSPA8 on the SH-SY5Y
membrane. Following   biotinylation of membrane proteins, they were applied onto
the monomeric avidin column. Finally, eluted proteins were recognized by Anti-
HSPA8 antibody in fractions TF3, TF4 and TF5 lanes.
Binding of Biotin-TLQP-21 to the surface of intact, live SH-SY5Y cells:
Demonstration by FACS analysis:
Live SH-SY5Y cells were incubated with 3 different volumes of 0.1 mM biotin-TLQP-
21: 5, 10 and 28 µl, respectively. Subsequently, cells were treated with fluorescein-
conjugated avidin and subjected to FACS analysis. Phenotypic expression of surface
binding of biotinyl-TLQP-21 by the cells was increased in the dose-dependent manner of
MW
(kDa) TF1   TF2     TF3      TF4   TF5     TF6   TF7   TF8
250---
150---
100---
75---
50---
37---
25---
20---
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biotin-TLQP-21. Surface binding of biotin-TLQP-21 by the cells were 5.16%, 8.77%
and 10.30% when the SH-SY5Y cells were incubated with 0.1 mM biotin-TLQP-21 with
5, 10 and 28 µl, respectively that showed the tendency of an increasing dose-dependent
manner. However, out of the whole cell population maximum 10.30% cells were proved
to display positive staining expression of surface binding of biotinyl-TLQP-21 by the
cells (Figure 13). Figure 14 shows the almost same result as Figure 13 though in that
case, fluorescein-conjugated avidin was used 50% less showing that surface binding of
biotin-TLQP-21 by the cells was increased in the dose-dependent manner due to biotin-
TLQP-21, not for fluorescein-conjugated avidin.
However, only a 10.37%  of cells out of the whole cell population display positive
staining, a proportion that might seem small, in Daudi cells, constitutive cell surface
expression of the 60 kDa heat shock protein (Hsp 60) is limited to about 10% (Cicconi,
et al., 2004).
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Figure 13: Binding of Biotin-TLQP-21 to SH-SY5Y cells analyzed by FACS.
Incubation of SH-SY5Y cells with 0.1 mM Biotin-TLQP-21 with 5 µl (B), 10 µl (C) and
28 µl (D), respectively followed by staining with avidin, fluorescein conjugated (20
µg/ml)   showed surface binding of biotin-TLQP-21 as 5.16%, 8.77% and 10.30%,
respectively representing the tendency of an increasing dose-dependent  manner.
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Figure 14: Binding of Biotin-TLQP-21 to SH-SY5Y cells analyzed by FACS.
Incubation of SH-SY5Y cells with 0.1 mM Biotin-TLQP-21 with 5 µl (B), 10 µl (C)
and 28 µl (D), respectively followed by staining with avidin, fluorescein conjugated
(10 µg/ml) showed surface binding of biotin-TLQP-21 as 5.69%, 8.20% and 10.37%,
respectively representing the tendency of an increasing dose-dependent  manner.
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Oxymatrine, inhibitor of HSPA8, reduces binding of biotin-TLQP-21 to the surface
of intact, live SH-SY5Y cells:
OMTR reduces the binding of Biotin-TLQP-21 to the surface of intact, live SH-SY5Y
cells: Live SH-SY5Y cells, treated and not treated with OMTR, at a concentration
known to inhibit expression of HSPA8 (Wang et al. 2010), were incubated with 3
different volumes of 0.1 mM biotin-TLQP-21: 5, 10 and 28 µl, equivalent to 0.5, 1.0 and
2.8 mmoles of biotin-TLQP-21 respectively. Subsequently, cells were treated with
fluorescein conjugated avidin and subjected to FACS analysis.
SH-SY5Y cells treated with OMTR showed a significant reduction of binding of the
peptide, particularly at the optimum conditions (16.66%, Figure 19): this is, when the
cells were incubated with 5 µl of the peptide (corresponding to 0.5 mmole) followed by
the addition of fluorescein-conjugated avidin was added at a concentration of 20 µg/ml.
Under other conditions, the inhibitory effect was also found: Surface binding of biotinyl-
TLQP-21 by the cells treated with OMTR were 2.81% (control, Figure-17A), 57.37%
(Figure-17C), 53.61% (Figure-17E) and 53.16% (Figure-17G); while surface binding of
biotinyl-TLQP-21 by the cells not treated with OMTR were 2.28% (control, Figure-
17B), 57.36% (Figure-17D), 59.33% (Figure-17F) and 58.73% (Figure-17H) when the
SH-SY5Y cells were incubated with 0.1 mM biotin-TLQP-21 with 5, 10 and 28 µl,
respectively. In this case, fluorescein-conjugated avidin was added at a concentration of
10 µg/ml.
In addition, using fluorescein-conjugated avidin at double concentration, 20 µg/ml ;
surface binding of biotinyl-TLQP-21 by the cells treated with OMTR were 1.98%
(control, Figure-18I), 30.78% (Figure-18K), 32.64% (Figure-18M) and 50.36% (Figure-
18O); whereas surface binding of biotinyl-TLQP-21 by the cells not treated with OMTR
were 3.51% (control, Figure-18J), 32.13% (Figure-18L), 40.75% (Figure-18N) and
61.16% (Figure-18P) when the SH-SY5Y cells were incubated with 0.1 mM biotin-
TLQP-21 with 5, 10 and 28 µl, respectively.
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Figure 17(A-B): Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells without biotin-
TLQP-21, staining with avidin, fluorescein conjugated at a concentration of 10 µg/ml
showed  as 2.81% (control, with inhibitor, A) and 2.28 % (control, without inhibitor, B).
A
B
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Figure 17(C-D): Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 28 µl of
0.1 mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (10
µg/ml)   showed surface binding of biotin-TLQP-21 as 57.37% (with inhibitor,  C), and
57.36% (without inhibitor, D).
C
D
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Figure 17(E-F):  Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 10 µl of 0.1
mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (10
µg/ml)   showed surface binding of biotin-TLQP-21 as 53.61% (with inhibitor, E), and
59.33% (without inhibitor, F).
E
F
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Figure 17(G-H):  Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 5 µl of 0.1
mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (10
µg/ml)   showed surface binding of biotin-TLQP-21 as 53.16% (with inhibitor,  G), and
58.73% (without inhibitor, H).
G
H
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Figure 18(I-J): Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells without Biotin-
TLQP-21, staining with Avidin, fluorescein conjugated at a concentration of 20 µg/ml
showed  as 1.98% (control, with inhibitor, I) and 3.51% (control, without inhibitor, J).
I
J
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Figure 18(K-L):  Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 28 µl of
0.1 mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (20
µg/ml)   showed surface binding of biotin-TLQP-21 as 30.78% (with inhibitor,  K), and
32.13% (without inhibitor, L).
K
L
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Figure 18(M-N):  Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 10 µl of
0.1 mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (20
µg/ml)   showed surface binding of biotin-TLQP-21 as 32.64% (with inhibitor,  M), and
40.75% (without inhibitor, N).
M
N
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Figure 18(O-P):  Expression of HSPA8 protein in SH-SY5Y cells reduced in flow
cytometry assays (24 hours treatment). Incubation of SH-SY5Y cells with 5 µl of 0.1
mM Biotin-TLQP-21 followed by staining with avidin, fluorescein conjugated (20
µg/ml)   showed surface binding of biotin-TLQP-21 as 50.36% (with inhibitor,  O), and
61.16% (without inhibitor, P).
O
P
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Figure 19: Representative histogram showing  decreased binding of Biotin-TLQP-
21 to the surface of intact, live SH-SY5Y cells treated with OMTR vs not treated 
cells in flow cytometry.   
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Of note, it has been shown by Wang and co-workers (2010) that OMTR treatment had
no lethal effect on cells both in short term therapy (84 hours) and long term therapy (8
months). Moreover, the down regulatory effect of OMTR was detected only in HSPA8
but not in other heat shock protein (HSP) members like HSP90 and HSPA4 (Wang et al.,
2010).
Results
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C3AR1 not trapped by TLQP-21affinity chromatography:
In 2013, Hannedouche et al., confirmed and later in 2014, Cero et al., confirmed C3AR1
as a putative receptor of the murine TLQP-21 peptide. Hence, the same PVDF
membrane used for probing with Anti-HSPA8 antibody, was stripped and probed with
anti-C3AR1 antibody but it was nullified here that it was not the C3AR1 protein (Figure
20).
Figure 20: C3AR1, a ~53 kDa protein, does not bind biotin-TLQP-21 following
Monomeric Avidin-agarose based affinity chromatography. The PVDF membrane,
previously used for immunochemical validation of HSPA8 (Figure 11), was stripped,
incubated with C3AR1 Ab but could not be detected, confirming that C3AR1 was not
present in the eluate.
Fraction from T-21 column   Fraction from C column
1            2             3             4          5           6
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Proteomic study:
To date, little is known about the signaling mechanisms in which TLQP-21 and its
receptor(s) take(s) part. For this reason a preliminary proteomic analysis was carried out
using protein extracts of control and SH-SY5Y cells treated with the peptide, to know
which proteins are modulated. It should be noted here that, besides confirming that
TLQP-21 exerts biological effects in our model system, the ultimate objective is to
investigate whether this modulation is due to the interaction between TLQP-21 and its
receptor HSPA8 or not, which will be done in future studies.
Figure 21: Representative gel obtained from the proteomic analysis. Identified spots
are designated with number.
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Control                           Treatment
Figure 22: Representative spots from the proteomic study showing altered protein
expression in SH-SY5Y cells. Samples from cells treated with TLQP-21 shows less
intensity of spots in comparison to control.
Six gels of each condition were processed; one representative gel is shown in Figure 21.
An example of one of the spots showing differential intensity in treated vs. not treated
cells is shown in Figure 22.A list of all the proteins whose expression was found to be
modified is presented in Table 8.
Table 8: List of proteins with altered expression levels in SH-SY5Y cells.
Protein Score MW(Da) Sequence
coverage
Function
Mediator of RNA
polymerase II transcription
subunit 24
71 111716 11% Involved in the
regulated
transcription of
nearly all RNA
polymerase II-
dependent genes
Adenylosuccinatesynthetase
isozyme 2
64 50465 14% Plays an important
role in the de novo
pathway and in the
salvage pathway of
purine nucleotide
biosynthesis.
Catalyzes the first
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committed step in the
biosynthesis of AMP
from IMP.
Spindle and kinetochore-
associated protein 2
65 14236 49% Essential for proper
chromosome
segregation.
Required for timely
anaphase onset
during mitosis,
1-phosphatidylinositol 3-
phosphate 5-kinase (type
III PIP kinase)
58 239609 7% Participates in
phosphatidylinositol
signaling system and
regulation of actin
cytoskeleton.
Heat shock protein beta-1 80 22826 37% Chaperone activity,
thermotolerance,
inhibition of
apoptosis, regulation
of cell development,
and cell
differentiation,
signal transduction.
Endothelial differentiation-
related factor 1
63 16359 46% Transcriptional
coactivator
stimulating NR5A1
and ligand-dependent
NR1H3/LXRA and
PPARG
transcriptional
activities. Enhances
the DNA-binding
activity of ATF1,
ATF2, CREB1 and
NR5A1. Regulates
nitric oxid synthase
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A total of 6 proteins were found to be in altered expression, listed in the Table 8. Out of
them, one is1-phosphatidylinositol 3-phosphate 5-kinase with MW ~240 kDa and
another one is adenylosuccinate synthetase isozyme 2 with MW ~51 kDa.
Preliminary phosphoproteomic study:
A preliminary phosphoproteomic study was carried out to further validate that TLQP-21
exerts biological effects in the model system (SH-SY5Y cells) used and as a starting
point for future, more comprehensive studies. Cell homogenates from TLQP-21 treated
or control cells were subjected to 1D SDS-PAGE followed by staining with the
phosphorous-specific dye Pro-Q Diamond.  As seen in Figure 23, differences in band
intensity were seen. Thus, the bands’ intensity at <56 and  >212 kDa were less in the
samples treated with the peptide in comparison to control ones suggesting that the
peptide on SH-SY5Y cells might provoke dephosphorylation of specific
phosphoproteins. In consistent with the proteomic study, the intensity of the band was
less in sample with the peptide treatment.
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Figure 23: Phosphoprotein detection in SDS-polyacrylamide gels using Pro-Q
Diamond dye. Incubation of SH-SY5Y cells with TLQP-21 at a concentration of
1µg/ml (Hunsberger et al., 2007) followed by staining with Pro-Q Diamond dye
showed difference in phosphoprotein expression at <56 and  >212 kDa proteins of
control, SH-SY5Y cell homogenates not treated with the peptide (1 and 3) and cell
homogenates, treated with the peptide (2 and 4).
Further studies are required to validate that the interaction of the peptide TLQP-21 with
its receptor, HSPA8 is involved in the altered protein expressions as found in the
proteomic study.
MW
kDa 1            2              3            4
212---
158---
116---
97.2---
66.4---
55.6---
34.6---
27---
14.3---
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Within the last two decades, if not more, increasing data illustrating the role of
neuropeptides in modulating behavior has encouraged researchers to look for
neuropeptide receptors (Griebel and Holsboer, 2012). Some researchers have even
claimed the inception and development of a separate discipline termed as
‘receptorology’ (Ariens, 1984). To ease the task for searching out for the receptors and
to exploit all the potential outcomes, a number of techniques and strategies have been
adopted. In the present work, the VGF derived peptide TLQP-21 was modified with N-
terminal biotin and C-terminal cysteine for effective cross linking, affinity
chromatography purification, and easy detection, leading to successful search to ‘fish’
out HSPA8 as a receptor of the VGF derived peptide  human TLQP-21.
Identification of HSPA8 as a receptor of human TLQP-21:
The VGF-derived peptide TLQP-21 was modified by attachment of biotin at the N
terminal via the amide bond and with an extra cysteine residue at the C terminal to
facilitate the search for receptor of TLQP-21, specially to serve multiple purposes like
detection of any binding with receptor/binding partner and the peptide itself using
streptavidin-HRP, also for purification from affinity columns.
Biotin-TLQP-21-C was mixed with an SH-SY5Y cell homogenate and cross-linked to
putative TLQP-21–binding proteins using the water-soluble analog of EMCS, Sulfo-
EMCS (N-(epsilon -maleimidocaproyloxy) sulfosuccinimide ester). Sulfo-EMCS is a
heterobifunctionalcrosslinker containing two groups: N-hydroxysuccinimide (NHS)
ester reacts at pH 7-9 with primary amines (ε-amine groups on lysine residues) by
nucleophilic attack, releasing N -hydroxysulfosuccinimide as a byproduct (Hermanson,
1996) and forms amide bonds, on the other hand, maleimide reacts with sulfhydryl
groups at pH 6.5-7.5 forming stable thioster bonds (Heitz et al., 1968). In aqueous
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solutions, the maleimide group is comparatively more stable than the N-
hydroxysuccinimide (NHS) ester group but will be hydrolyzed slowly, and at pH > 7.5,
reaction specificity for sulfhydryl groups diminishes. Considering all these factors,
conjugation experiments with Sulfo-EMCS are carried on at pH 7.2-7.5.
Peptides were incubated with SH-SY5Y cell homogenate for crosslinking. The cross-
linking experiment identified a ≤75 kDa band, not in the control (reaction mixture
without peptide) (Figure 8).
Once that the presence in SH-SY5Y cell homogenates of a TLQP-21-binding protein
had been confirmed, an affinity chromatography-based approach was set up to identify
it. Biotin-TLQP-21-C peptides were attached to the affinity column through their biotin
tags, and SH-SY5Y cell homogenates were loaded to the column. The eluates from
affinity chromatography were analysed by SYPRO® Ruby staining, following SDS-
PAGE. A specific ≤75 kDa protein band was present in the eluates from the TLQP-21-
containing column, not in the corresponding control fractions (Figure 9).
The band was excised and analysed by nanoHPLC-electrospray MS.MASCOT analysis
of the spectra confirmed 3 proteins (Table 7): HSPA8 (MW 71 kDa), HSPA9/mortalin
(MW 74 kDa), and HSPA5 (72 kDa). Out of these three, HSPA5 was excluded due to its
lowest sequence coverages, scores and more importantly, for number of unique peptides.
The number of unique peptides for HSPA5 was only 3 and cut-off parameter was set at
≥3 ((Nesvizhskii et al., 2007; Ayub, 2012). It seems that the band excised and analyzed
here contains all these three proteins as the molecular weight (MW) of the proteins are
close to each other but following stringent filtering parameters, HSPA8 and
HSPA9/mortalin were considered as the target proteins, excluding HSPA5. It has been
observed that HSPA8 is a multiligand binding, multifunctional protein that has affinity
for a variety of ligands. Its localization to cell surface to perform directly as a receptor
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was already well established (for details, see the section: HSPA8). Taken together all
these into account, in this study, HSPA8 was given more preference and was confirmed
by immunostaining.  Later on, couple of experiments validated the presence of HSPA8
in cell surface and binding the peptide TLQP-21 (see below).
On the other hand,  the localization of HSPA9 remains mostly restricted to one
compartment of the cell, namely the mitochondria (Stricher et al., 2013); hence they are
also known as ‘mtHSP70’. But taken together all the data regarding the localization of
HSPA9, it can be concluded that  HSPA9/mortalins are mostly found in  mitochondrial
localizations, though surface expressed mortalins are evident (Deocaris et al., 2008;
Wadhwa et al., 2002; Deocaris et al., 2006; Bhattacharyya et al., 1995).  However, at
this moment its role as a second TLQP-21 receptor cannot be ruled out. Further studies
are required to assess whether TLQP-21 binds HSPA9/mortalin on the cell surface (like
those applied to HSPA8) or not.
The samples, in which the ≤75 kDa bands were detected by Sypro® ruby staining (Figure
9), subjected to Western blot analysis with an anti-HSC70 (HSPA8) antibody. The
antibody reacted positively with the protein at 71 kDa band (Figure 11).
Hannedouche et al. (2013) have identified C3AR1 as a putative receptor of murine
TLQP-21. Hence, we probed the same membranes with an anti-C3AR1 antibody but no
signal was detected (Figure 20).
Discussion
136
Binding of biotinylated TLQP-21 to HSPA8 on the SH-SY5Y membrane:
Since for practical reasons, whole cell homogenates were used to identify HSPA8 as a
human TLQP-21 receptor, there was the possibility that its interaction with TLQP-21
might be artifactual, i.e., that TLQP-21 bound to intracellular HSPA8 made available
after homogenization. Therefore, it was necessary to prove that TLQP-21 actually binds
HSPA8 on the cell membrane.
For this, biotinylated TLQP-21 was added to intact, live SH-SY5Y cells and cross-linked
to putative membrane receptors with sulfo-EMCS. Subsequently, the cells were
homogenized and the homogenate subjected to affinity chromatography using the
monomeric avidin column. Eluted fractions were resolved by SDS-PAGE, blotted, and
membranes probed with anti-HSPA8 antibody. A positive 71 kDa band corresponding to
HSPA8 was detected in elutant fractions of the avidin column, not in the control samples
(homogenate of cells not treated with biotinylated TLQP-21). The small mass increment
added by biotinyl-TLQP-Cys (2820.33 Da) to HSPA8 is not sufficient to be detected in
our SDS-PAGE system (Figure 12).
Binding of biotin-TLQP-21 to the surface of intact, live SH-SY5Y cells:
Demonstration by FACS analysis:
Viable, live SH-SY5Y cells were incubated biotin-TLQP-21. Subsequently, cells were
treated with fluorescein-conjugated avidin and subjected to FACS analysis. Phenotypic
expression of surface binding of biotinyl-TLQP-21 by the cells increased in the dose-
dependent manner of biotin-TLQP-21, not on the increasing amount of fluorescein-
conjugated avidin. Even in both the concentrations (10µg/ml and 20 µg/ml) (Figures 13
and 14) of Immunopure Avidin, Flourescein Conjugated, SH-SY5Y cells were stained in
more/less same manner/amount. However, out of the whole cell population maximum
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10.37% cells were proved to display positive staining expression of surface binding of
biotinyl-TLQP-21 by the cells in consistent with  Daudi cells where constitutive cell
surface expression of the 60 kDa heat shock protein (Hsp 60) was limited to about 10%
(Cicconi et al., 2004).
Using affinity chromatography and mass spectrometry-based protein identification,
HSPA8 was identified as a receptor of the human VGF-derived peptide TLQP-21.  In
agreement with Pino et al., 2013; Shin, et al., 2003; Vega, et al., 2008; Altin and Pagler,
1995 who confirmed the abundance of several HSPs including HSPA8 on cell surface,
cross-linking and FACS studies here confirmed that TLQP-21 binds to HSPA8 on the
surface of SH-SY5Y cells. Furthermore, molecular modeling studies show that TLQP-21
can be docked into the peptide binding pocket of HSPA8.
OMTR down regulates the expression of HSPA8:
FACS studies, as described before, confirmed that TLQP-21 binds to HSPA8 on the
surface of SH-SY5Y cells. But when OMTR, an inhibitor of the expression of HSPA8
(Wang et al., 2010), was used; binding of TLQP-21 to the surface of cells decreased
(Figures 17, 18 and 19), strongly suggesting that TLQP-21 binding was through HSPA8.
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Molecular dynamics study:
A docking and simulation study, prompted by the identification of HSPA8 as a receptor
of TLQP-21, was carried out by Sandipan Chakraborty, Department of Microbiology,
University of Calcutta, India.  This collaborative study concluded that the ligand human
TLQP-21 directly fits into the receptor HSPA8, as detailed in the Annex II.
Molecular dynamics simulation study explored the structural dynamics of TLQP-21
bound to the HSPA8 receptor binding site.  Protein-peptide docking was designed to
investigate the recognition mechanism of the ligand peptide TLQP-21 by receptor,
HSPA8. TLQP-21 appropriately fits within the substrate binding site of the HSPA8
showing strong interaction with the β-sheet region of the HSPA8. The bound TLQP-21
keeps its helical conformation in bound condition with HSPA8. Thus, molecular docking
study confirms an appropriate spatial fit of the peptide inside the cavity of HSPA8
(Annex II, Figure 26).
During the simulation of the complex HSPA8 and TLQP-21 any dissociation of the
complex was not noticed suggesting  that the peptide TLQP-21 formed strong, steady
complex with HSPA8. As the simulation progresses goes on, the formation of more
number of hydrogen bonds functions as one of the principal driving forces that allows
stronger interaction of the peptide, TLQP-21, within HSPA8 substrate binding site. With
the simulation process continuation, the peptide comes closer and settled around at an
optimum distance guided by strong surface complementarity and increasing hydrogen
bonding possibilities (Annex II, Figure 30).
It is obvious from the electrostatic surface potential of HSPA8, the peptide binding
region of the protein is highly charged and contains negatively charged residues,
Discussion
139
facilitating binding interaction between TLQP-21 and HSPA8.  From the middle of the
peptide positively charged Arg residues R10-R11, in addition, R21, from the C-terminal
region of the peptide TLQP-21, predominantly interacts strongly with the negatively
charged region of the HSPA8 substrate binding site (Annex II, Figure 30). In relation to
this, it is noteworthy that peptide binding affinity of the HSPA8 domain was found to
increase significantly for basic sequences with Arg-Arg (RR) (Takenaka et al., 1995).
HSPA8:
HSPA8 (Heat shock cognate protein A8, 71 kDa), a constitutively expressed protein, is a
fascinating member of the HSP70 (Heat shock protein) family. It is also known as stress-
inducible protein.
Distribution:
While HSPA8 is mostly localized in the cytoplasm and nucleus, where it carries out a
number of functions that are discussed below, it can also be found in a membrane-bound
manner on cell surfaces, particularly in cancer cells, undifferentiated human embryonic
stem cells, virus transformed B cells (Liao and Tang, 2014; Mambula et al., 2006;
Kettner et al., 2007; Powers et al., 2008). It is present in lipid rafts isolated from rat
forebrain and cerebellum (Chen et al, 2005). In this respect, HSPA8 is not the only
member of the HSP family to be found on cell surfaces: HSP60 has been found present
on the surface of the human leukemic CD4-positive T-cell line CEM-SS (Soltys and
Gupta, 1997), where it localizes in response to infection (Belles et al., 1999); in turn,
HSP70 interacts with phosphatidylserine on the surface of PC12 cells, resulting in a
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decrease of viability (Arispe et al., 2004).  HSPA8 can also be found extracellularly
(Barreto et al., 2003; Evdokimovskaya et al., 2010; Nirdé P et al., 2010; Clayton et al.,
2005).  Shin et al., 2003 obtained a profile of the cell surface proteome of SH-SY5Y
neuroblastoma, A549 lung adenocarcinoma, LoVo colon adenocarcinoma, Sup-B15
acute lymphoblastic leukemia and ovarian tumor cells, found HSPs including HSPA8 at
cell surface andpostulated that these proteins  reach the cell surface either by active
transportation from their site of synthesis  to maintain structural integrity among
receptor complexes, or by accompanied misfolded proteins or peptide fragments out of
the cytosol via a non-classic pathway.
Functions:
While HSPA8 is involved in housekeeping chaperoning functions (He M et al., 2010;
Pfaffenbach  et al., 2010; Daugaard et al., 2007; Powers et al., 2008), that is not its only
role: additionally, it carries out biological functions relevant to immunity, antigenicity,
hematopoiesis, and autophagy (Stricher  et al., 2013). HSPA8 is also involved in
exocytosis, endocytosis and vesicular trafficking and participates in multiple cellular
signalling pathways (Meimaridou et al., 2009) (for further description, see below).
HSPA8 signaling:
HSPA8 not only functions to play important roles in intracellular response but also as
extracellular signal molecules participating in a number of signaling pathways. There are
couple of secretion mechanisms of HSPA8 (Liao and Tang, 2014): firstly, cell lysis,
HSPA8 is secreted by necrotic tumor cells into the blood stream via this mechanism.
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Secondly, it follows secretory vesicles pathway to be secreted in exosomes, for example,
B cells secrete HSPA8 following this pathway (Clayton et al., 2005). Thirdly, secretory
lysosomal endosomes pathway, tumor cells and macrophages release HSPA8 via this
pathway (Chen et al., 2005). Of note, HSPA8 release has more multiple cellular
functions than other HSPs as the constitutive HSPA8 is much more abundantly secreted
than other HSPs in most of the cells, interacting with multiple molecules/partners.
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Figure 32: Interactions of HSPA8 (red ellipses) with a wide range of target
molecules. After being released, extracellular HSPA8 interact with neuronal cells,
macrophages, cancer cells, sperm, antigenic peptides (yellow squares) and by dendritic
cells (act as antigen presenting cells) or enter the blood circulation.  Antigenic peptides
undergo cross-presentation caused by major histocompatibility class I molecules (blue
trapezium) and activate CD8+ T lymphocytes (From Liao and Tang, 2014).
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After being released into the extracellular microenvironment, HSPA8  interacts with
surface signaling molecules including CD14, CD40, CD91, TLR2/TLR4, CCR5,  CD36,
FEEL, Lox-1, SR-A, and SREC (Calderwood et al., 2007),  initiating extracellular signal
transduction cascades (Figure 27). HSPA8 also interacts with TLR2/TLR4, induce
cytokine expression, TNF-α, IL- 1β, and IL-6, and finally activates p38MAPK, NF-κB
pathways (Zou et al., 2008). HSPA8 can trigger inflammatory response, combinedly
with macrophage and dendritic cells (DCs). Extracellular HSPA8 was found to regulate
the proliferation of human cancer cells, as demonstrated by Derocq and Nirdé. HSPA8
was found to bind with sulfated glycolipids on the apical region of the sperm head,
inducing the cell signalings between the oviductal cells and spermatozoa (Figure 32)
(Elliott et al., 2009; Gadella et al., 1995). Consequently, this binding of HSPA8 affects
the activity of both cell types: the oviductal cells and spermatozoa (Fazeli et al., 2003).
Although HSPA8 has been found to be an important signaling molecule interacting with
a wide range of molecules, the molecular mechanisms involved remained largely
elusive.
Protein folding:
One important cellular function of HSPA8 is its involvement in protein folding. For
refolding mechanisms, HSPA8 in most of the cases, functions simultaneously with a
variety of co-chaperones, upon ATP hydrolysis in order to bind nascent polypeptides
inducing its refolding   (Beckmann et al., 1990; Frydman et al., 1996), that take place in
a protected environment formed by chaperones and cochaperones, and is directly
coupled to translation (Thulasiraman et al., 1999).  It is noteworthy that HSPA8 binds
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unfolded neo-synthetized proteins, interacting with different protein aggregates to reduce
their formation (Watanabe et al., 2001; Wang et al., 2009).
Protein import:
There are reports confirming the involvement of HSPA8 to import protein into
organelles or cellular compartments like nucleaus, mitochondria and ER:  Upon ATP
hydrolysis, HSPA8 was found to shuttle between nucleaus and cytoplasm(Mandell et al.,
1990; Kodiha et al., 2005) to import cytoplasmic proteins into the nucleaus(Imamoto et
al., 1992; Okuno et al., 1993). Furthermore, it facilitates the import of proteins for other
organelles like mitochondria, ER(Chirico et al., 1988; Deshaies et al., 1988) and
microtubules in an ATP dependent manner(Tsai et al., 2000; Terada et al., 2010).
Immunity:
HSPA8 has been found as highly immunogenic and central in the immunity system.
Interacting with MHC molecules(Auger et al., 1996), HSPA8 was found to be involved
in binding and protecting peptide for MHC-II molecules(Panjwani et al., 1999). HSPA8
was found to function as antigen: in rheumatoid arthritis (Hayem et al., 1999), SLE
(Hayem et al., 1999; Minota et al., 1988), lupus (Stricher et al., 2013) and mixed-
connective disease (Hayem et al., 1999; Minota et al., 1988), increased concentrations of
IgG and IgM antibodies to HSPA8 were observed.
Hematopoiesis:
In combination with other co-chaperones like HSP40, BAG4, STUB1 and ST13/HIP,
HSPA8 acts on BCL2L11/BIM mRNA stability in order to regulate total cell number
(Matsui et al., 2007). Of note, BCL2L11-deficient mice show hyperplasia and increased
WBCs(Bouillet et al., 1999).
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Autophagy:
The involvement of HSPA8 in microautophagy was reported: in this process, HSPA8 is
involved to engulf cytosolic material by the lysosome via invaginations of the membrane
of the lysosome (Li et al., 2012), followed by internalization and degradation via
endosomal microautophagy (Sahu et al., 2011). In macroautophagy, cytosolic material
with a large portion are engulfed inside autophagosome, the double membrane vesicle,
followed by degradation by lysosomes. To remove damaged organelles and intracellular
proteins aggregates, this pathway plays a siginificant role (Wong et al., 2011).
Thus, a variety of cellular functions: Protein folding, import, immunity, hematopoesis
and autophagy; have been attributed to HSPA8.
HSPA8 as receptor/binding partner:
There are multiple evidences showing the ability of HSPA8 to interact with variety of
ligands/binding partners of cellular, bacterial, and viral origin, illustrating their
functional consequences downward, though in most cases they are still to be more
clarified. Already HSPA8 has been known as a multifunctional and multiligand binding
protein with multi-location.
It also localizes to the cell surface for cell recognition by immune cells, even more
directly performing as a receptor (Tsuboi et al., 1994; Fishelson et al., 2001; Page et al.,
2011; Kishi et al., 2001; Sagara et al., 1998; Guerrero et al., 2012). For example, the first
ever demonstration  of  HSPA8’s  involvement in cell protection from complement-
mediated damage showed that sublytic complement activation provoked the
translocation of HSPA8 from the cytosol to the exoplasmic side of the plasma membrane
of human erythroleukemia cells, K562. Treatment with HSPA8 inhibitor,
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deoxyspergualin (DSG) sensitized K562 cells to complement lysis, on the other hand,
treatment with HSPA 8 inducers like ethanol, butanol or hemin,  protected the cells from
complement-mediated lysis. Moreover, on the surface of intact, viable complement-
stressed cells, HSPA8 was identified by antibodies. All these data validated the role of
HSPA8 in cell defense against complement as well as its translocation to the plasma
membrane of the cells (Fishelson et al., 2001).
The HSPA8 proteins were also found to  interact with rat CD3+, CD4-, CD8-, T-cell
receptor (TCR) alphabeta-, natural killer recetor-P1- T cells (Kishi et al., 2001).
Moreover, the HSPA8 was found to perform directly as a receptor:  P140, a
phosphopeptide issued from the spliceosomal U1-70K small nuclear ribonucleoprotein
protein, showed defensive property in MRL/lpr lupus-prone mice. The interaction
between the ligand, P140 peptide and its receptor, HSPA8, induced the endogenous
(auto)antigen processing  affecting  MRL/lpr antigen-presenting B cells,  that led to the
observed decrease of autoreactive T-cell priming and signaling via a mechanism
involving a lysosomal degradation pathway (Page  et al., 2011).
With respect to the functions of membrane-associated HSPA8, HSPA8 localized on the
cell surface was shown to act as a cellular receptor for HTLV-1 induced syncytium
formation (Sagara et al., 1998). Also, a peptide analogue phosphorylated on Ser140
termed peptide P140 was seen to bind ‘a unique cell surface receptor’, HSPA8 (Page et
al., 2009) through the HSPA8 N-terminal domain (Stricher et al., 2013), and P140 has
successfully completed phase II clinical trials as a potential treatment of systemic lupus
erythematosus (Muller et al., 2008; Zimmer et al., 2013); phase III clinical trials are on-
going (Stricher et al., 2013).
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HSPA8 possesses a peptide binding domain (Wang, 1993), a feature it shares with other
members of the HSP70 family although each one exhibits exclusive and diversified
peptide binding features (Fourie et al., 1994). Peptide binding affinity of the HSPA8
domain was seen to increase dramatically for heptamers compared with hexamers
containing basic sequences with at least KK, KR, or RR from a phage display peptide
library (Takenaka et al., 1995). Interestingly, the peptide sequence of TLQP-21 contains
RR sequence at the region R9- R10- R11.
Further, a circular dichroism study has shown the conformational change of HSPA8 due
to binding of a decapeptide (Park et al., 1993). HSPA8 has also been shown to bind
proteins, such as the prion protein (Wilkins et al., 2010) or the listeria adhesion protein,
for which it acts as a receptor in caco-2 cells (Wampler et al., 2004). HSPA8 has been
proved to interact with phosphatidylserine on the surface of PC12 cells (Arispe et al.,
2004). Binding site has also been unveiled on HSPA8 for 15-deoxyspergualin, DSG
(Nadler et al., 1998).
It is also suggested that chaperones like HSPA8 function through ‘transient exposure’ of
their ‘interactive surface’ (regions of intramolecular or intermolecular contact) (Gatenby
and Ellis, 1990) important in maintaining their interactions with other proteins (Park et
al., 1993).
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HSPs inducers:
Both the extrinsic factors ( hypothermy , toxins, radiation, wound, infection, hypoxia,
autophagy and aging) and the intrinsic factors (ER and genetic stress) can induce
HSPA8 expression (Liao and Tang, 2014; Preuss et al., 2008; Kettner  et al., 2007;
Pfaffenbach  and Lee , 2010). (For details, see the Table: 9)
Table 9: HSPA8, at a glance.
Name HSPA8 (Heat shock cognate 71 kDa protein A8)
Other names HSC70, HSC54, HSC71, HSP71, HSP73,
HSPA10, LAP1, NIP71(Liu and Cao, 2014).
Location 11q24.1
Gene Nine exons and eight introns : the promoter region of the
HSPA8 gene includes a TATA box, two CCAAT boxes,
two SP1 elements and two sets of heat shock response
elements (HSE) where the heat shock transcriptional
factors bind (Chen et al., 2002).
Structure
The basic structure of human HSC70 includes three parts: a 44 kDa ATPase domain,
an 18 kDa peptide (substrate) binding domain and a 10 kDa carboxyl-terminal
domain, also known as "lid" domain.
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(Liu and Cao, 2014)
(Tsukahara et al., 2000)
Expression factors Increase HSPA8
expression
Decrease HSPA8 expression
Stress, Heat, Exercise,
Organochlorine, Sodium
arsenite, Azetidine,
Heavy metals (Nickel,
Copper, Lead,
Cadmium), Antimony
containing Drugs,
Geranylgeranylacetone,
Ethanol, Estrogen,
Progesterone, IL-1 beta,
Kruppel like factor 4,
Phorbol 12-myristate 13-
Sodium-4 phenylbutarate,
Butarate, Glycerol, Arginase,
Quercetin, 3,3’,4,4’,5-
Pentachlorinated biphenyl
(PCB 26), Mototane (in
mitochondria),
Deoxyspergualin (DSG),D-
Galactose amine, cAMP,
Lipopolysaccharide (LPS),
INF gamma, TNF alpha,
Oxymatrine, HSP 70 over
expression (Liu et al., 2012)
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acetate, Insulin (Liu et
al., 2012),  toxins,
radiation, wound,
infection, hypoxia,
autophagy, aging, ER
and genetic stress (Liao
and  Tang, 2014;
Preusset al., 2008;
Kettner  et al., 2007;
Pfaffenbach and Lee,
2010).
Localization Both extracellular and intracellular location have been
proved (Barreto  et al, 2003; Evdokimovskaya  et al,
2010; Nirdé  et al, 2010; Clayton  et al., 2005) : major
cytosolic molecular chaperone (Place and Hofmann,
2005), also located in various cellular locations such as
nuclear and close to cellular membrane (Arispe and
Maio, 2000).  Interact with the lipid bilayer in the cellular
membrane directly (Otto et al., 2001), cell surface (Shin,
et al., 2003; Virginia et al., 2008; Altin and Pagler, 1995).
Allied with cell surface for cell recognition by immune
cells, even more directly carry out function as a receptor
(Tsuboi et al., 1994; Fishelson et al., 2001; Page et al.,
2011; Kishi et al., 2001; Sagara et al., 1998; Guerrero et
al., 2012).
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Functions As a molecular chaperone, it regulates protein folding,
protein maturation, maintains protein normal structure
and functions, and protects cells from physical and
chemical damage, interacts with nascent polypeptides in
the process of new protein synthesis (Beckmann et al.,
1990; Beckmann et al., 1992), regulates the translocation
of proteins into different cellular organelles such as
endoplasmic reticulum and mitochondria (Chirico et al.,
1988, Sheffield et al., 1990). Cellular signaling and
functions such as steroid receptor maturation (Kimmins
and MacRae, 2000), Akt signaling pathway (Shiota et al.,
2010). Regulating apoptosis, embryonic development and
aging (Beere, 2004; Sreedhar and Csermely, 2004;
Kodiha et al., 2005), immunity, antigenicity,
hematopoiesis, autophagy, etc. (Stricher et al, 2013),
exocytosis, endocytosis, vesicular trafficking, etc. and its
association in the regulation of multiple cellular
signalling pathways (Meimaridou et al., 2009).
Implications in
diseases/physiology
Diabetes (Tiss et al., 2014), Cancers: colon cancer
(Kubota et al., 2010), lung cancer (Rusin et al., 2004),
Cadiovascular diseases (Dupont et al., 2008), (Chen et
al., 2006). Neurological diseases : Parkingson's disease
(Mak et al., 2010), Huntington's disease (Bauer et al.,
2010), Liver diseases (Wang et al., 2010), obesity ( Tiss
et al., 2014), Fertility (Moein-Vaziri et al., 2014;
Discussion
152
Zaprjanova et al., 2013; Kaur et al, 2013;  Elliott et al.,
2009). Ulcer (Tsukimi et al., 2001), Gastronomy
(Bondia-Pons et al, 2011; Daniell et al., 2012).
Hypertension ( Lian et al., 2014; Oguri et al., 2009; Kato
et al., 2008; Timofeevaet al., 2006), Stress (Singh et al.,
2014; Magdeldin et al., 2015; Niu et al., 2014).
Noteworthy Sagara Y et al., 1998 confirmed that HSPA8 expressing
on the cell surface performed as a cellular receptor for
HTLV-1(Human T-cell Lymphotropic Virus Type 1)
induced syncytium formation.
Page et al, 2009 validated HSPA8 as ‘a unique cell
surface receptor’ as  P140 peptide (a peptide analogue
phosphorylated on Ser140) bound with it through N-
terminal domain of HSPA8 and P140 has successfully
completed phase IIa and IIb clinical trials for SLE
(systemic lupus erythematosus) by ImmuPharma France
(Muller et al., 2008; Zimmer et al., 2013). Phase III
clinical trial was on-going. (Stricher et al., 2013).
Discussion
153
The HSP family of proteins:
HSPs, the protein family to which HSPA8 belongs, are ubiquitously distributed and
highly expressed in tissues (Hantschelet al., 2000). There are evidences of plasma
membrane localization of cytoplasmin HSPs ranging from 70 to 90 KDa, though some
of them term it as ‘unusual plasma membrane localization of cytoplasmin
HSPs’(Altmeyer  et al., 1996; Ferrarini et al., 1992; Multhoff  et al., 1995 ; Piselli et al.,
1995; Tamura , et al., 1993). In fact, HSPs are contained intracellularly but they are
translocated into the plasma membrane and released into the extracellular environment
especially after various pathological conditions (Campisi, 2003; Singh-Jasuja, 2001;
Srivastava, 2002, Vega et al., 2008). It is now well established that the HSPs act in
various intracellular compartments (Buchner, 1996; Frydman and Hohfeld, 1997; Hartl,
1996; Hightower, et al., 1994; Melnick, and Argon, 1995), although there are evidences
suggesting the function of certain HSPs after being expressed on the cell surface (Kaur,
et al., 1993, Takashima, et al., 1996; Tamura, et al., 1993; Tsuboi, et al., 1994). HSPs
interact with the proteins in unfolded, misfolded or aggregated states but do not react
with the folded counterparts. However, they can interact with a limited set of native
proteins (Mayer, 2013; Mayer and Bukau, 2005, Meimaridou, 2009). A list of wide
variety of chemical scaffolds like polyamines, fatty acids, sulfoglycolipids, adenosines
and peptideshave been identified which show remarkable affinity for HSPs (Evans et al.,
2010).
In stress conditions, HSPs are up-regulated and play an important role in cellular repair
and protective mechanisms. For example, they bind as well as refold the denatured
proteins due to be in stress, whereas in unstressed normal conditions, they perform their
routine works like proper folding, assembly, and intercellular trafficking of newly
synthesized proteins (Becker and Craig, 1994; Hartl, 1996, Lindquist and Craig, 1988).
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Physiological relevance of the TLQP-21 and HSPA8 interaction:
Although it may be unanticipated at first sight that HSPA8 be a receptor for TLQP-21,
this is consistent with several earlier and very recent findings. First, expression of
HSPA8 has been found to increase in association with obesity and diabetes (Tiss et al.,
2014). Increased expression of HSPs is required in persons with obesity to minimize
inflammatory and metabolic stresses imposed by obesity. HSPs are believed to play
crucial role in renovating cellular and metabolic homeostasis (McArdle et al., 2002;
Morton et al., 2006) by decreasing inflammation, uprising skeletal muscle oxidation
(Morino et al., 2008; Gupte et al., 2009; Liu et al., 2012; Henstridge et al., 2014). In
consistent with the finding of less expression of HSPs in T2DM (Kurucz et al., 2002;
Bruce et al., 2003); HSPs have been considered with importance for the treatment of
insulin resistance and obesity related T2DM (Chung et al., 2008; Literati-Nagy et al.,
2009). In fact, the role of HSPs was under-recognized previously in the maintenance of
homeostasis in the physiology, with reference to the obesity-driven inflammation that
promotes insulin resistance (Hooper and Hooper, 2009). All these lend support to the
argument in favour of a TLQP21-HSPA8 connection in modulating obesity. In this
respect, it should be remembered that TLQP-21 is the first identified VGF-derived
peptide involved in energy homeostasis (Bartolomucci et al., 2007) and considered as
putative target to treat obesity related disorders (Cero et al., 2014) as its role in diabetes
(Zhang et al., 2013; Stephens et al., 2012), hypertension (Fargali et al., 2014) and
lypolysis (Possenti et al., 2012) has already been confirmed.
TLQP-21 exerts important effects on energy metabolism, its administration decreased
food intake and increased energy expenditure in Siberian hamsters (Jethwa et al., 2007).
It also decreased body weight and WAT in mice fed high fat diet for 14 days, blocking
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hormonal changes associated with this diet and provoking the autonomic activation of
the adrenal medulla and adipose tissue. Furthermore, intracerebroventricular
administration of TLQP-21 reduced early phase diet induced obesity (Bartolomucci et
al., 2006). It is therefore noteworthy that expression of HSPA8 has been shown to be
modulated by diet. Thus, significant downregulation was seen in liver from rats fed
high-fat sucrose diet versus starch-rich control diet (Bondia-Pons et al., 2011), and in
response to increased bean consumption ( Daniell et al., 2012).
Another argument favoring the physiological relevance of this newly discovered TLQP-
21/HSPA8, ligand-receptor relationship comes from the study of reproduction. HSPA8
contributes to survival of sperm in the oviduct (Elliott et al., 2009). And enhances the
ability of spermatozoa to bind oviductal epithelial cells, boosting up in-vitro fertilization
performance (Moein-Vaziri et al., 2014). Furthermore, HSPA8 has crucial protective
functions in the process of spermatogenesis and epididymal maturation of male germ
cells under stress conditions (Zaprjanova et al., 2013). SRY (sex determining region on
the Y chromosome) plays a key role in mammalian sex determination within the
nucleus. HSPA8 plays a key role in calcium-binding protein, calmodulin (CaM)
dependent nuclear import of SRY (Kaur et al., 2013). On the other hand, after
administration of TLQP-21 on adolescent males with chronic food deprivation, the
gonadotrophin response of hyphothalamic-pituitary-gonadal (HPG) axis was found to be
reduced and in fed males it caused puberty delay (Pinilla et al., 2011), consistent with
the infertility found in male VGF knockout mice (Hahm et al., 1999; 2002).
HSPA8 was reported to be involved in the healing of acetic acid-induced gastric ulcers
in rats. The protein was expressed highly in the normal mucosa and ulcerated tissue,
though the level of protein expression was not changed during the ulceration and ulcer
Discussion
156
healing process (Tsukimi et al., 2001). Remarkably, the central inhibitory effect of
TLQP-21 on gastric acid secretion was proved, confirming that it is mediated by
endogenous somatostatin and prostaglandins and requires the integrity of sensory nerve
fibres (Sibilia et al., 2012).
Altered gene expression of HSPA8 was also found to be involved in hypertension in
patients with blood-stasis syndrome ( Lian et al., 2014), in Japaneese individuals with
chronic kidney disease (Oguriet al., 2009), patients with thoracic aortic aneurysm
(Katoet al, 2008), patients with arterial hypertension (Timofeeva et al., 2006).  The
findings that acute and chronic administration of the VGF-derived peptide TLQP-21 to
rodents improved hypertension (Fargali et al., 2014) indicates that the action of TLQP-
21 may be mediated by the receptor HSPA8.
The findings highlighting the physiological relevance of the HSPA8 and TLQP-21
connection give more credence to the interaction of HSPA8 and TLQP-21 or at least the
probable involvement of HSPA8 in TLQP-21 induced biological actions. In fact, due to
all these physiological relevances of HSPA8 and TLQP-21, it is highly likely that the
HSPA8-TLQP-21 interaction prompts various cellular responses, though the
consequences of HSPA8-TLQP-21 are still elusive and need more clarification in
signaling pathways.
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Recent identification of murine TLQP-21 receptors:
gC1qR (Chen et al, 2013) and C3AR1 (Cero et al., 2014; Hannedouche et al, 2013) have
been reported as receptors of murine TLQP-21. gC1qR was identified as the receptor of
the peptide TLQP-21 using chemical crosslinking and monomeric avidin column
purification following by MS analysis : the conjugated peptide (confirmed by MALDI-
TOF)  was crosslinked to the protein preparations  showing ~30 kDa band (Ayub, 2012).
Then the peptide attachment to monomeric avidin column, followed by the application
of membrane protein and the elutants showed the ~30 kDa band, confirming it as gC1qR
after MS analysis (Chen et al., 2013).
Hannedouche and his co-workers used the TLQP-21 responsive CHO-K1 cells to search
for its receptor. Following unbiased genome wide sequencing of the transcriptome from
CHO-K1 cells, possible GPCRs responsible for bringing about the TLQP-21 induced
biological activities in the cells were listed. The TLQP-21 response in the cells were
found reduced by the gene knockdown with the siRNAs targeting C3AR1. Moreover,
the C3AR1 antagonist, SB290157 was shown to inhibit the TLQP-21 response in CHO-
K1 cells. All these validate that the binding of TLQP-21 to its receptor C3AR1 has
biological effects in CHO-K1 cell line, though this finding was not demonstrable to the
human receptor (Hannedouche et al., 2013).
Even more recently, Cero et al., 2014 confirmed the binding of murine TLQP-21 to
C3AR1 in CHO and 3T3L1 cells by photoactivated crosslinking method. In addition,
structural analysis of TLQP-21 alone and in the presence of  3T3L1 cells, wild type
splenocyte, C3AR1 knockout splenocyte and  C3AR1 antagonists confirmed that the
peptide goes from a disordered to ordered transition upon targeting  cells expressing the
C3AR1 and adopts a α helical conformation, in consistent with the findings of a
molecular dynamics study (Chakraborty et al., 2015). Based on the  contraction of
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stomach fundus strips (Severini et al., 2009) : one of the most reliable bioassays for
TLQP-21; hot spots responsible for the function of the peptide were found lying at the
C-terminal sequence (HFHH-10) whereas  TLQP-11 (TLQPPASSRRR), the one without
the C-terminal sequence was found inactive. Additional study by β-arrestinn recruitment
assay using HTLA cells transfected with human C3AR1 receptor revealed that the
rodent version of the peptide possesses higher potency than human version of the
peptide towards human C3AR1. It is hypothesized that the human version of the peptide
differs by 4 amino acids compared to rodent version (as cited by Bartolomucci et al.,
2011 but apparently human version of TLQP-21: TLQPPSALRRRHYHHALPPSR
shows extensive homology but also substantial differences with mouse TLQP-21:
TLQPPASSRRRHFHHALPPAR by 5 amino acids), resulting in the lower potency of
the human TLQP-21 towards both of the human and rodent C3AR1 receptor (Cero et al.,
2014).
Receptor(s) for human vs rodent TLQP-21:
Both human and rodent version of the peptide contains basic sequence RR to which the
binding affinity of the HSPA8 was found to increase considerably (Takenaka et al.,
1995). Structural dynamics of TLQP-21 bound to the HSPA8 receptor binding site
explored by molecular dynamics simulation also reported that R10-R11of the peptide
TLQP-21 interacts strongly with the HSPA8 substrate binding site (For details, see the
annex II).
However, to date most of the works focusing the characterization of TLQP-21 effects
were based on rodent models, rather on human beings (Zhang et al., 2013). In fact, very
few studies have been carried out with TLQP-21 using human cells.  It is important to
note here that for the first time Stephens et al., 2012 showed the controlled TLQP-21
secretion from human islets and effect of TLQP-21 on human pancreatic islet cells was
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established by the same group (Stephens et al., 2012). Later on, in 2013, Zhang et al
ascertained that in human umbilical vascular endothelial cells (HUVECs) TLQP-21 was
capable of stopping apoptosis when the cells were treated with high glucose
concentration; additionally they validated the signaling pathway in HUVECs: TLQP-21
uplifts the synthesis of NADPH and GSH (glutathione) in response to the boost up
expression of G6PD (glucose-6-phosphate dehydrogenase), finally restoring the ROS
(reactive oxygen species). All these data suggest that the peptide has effects in human
cells but there might be different processing mechanism than rodents leading to a
different receptor recognition in humans (Hannedouche et al., 2013).  Recently, Cero et
al., 2014 showed that human TLQP-21 with a S20A substitution binds to human
C3AR1; however though the binding was found to be weaker in comparison to that of
rodent TLQP-21. Moreover, human TLQP-21 was found to exert only a limited
biological activity, five times less than the corresponding rodent TLQP-21
(Hannedouche et al., 2013), upon interaction with the rodent C3AR1 receptor (Cero et
al, 2014).
All these data support the existence of different receptors for human vs rodent TLQP-21
that will potentiate 100 % biological activity in humans.
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Downstream effects of human TLQP-21 binding to its receptor:
Till now, what is known about the downstream effects of binding of murine TLQP-21 to
its receptors:  TLQP-21 was found to increase the calcium levels in macrophages in a
gC1qR dependent manner in rats (Chen et al., 2013). The biological activity of TLQP-
21 signaling was also reported as mediated by G protein coupled receptor (GPCR) in
CHO-K1 cell line. In CHO-K1 cells it was found that there is increase in intracellular
calcium in response to TLQP-21, though to get strong signal ATP priming was required
(Hannedouche et al., 2013). However, these outcomes were not possible to translate in
human suggesting that human TLQP-21 might not work very well in those systems.
Since it is unknown that whether similar effects, as cited by Chen et al., 2013 and
Hannedouche et al., 2013, would be exerted by human TLQP-21 in the experimental
system of this study, a proteomic as well as phosphoproteomic study was carried out. Of
note, it is also important to validate that TLQP-21 is indeed having a biological effect in
the model used in this study. Further, this is a starting point and pioneer work for future
studies regarding the binding of the human version of the peptide to its receptor HSPA8.
Till now, HSPA8 was shown to interact with variety of ligands/binding partners with its
functional consequences downward. But in most cases they are still to be more clarified.
HSPA8 was reported to interact with TLR2/TLR4, induce cytokine expression,  TNF-α,
IL- 1β, and IL-6, initiating p38MAPK, NF-κB pathways (Zou et al., 2008). It was also
found to  interact with surface signaling molecules including CD14, CD40, CD91,
TLR2/TLR4, CCR5, CD36, FEEL, Lox-1, SR-A, and SREC (Calderwood et al., 2007),
commencing  signal transductions (Liao and Tang, 2014). HSPA8 found to provoke the
endogenous (auto)antigen processing  affecting  antigen-presenting B cells,  reducing
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autoreactive T-cell priming; via a signalling mechanism involving a lysosomal
degradation pathway (Page  et al., 2011).
Here both the proteomic and the phosphoproteomic study showed altered protein
expressions. Further investigations required to validate the result, also to confirm
whether HSPA8 is involved in this altered protein expression or not. As a whole, further
studies are required to clarify the overall downstream signaling pathways involved in the
interaction of TLQP-21 and HSPA8.
Concluding remarks:
So far it is known, HSPA8 is the first putative receptor of TLQP-21 in human cells.
Considering all these aspects, identification of HSPA8 as a receptor of human TLQP-21
would open new approaches for diagnostics and therapeutics for a wide range of human
diseases related with VGF, in particular those in which TLQP-21 has been shown to
have an effect. Further advance exploration into the HSPA8-TLQP-21 interaction
emphasizing, specially the downstream consequences is an essential need now.
In this study, HSPA9/mortalin, another member of the HSP-70 family, was found to
bind TLQP-21. Further validation is required to make sure that TLQP-21 binds
HSPA9/mortalin on the cell surface like HSPA8.
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Future prospective:
The ligand TLQP-21 and its putative receptor HSPA8 is in its infancy and extensive
work remains before to make it clear how the interaction between the receptor and the
ligand, HSPA8 – TLQP-21 can be best exploited. Future works should aim to have a
better understanding of the downstream consequences of the cell treatment with TLQP-
21 which would uncover the proteins (both qualitative and quantative) being regulated in
TLQP-21 treated cells, also intracellular molecular mechanisms of TLQP-21 actions.
The mechanisms by which HSPA8 is released and acts later on after having bound with
TLQP-21 will provide valuable information regarding different physiological processes
as well as will provide viable therapeutic strategies for numbers of pathologic conditions
treatment.
Conclusions
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-HSPA8 was identified as the receptor of human TLQP-21 using SH-SY5Y cells.
-Cross-linking of biotinylated TLQP-21 to putative membrane receptors of SH-
SY5Ycells with subsequent cell homogenization, affinity chromatography using a
monomeric avidin column and Western blot could detect a ~71 kDa band corresponding
to HSPA8.
-Surface binding of biotinylated TLQP-21 by the SH-SY5Y cells was increased in the
dose-dependent manner of biotin-TLQP-21, demonstrated by FACS analysis.
- TLQP-21 can be docked into the peptide binding pocket of HSPA8: illustrated by
molecular modeling studies.
-TLQP-21 induced altered protein expressions in SH-SY5Y cells: confirmed by
proteomic and phosphoproteomic study.
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Figure 24: HPLC analysis report of TLQP-21 (A) and biotin-TLQP-21-Cys (B).
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Figure 25: MS analysis report confirming biotin-TLQP-21-Cys. A. (1) The peak at
m/z 940.9 corresponds to the biotin-TLQP-21-C, in its triple protonated form [(biotin-
TLQP-C + H+)/3]. (2) The peak at m/z 1410.7 represents to the doubly protonated
biotin-TLQP-21-C, [(biotin-TLQP-21-C + H+)/2]. B. (1) The peak at m/z 624.1
corresponds to TLQP-21, in its quadrupole protonated form [(TLQP + H+)/4]. (2) The
peak at m/z 831.3 represents to the triple protonated TLQP-21, [(TLQP-21 + H+)/3]. (3)
Peak at m/z 1246.4 represents to the doubly protonated TLQP-21, [(TLQP-21 + H+)/2].
1
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Structural dynamics of TLQP-21 bound to the HSPA8 receptor binding site:
Explored by molecular dynamics simulation
This part of the work was performed by Sandipan Chakraborty, Department of
Microbiology, University of Calcutta, India. The study was directly prompted by our
findings that HSPA8 is a receptor of the human VGF-derived bioactive peptide TLQP-
21 as described in this report. Data reported here will be submitted for publication
together with data reported in the results section of this thesis, and are presented here
with permission of Sandipan Chakraborty. In the Figures of this part, HSPA8 has been
cited as HSC70.
Introduction
Structural details of the interactions needed for TLQP-21 recognition have been explored
by molecular modeling studies. TLQP-21 is a highly flexible peptide. Recent NMR
study suggest that TLQP-21 is probably unstructured in solution devoid of any defined
secondary structure and in the presence of 3T3L1 cells expressing its putative receptor
induces a conformational change with more α-helical propensity (1). Recently, we used
an extensive 550 ns molecular dynamics to explore the folding energy landscape of the
peptide to identify the probable native structure of the peptide in solution and found that
the most populated structure of the peptide adopts a highly compact globular form
stabilized by several hydrogen bonding interactions and π-cationic interactions (2). Thus
the peptide is an interesting biological system exhibiting exquisite structural flexibility
which is highly sensitive of its environment. Here, we also explored the structural
dynamics of TLQP-21 bound to the HSPA8 receptor binding site has been explored by
molecular dynamics simulation and compare the peptide dynamics when it is in water.
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Material and Methods
Free peptide simulation:
TLQP-21 is known to be highly flexible peptide and there is no structural information
available about the native structure of the peptide. We performed secondary structure
analysis of human TLQP-21 (TLQPPSALRRRHYHHALPPSR) from its amino acid
sequence using Jpred3 web-interface (3, 4). The program predicts a strong helical
propensity in the region 6-13. So, the peptide initially has been modeled as helical and
both the C and N terminal amino and carboxylic group were prepared in neutral form.
The initial model was then subjected to molecular dynamics simulation using
GROMACS 4.5 (5, 6) simulation package using OPLS force field (7). The peptide was
subjected to a short 100 steps energy minimization using the steepest descent algorithm
in vacuo which is followed by 3000 steps of in vacuo conjugate gradient minimization.
Then the minimized peptide was solvated with TIP3P explicit water model in a cubic
box with periodic boundary condition. The box dimension was chosen such that all the
protein atoms were at a distance equal to or greater than 10 Å from the box edges. The
simulated system was then made neutral by adding appropriate number of Cl- ions and
the protonation state considered for each residue was consistent with neutral pH. The
solvated system was then subjected to 500 steps of energy minimization using steepest
descent algorithm in water. Simulation was carried out in the isothermalisobaric (NPT)
ensemble at 300 K, using an external bath with a coupling constant of 0.1 ps. The
pressure was kept constant (1 bar) by using pressure coupling with the time-constant set
to 1 ps. The LINCS algorithm was used to constrain the bond lengths involving
hydrogen atoms, allowing the use of 2.0 fs time step. Electrostatic interactions were
calculated using particle mesh Ewald summation method. Van der Waals interactions
were truncated at 14 Å. The trajectories were stored at every 5 ps.
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Modeling the HSPA8:
The HSPA8 shows high degree of conformational flexibility. It is an ATP binding
chaperone and has intrinsic ATPase activity which hydrolyzes ATP into ADP. HSPA8
hydrolyzing ATP initiates the conformational change of HSPA8 and further causes
substrate binding by HSPA8. But in all the available PDB of the HSPA8 is in closed
conformation where lid moves over the substrate binding domain to close the cavity
opening. This conformation does not allow the binding of the peptide TLQP-21. Thus
we modeled the HSPA8 in open conformation where the lid is further away from the
substrate binding domain using SWISS-MODEL web-server (8) and the quality of the
generated model was judged using ANOLEA and QMEAN analysis. We used the
structural homolog of HSPA8, E.coli DnaK in open conformation, which has a sequence
identity of 52.82 % to model the protein using homology modeling. The modeled
HSPA8 was then subjected to a short 500 steps energy minimization using the steepest
descent algorithm in vacuo which is followed by 500 steps of energy minimization using
steepest descent algorithm in water using TIP3P explicit water model in a cubic box with
periodic boundary condition. The minimized structure was then subjected to further
1500 steps of energy minimization using conjugate gradient algorithm in explicit water.
Protein-peptide Docking:
To dock TLQP-21 within HSPA8 substrate binding site, we have used protein-peptide
docking procedure. Firstly, we have used ClusPro 2.0 web-interface (9, 10) to dock the
TLQP-21 with HSPA8. ClusPro uses a fast Fourier transform (FFT) based rigid body
docking algorithm to explore all possible binding possesses of the peptide within the
active site by a systematic rotation and translation of the peptide. Then 1000 lowest
energy solution judged by a balanced scoring function are clustered and solutions from
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the 10 best clusters are reported. The best solution was selected which has the most
favorable energy and also belongs to the most populated cluster.
Molecular dynamics simulation of the HSPA8-TLQP-21 complex:
Conformational dynamics of both free TLQP-21 and HSPA8-TLQP-21 complex were
studied using extensive molecular dynamics simulation with the aid of GROMACS 4.5
packages 95, 6) with OPLS force field (7).
Both free and HSPA8 bound TLQP-21 complex were subjected to a preliminary short
energy minimization in vacuo using the steepest descent algorithm. Then each system
was solvated with TIP3P explicit water model in a cubic box with periodic boundary
condition. The box dimension was chosen such that all the protein atoms were at a
distance equal to or greater than 10 Å from the box edges. The simulated system was
then made charge neutral by adding appropriate number of counter ions. The solvated
system was then subjected to 1000 steps of energy minimization using steepest descent
algorithm which is followed by 5000 steps of minimization using conjugate gradient
algorithm. After that, a 100 ps position restrained dynamics was carried out where the
protein/complex was restrained by adding restraining forces while the water molecules
were allowed to move freely. It allows proper equilibration of solvent around the solute.
It was then followed by 100 ps of NVT simulation at 300 K and 100 ps of NPT
simulation to achieve proper equilibration of the system to be simulated. Final
production simulations were performed in the isothermal isobaric (NPT) ensemble at
300 K, using an external bath with a coupling constant of 0.1 ps. The pressure was kept
constant (1 bar) by using pressure coupling with the time-constant set to 1 ps. The
LINCS algorithm was used to constrain the bond lengths involving hydrogen atoms,
allowing the use of 2.0 fs time step. Electrostatic interactions were calculated using
particle mesh Ewald summation method. Van der Waals interactions were truncated at
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14 Å. The trajectories were stored at every 5 ps. Analyses were carried out with the
trajectory analysis tools implemented in GROMACS.
Result and Discussion
Recognition of TLQP-21 by HSPA8:
To explore the recognition mechanism of TLQP-21 by HSPA8, we have employed
protein-peptide docking implemented in ClusPro 2.0 web-interface. It is to be noted that
we have modeled the HSPA8 in open conformation where lid is further away from the
substrate binding domain. In this lowest energy docking complex, TLQP-21, binds
properly within the substrate binding domain of HSPA8. Structures of the TLQP-21-
HSPA8 complex obtained from ClusPro shown in Figure 21.
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Figure 26: Structures of the TLQP-21- HSPA8 obtained from molecular docking
study in cartoon representation. HSPA8 is colored in green whereas the bound TLQP-
21 is colored in pink.
As evident from the figure, TLQP-21 appropriately orients within the substrate binding
site of the HSPA8. The peptide interacts strongly with the twisted β-sheeted plate sheet
region of the HSPA8 substrate binding site. The complex displays high steric
compatibility in size and shape between the TLQP-21 and HSPA8, resulting a tighter
spatial fit of the peptide inside the cavity. The bound TLQP-21 still maintains its helical
conformation.
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Molecular dynamics simulation:
To further investigate the conformational dynamics of TLQP-21 in its free and receptor
bound state, we have used molecular dynamics (MD) simulation using GROMACS
packages (5, 6) for both free and HSPA8 bound TLQP-21 obtained from docking
studies.
Figure 27: Variations of RMSD (A, B) and Rg (C, D) with simulation time for
TLQP-21 in complex with HSPA8 and free TLQP-21 in solution obtained from
molecular dynamics simulation.
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Figure 22 depicts the variations of two global structural parameters root mean square
deviation (RMSD) and radius of gyration (Rg) for both free and HSPA8 bound TLQP-21.
The RMSD (root means square deviations) of the backbone Cα atoms of the simulated
protein over time can be used to analyze the structural stability of the system. Figure
22A shows that the complex undergoes significant conformational changes during the
first 25 ns of the simulation, after that the system monotonically reaches to an
equilibrium state, evident from the stable RMSD profile of the complex. We then
analyzed the variations of the RMSD of each of the component of the complex, i.e.,
HSPA8 and TLQP-21, during the simulation. As evident from the Figure 22A, changes
in the observed in the complex during the initial period of the simulation is mainly
contributed by the receptor HSPA8. It is to be noted that the HSPA8 is a highly flexible
protein that undergoes significant conformation changes upon substrate binding and
dependent on ATP hydrolysis. We have modeled the HSPA8 in open conformation where
the lid is further away from the substrate binding domain. Thus it is expected that upon
peptide binding there should be significant conformational changes. Throughout the
simulation, we do not find any dissociation of the complex, indicating that the peptide
TLQP-21 form strong, stable complex with HSPA8. It is to be noted that we modeled
TLQP-21 in helical form and interestingly we found that this helical form is highly
stable upon complex formation. Figure 22A shows that the peptide within the complex
undergoes very small changes in its RMSD profile during very initial equilibration
period of the simulation after that it is highly stable throughout the simulation and settled
down ~ 0.3 nm with respect to the initial helical conformation of the peptide while it is
bound to the HSPA8 substrate binding site. But the TLQP-21 in solution is highly
flexible as evident from the RMSD profile of the peptide, shown in Figure 22B. The
initial helical conformation of the peptide, TLQP-21, changes significantly up to 0.7 nm
during ~ 20 ns of the simulation with respect to the initial helical conformation of the
peptide in water. During the simulation period, particularly during 50 to 100 ns of the
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simulation the RMSD profiles varies significantly indicating that the peptide is highly
flexible in solution and accessing different conformation states during simulation.
On the other hand, radius of gyration (Rg) provides insight into the overall dimension
and shape of the protein. The plot of Rg of TLQP-21 in bound and free states with
simulation time is shown in Figure 22C and 22D. The initial helical conformation of the
peptide TLQP-21 when bound to HSPA8 is highly stable during the 100 ns simulation of
the complex, evident from a highly stable Rg profile of the peptide in bound condition
throughout the simulation. While during the simulation of the peptide in free state, the
initial helical conformation of the peptide changes rapidly and adopts a more compact
form, evident from a sharp decrease of Rg from 1.10 nm to 0.75 nm. This conformation
fluctuates between numerous states throughout the simulation time evident from the
changes of the Rg profile and the sharp spikes indicate metastable states with partial
unfolded structures. Overall the RMSD and Rg profile reveals the peptide, TLQP-21, in
water adopt a highly flexible conformation and fluctuates between many conformations
during simulation, while receptor binding provides stabilization of its initial helical
conformation.
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Figure 28: A: Secondary structural propensity variation analysis of each residue of
the peptide with simulation time when complex with HSPA8. B: Secondary
structural propensity variation analysis of each residue of the free peptide with
simulation time in solution.
Secondary structural propensity analysis of each residue of the peptide in bound and free
state throughout simulation time is shown in Figure 23. TLQP-21 when bound to the
HSPA8, the peptide possess strong helical propensity and it’s helical is highly stable
throughout the simulation. Particularly, the region 4-14 exists as α-helix when bound to
the receptor binding site. Interestingly, in solution the peptide is highly flexible and
mostly unstructured in solution which corroborates well with the existing assumptions.
Most of the residues of the peptide possess high turn/bend propensity. Residues of the
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region S6-R10/R11 shows some helical propensity during the initial period but it rapidly
dissolves during the later period of the simulation.
Figure 29: Superimposed structure of the five most populated conformations of the
peptide TLQP-21 obtained from cluster analysis. A: Peptide conformations obtained
from the cluster analysis from the TLQP-21- HSPA8 complex simulation. B: Free
peptide simulation in solution.
To identify most frequently visited conformations during MD simulation, cluster
analysis has been performed over the 100 ns trajectory using a stringent RMSD cutoff of
0.1 nm using gromos algorithm. Analysis on the whole trajectory of the complex
simulation results in 907 clusters of TLQP-21 peptide conformations while in solution
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the peptide conformations observed during the simulation resulted 2816 conformations.
This observation again indicates that the peptide is highly stable upon binding with the
receptor, HSPA8 while in solution it is highly flexible accessing many conformations.
Average conformation of the peptide, TLQP-21, of the five most populated clusters from
TLQP-21- HSPA8 complex simulation and simulation of the peptide in solution is also
shown in Figure 24. When peptide is bound to HSPA8 substrate binding site (Figure
24A), all the five conformations of the peptide have very similar side-chain orientations
and exist as long α-helix. In solution, all the five structures of the peptide adopt a highly
compact globular form in contrast to their initial long helical form. This observation is in
accordance with the Rg distribution. Most of the conformations in the MD simulation are
centered ~ 0.75 nm of Rg, represent highly globular forms. All the five conformations of
the peptide are highly flexible with widely distributed side-chain orientations. Although
a helical propensity is observed for a very short region of the peptide, but most of the
residues are in coil/turn conformation.
We then analyzed the essential interactions responsible for TLQP-21 recognition by
HSPA8. Analysis of the average center of mass distance variations between TLQP-21
and HSPA8 reveals that the initial docked complex varies greatly with the simulation
and as the simulation progresses TLQP-21 comes closer and binds strongly to the
HSPA8 binding site (Figure 25A).
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Figure 30: Variations of center of mass distance (A) and hydrogen bonding (B)
between TLQP-21 and HSPA8 with simulation time.
One of the principal driving force that allows stronger interaction of the peptide, TLQP-
21, within HSPA8 substrate binding site as the simulation progresses is the formation of
more number of hydrogen bonds. Figure 25B demonstrates the variation of number of
hydrogen bonds between TLQP-21 and HSPA8. As evident from the figure, with
simulation time, the number of hydrogen bonds increases compared to the number of
hydrogen bonds observed in the docked complex. Also evident from the RMSD profile
of the complex (Figure 25A), during the initial 30 ns of the simulation, the docked
complex undergoes conformational readjustment. During this time the peptides comes
closer to the HSPA8 binding site and during this period number of hydrogen bonds with
the receptor varies greatly. With the simulation, the peptide comes closer and settled
around at an optimum distance guided by strong surface complementarity and increasing
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hydrogen bonding possibilities. During latter half of the simulation, the number of
hydrogen bonds between TLQP-21 and HSPA8 settled ~ 5-6.
Variations of RMSD fluctuations of the complex, center of mass distance between
TLQP-21 and HSPA8 as well as the protein-peptide hydrogen bonding reveal that the
complex reaches a stable equilibrated state in the later 50 ns of the simulation. We then
performed the cluster analysis of the TLQP-21- HSPA8 complex reveals that the most
populated conformations belongs to the conformations of the complex from the latter
half of the simulation, where the system is properly equilibrated. So we have chosen the
average structure from the most populated clusters obtained from the TLQP-21- HSPA8
complex simulation. Protein peptide interactions have been analyzed and shown in
Figure 26.
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Figure 31: Details of the interactions involved in TLQP-21 recognition by HSPA8.
A: Details of the hydrogen bonding interactions between TLQP-21 and HSPA8. HSPA8
and TLQP-21 are colored as salmon and lime-green color, respectively. B: Electrostatic
surface potential of HSPA8 when TLQP-21 is bound to the protein. Regions of
positively and negatively charged surface area are colored in blue and red color.
We have also analyzed the hydrogen bonding interactions between TLQP-21 and HSPA8
using PIC web-server (11). Details of hydrogen bonding interactions between TLQP-21
and HSPA8 are shown in Figure 26A. THR 1 at the N-terminal of the TLQP-21 is
involved in hydrogen bonding interaction with THR 419 of HSPA8. At the middle of the
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peptide, SER 6 and ARG 10 are involved in hydrogen bonding interactions with LEU
390 and ASP 380, respectively at the HSPA8 receptor binding site. These interactions
might play crucial role in mainlining the helical structure of the peptide within receptor
binding site. At the C-terminal region, ARG 21 of TLQP-21 is involved in a hydrogen
bonding interaction with GLU 383 of HSPA8. Figure 26B shows electrostatic
interactions between HSPA8 and TLQP-21. As evident from the electrostatic surface
potential of HSPA8, the peptide binding region of the protein is highly charged and
contains negatively charged residues. Specific electrostatic interactions between TLQP-
21 and HSPA8 facilitate binding. Particularly, two positively charged residues ARG 10
and ARG 11 at the middle of the peptide and ARG 21 at the C-terminal region of the
peptide TLQP-21 interacts strongly with the negatively charged region of the HSPA8
substrate binding site.
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Annex III:
Probing the conformational dynamics of the bioactive peptide TLQP-21 in
solution: A molecular dynamics study
This part of the study was performed as a collaborative work with Sandipan Chakraborty
and Soumalee Basu, Department of Microbiology, University of Calcutta, India. The
study was directly prompted by our findings that HSPA8 is a receptor of the human
VGF-derived bioactive peptide TLQP-21 as described in this report. Data reported here
has already been published in the Journal of Chemical Biology and Drug design
(CBDD).
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A study on the effect of TLQP-21 on ERK/AKT signaling in SH-SY5Y cells
Introduction
Taken together all the data into consideration, as presented in the Figure 1 and 2;
ERK/AKT signaling pathway was chosen to perform a study to have a read out whether
the peptide potentiates ERK/AKT signaling in the SH-SY5Y cell model or not. Of note,
besides confirming that TLQP-21 shows biological effects on ERK and AKT in our
model system, the ultimate objective was to explore whether the modulation effect is due
to the interaction between TLQP-21 and its receptor HSPA8 or not.
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Figure 1: Proposed mechanism of action of TLQP-21: Intracellular signaling
downstream  in adipocyte membrane after activation of a putative TLQP-21
receptor activation (Possenti, et al. 2012).
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Figure 2: Schematic demonstration of TLQP-21 intracellular signaling (Passeri et
al., 2013).
Materials and methods
Petri dishes with confluent SH-SY5Y cells were incubated for 6 hours with the peptide
TLQP-21 at a concentration of 1µg/ml. SH-SY5Y cells in Petri dishes were washed
twice with cold PBS, followed by solubilization in lysis buffer, composed of 20 mM
HEPES, 2mM EGTA, 1mM DTT, 1mM sodium orthovanadate, 1% Triton X-100, 10%
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Glycerol, 2µM leupeptin, 400 µM PMSF, 50 µM ß-glycerophosphate, 100 µg/ml
trasylol. The cells were scrapped on ice for 10 minutes and were incubated on ice for 30
minutes with periodic vortexing at each 5 minutes interval, followed by centrifugation
for 20 minutes at 14000g at 4 °C. The supernatant was saved for further use. Protein
concentration was quantified using the BCA protein assay kit (Pierce Chemical). As
control, cells without peptide incubation were grown, then homogenized under the same
conditions as treated cells.
Cell homogenate samples (20 µl) were boiled in 2X Laemmli buffer (Bio-Rad) for
10minutes at 100 °C, spun, and loaded to SDS-PAGE gel. After electrophoresis (200V,
01h), proteins were transferred onto Polyvinylidene fluoride (PVDF) membrane
(Millipore, Bedford, MA) in the condition of 0.8 mA/cm2 for 90 minutes using semi-dry
method (Trans-blot SD semi-dry transfer cell, Biorad). The  PVDF membrane was then
blocked by 5% BSA (Bovine Serum Albumin) in TBS-T solution (Tris-buffered saline
with 0.1% tween 20) for 01 hour at room temperature, followed by three washes by TBS-
T each for 10 minutes and then, the membranes were probed by primary antibodies in
TBS-T, as specified in the Table 1.
Table 1: Specifications of the antibodies used.
Antibody Commercial source Dilution Other specifications
pERK(Thr202/Tyr204) Cell signaling 1:2000 Overnight incubation
ERK Cell signaling 1:1000 Overnight incubation
pAKT (Ser473) Cell signaling 1:1000 Overnight incubation
AKT Cell signaling 1:1000 Overnight incubation
GAPDH Sigma-Aldrich 1: 5000 Overnight incubation
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Then the PVDF membrane was washed 3 times with TBS-T for 10 minutes each wash,
followed by incubation with the secondary Anti-rabbit antibody (Dako) at 1 : 2000
dilution in TBS-T. The control was performed using a GAPDH antibody, as specified in
the Table 1. The membrane was washed 3 times with TBS-T for 10 minutes each wash.
Subsequently, the membrane was incubated with chemiluminescence solution Luminata
Forte Western HRP substrate (Merck Millipore) for 5 minutes covering the membrane
containing container to protect it from light and was developed using Hypercassette and
Amersham hyperfilm (GE Healthcare).
Results and discussion
With protein extracts obtained from TLQP-21 treated cells and not treated (control) cells,
the following Western blot analyses were performed. The result obtained in this case
showed no difference in expression of the proteins in SHSY-5Y cells. Results shown are
from a single experiment and are representative of three separate experiments.
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pERK
GAPDH
pAKT
GAPDH
Figure 2: Representative Western blot showing that treatment of TLQP-21 did not
alter in the expression of pERK,  ERK, pAKT(Ser473) and AKT. (C- Not treated with
peptide, Control; T- Treated with TLQP-21). GAPDH was checked as load control.
Of note, in TLQP-21 treated  rat pituitary tumor cell lines (GH3), no difference was
found in pERK and pAMPK though there was difference in expression of pAKT and p-p38
(Passeri et al., 2013).  In another study, TLQP-21 was found to signiﬁcantly activate
ERK ½. Akt phosphorylation was found to be increased after 15 min of treatment with
TLQP-21, while phosphorylation of Akt increased further after that time using insulin-
like growth factor-1 (IGF-1). After 24 and 48 h of incubation, IGF-1 treatment increased
Akt phosphorylation while TLQP-21 did not modify the amount of phosphorylated Akt,
ERK
GAPDH
AKT
GAPDH
C T C T
C T C T
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although total Akt and α-tubulin were found to be increased in both cases (Severini et
al., 2008).
Conclusion
In SH-SY5Y cells, TLQP-21 did not bring any alternation in the expression of  ERK and
AKT proteins.
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A comparative study on the phosphoproteins and total proteins in TLQP-21 treated
vs. control SH-SY5Y cells
Introduction
In addition to the phosphoproteomic study of SH-SY5Y cells treated with TLPQ-21
described before in the thesis, a preliminary analysis of total protein expression was also
carried on using the same cell extracts. Comparison of simple 1D SDS-PAGE gels
stained with SYPRO® Ruby protein gel stain was carried out. The purpose of this study
was to assess whether changes in protein expression could be seen even at such low
separation resolution.
Materials and methods
The materials and methods used for Pro-Q® Diamond phosphoprotein gel staining as
well as mass spectrometry in this part of the work were exactly as same as it has been
described in the Materials and Methods section of the thesis.
For SYPRO® Ruby protein gel staining : Samples (25 µl) from cell homogenates of the
cells treated with the peptide and not treated were boiled in 2X Laemmli buffer (Bio-
Rad) for 10 minutes at 100 °C, spun, and loaded to SDS-PAGE gel. After electrophoresis
(200V, 01h), the gel was washed in dH2O for 10 minutes. Then the gel was incubated
with fixing solution (10% methanol, 7% acetic acid) for 1 hour at room temperature in an
orbital shaker step at 50 rpm, followed by overnight incubation with SYPRO® Ruby
Protein Gel Stain at room temperature with shaking. The gel was then placed into a
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staining container covering with a lid to protect it from the light, in addition, the
container was wrapped in aluminum foil to further shield the stain from light during the
staining process, as per instruction of the supplier. After overnight staining, the gel was
transferred to a clean staining dish, washed with the fixing solution in the same condition
of staining followed by 5 minutes washing in dH2O. Finally, the gel was taken from the
container to take the image in a Molecular Imager® Gel Doc TM system (Bio Rad,
Hercules) using the highest sensitivity of the CCD camera  at a resolution of 1392 x 1040
pixels with 12 bit gray scale levels per pixel.
Results and discussion
As supplementary confirmation that TLQP-21 exerts biological effects in the model
system, SH-SY5Y cells; homogenates from TLQP-21 treated or not treated (control)
cells were subjected to 1D SDS-PAGE followed by staining with the dye Pro-Q
Diamond, followed by SYPRO® Ruby dye .  As seen in the Figure 1 : At positions 3, 4
and 5; band intensity becomes higher in SYPRO® Ruby dye staining indicate the
nonphosphorylated proteins. Several bands with altered intensity in the SYPRO® Ruby
experiment were of the same positions in the gels  as those in the Pro Q® Diamond,
suggesting that both techniques were detecting, to some extent, similar changes. This
also suggested that the proteins with altered phosphorylation status were probably
abundant proteins, hence their changes were "picked up" by SYPRO® Ruby staining.
Differences in band intensity were seen at positions 1 to 5 of the gels. The bands’
intensity at 1 (A, Pro Q® Diamond) and 3 (both in A, Pro Q® Diamond and B, SYPRO®
Ruby dye) were less in the samples treated with the peptide in comparison to not treated
(control) ones suggesting that the peptide on SH-SY5Y cells might provoke
dephosphorylation of specific phosphoproteins.
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C T C T C T C T
B. SYPRO® Ruby
(total)protein  staining
A. Pro-Q® Diamond
phosphoprotein staining
---2---
---3---
---4---
---5---
Figure 1: Comparative selectivity of A. Pro-Q® Diamond phosphoprotein staining
and B. SYPRO® Ruby (total)protein  staining. Gel, at first, was stained with Pro-Q
Diamond dye.  Same gel poststained with SYPRO Ruby protein gel stain to visualize all
proteins of the cell homogenates treated (T) and not treated (C) with the peptide showing
differences in protein expression at position 1, 2, 3, 4 and 5.
---1---
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The bands at position 1 and 3 from A, Pro Q® Diamond stained gel was cut and analysed
by mass spectrometry, as described in the Materials and Methods section; results are
detailed in the Table 1.
Table 1: List of proteins with altered expression levels in Pro Q® Diamond stained
gel. Proteins of the cell homogenates treated (T) and not treated (C) with the peptide.
A 1
Control (C)                                              Treated (T)
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A3
Control (C)                                              Treated (T)
Out of the proteins listed in the Table 1, several proteins like Microtubule-associated
protein 1B (MW 271 kDa), Tubulin beta chain (MW 57 kDa), Tubulin beta-4B chain
(MW 50 kDa), Alpha-2-macroglobulin (MW 163 kDa) were of interests. Further
studies are required to validate the results obtained from mass spectrometry.
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Conclusion
Changes in protein expression were detected even with a low resolution (1D) separation
technique, suggesting that more complete, 2D separation-based proteomic studies should
be carried out.
Annex VI:
A study on the effect of TLQP-21 on the expression of Egr-2 and Grb-2
in SH-SY5Y cells.

Annex VI
271
A study on the effect of TLQP-21 on the expression of Egr-2 and Grb-2
in SH-SY5Y cells.
Introduction
Egr-2 and Grb-2 genes were found as VGF (AQEE-30: 1μg/ml) induced genes in PC12
cells (Figure 1, Hunsberger et al., 2007). So, it was of interest to study the effect of
TLQP-21 treatment on Egr-2 and Grb-2 protein expression in SH-SY5Y cells in order to
know the read out that either or both of the two proteins were modulated. In this
connection it should be noted here that, besides confirming that TLQP-21 exerts
biological effects on Egr-2 and Grb-2 in our model system, the ultimate objective was to
investigate whether this modulation is due to the interaction between TLQP-21 and its
receptor HSPA8 or not.
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Figure 1: Schematic diagram of neurotrophic factor signaling pathway, showing
target gene products, including Egr-2 and Grb-2 (Hunsberger et al., 2007).
Materials and methods
The materials and methods used in this part of the work were exactly same as it has been
described in the materials and method section of annex IV, using the antibodies as
specified in the Table 1.
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Table: Specifications of the antibodies used.
Antibody Commercial source Dilution Other specifications
Grb-2 Cell Signaling 1:1000 Overnight incubation
Egr-2 Santa Cruz Biotechnology 1: 500 Overnight incubation
Results and discussion
The level of expression of the proteins: Egr-2 and Grb-2 was measured by means of
Western blot using protein extracts obtained from SH-SY5Y cells treated with the
peptide TLQP-21 and not treated (control). Expression of the proteins remained
unchanged, as shown in the Figure 2.
Egr-2
GAPDH
cont. treat. cont.   treat.
Figure 2: Western blot analysis of Egr-2 and Grb-2 expression in SH-SY5Y cells.
Grb-2
GAPDH
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Conclusions
No change in the expression of the Egr-2 and Grb-2 proteins was found here.  But
another VGF derived bioactive peptide AQEE-30 was found to alter in the expression of
the proteins in PC12 cells. It might be that AQEE-30 in PC12 cells altered the signaling
of Egr-2 and Grb-2 protein expressions whereas in SH-SY5Y cells, TLQP-21 could not
bring about such changing effect.
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AA: Amino acids
AD: Alzheimer’s disease
AFM: Atomic force microcopy
ALS: Amyotrophic lateral sclerosis
AR: β-adrenergic
BAT: Brown adipose tissue
BDNF: Brain derived neurotrophic factor
BSA: Bovine serum albumin
C3a: Complement component-3a
C3AR1: Complement component-3a receptor 1
C4a: Complement component-4a
cAMP: Cyclic adenosine monophosphate
cDNA: Complementary deoxyribonucleic acid
CgA: Chromogranin A
CGCs: Cerebellar granule cells
CHO: Chinese hamster ovary
CNS: Central nervous system
COX-2: Cyclooxygenase-2
CSF: Cerebrospinal fluid
Da: Daltons
DISC1: Disrupted in Schizophrenia 1
DRG: Dorsal root ganglion
DSG: 15-deoxyspergualin
EBSS: Earle’s balanced salt solution
ER: Endoplasmic reticulum
ERK: Extracellular-signal-regulated kinase
FACS: Fluorescence-activated cell sorting
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FBS: Foetal bovine serum
FFA: Free fatty acids
FSH: Follicle stimulating hormone
FSH: Follicle-stimulating hormone
FTD: Fronto-temporal dementia
G6PD: Glucose-6-phosphate dehydrogenase
gC1q-R: Receptor (R) for globular head (g) region of C1q
GIP: Glucose-dependent insulinotropic polypeptide
Gln: Glutamine
GLP-1: Glucagon-like peptide-1
GnRH: Gonadotrophin releasing hormone
GPCR: G-protein coupled receptor
GSIS: Glucose-stimulated insulin secretion
hCG: Human chorionic gonadotrophin
HFD: High-fat diet
HPG: Hypothalamic-pituitary-gonadal
HPLC: High performance liquid chromatography
HRP: Horseradish peroxidase
HSP70: Heat shock protein 70 (family)
HSPA5: Heat shock protein A5
HSPA8: Heat shock cognate protein A8
HSPA9: Heat shock protein A9
HSPs: Heat shock proteins
HUVECs: Human umbilical vascular endothelial cells
i.c.v.: Intracerebroventricular
IL-8: Interleukin-8
Ip: Intraperitoneal
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Iv: Intravenous
kDa: Kilo Dalton
LC-MS: Liquid chromatography mass spectrometry
LH: Leutinizing hormone
mA: Milliampere
MALDI-TOF: Matrix Assisted Laser Desorption Ionization Time-of-Flight
MAPK: Mitogen-activated protein kinase
MDD: Major depressive disorder
MM: Molecular mass
MS: Mass spectrometry
NEAA: Non-Essential Amino Acids
NERPs: Neuroendocrine regulatory peptides
NGF: Nerve growth factor
NHS: N-hydroxysuccinimide
NPCs: Neural progenitor cells
P/S: Penicillin-Streptomicin
PAGE: Polyacrylamide gel electrophoresis
PBS: Phosphate buffered saline
PCs: Prohormone convertases
PG: Prostaglandin
PGE2: Prostaglandin E2
PKA: Protein kinase A
PNS: Peripheral nervous system
PSNL: Partial sciatic nerve ligation
PTX: Pertussis toxin
PVDF: Polyvinylidene fluoride
ROS: Reactive oxygen species
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SCZ: Schizophrenia
SDS: Sodium dodecyl sulphate
SgII: Secrotogranin II
ShRNA: Small hairpin RNA/ short hairpin RNA
siRNA: Small interfering ribonucleic acid
SN: Secretoneurin
T2DM: Type 2 diabetes mellitus
TBS: Tris-buffered saline
TG: Triglycerides
TNF-α: Tumor necrosis factor alpha
TrkB: Tropomyosin receptor kinase B
UCP1: Uncoupling protein 1
VEGF: Vascular endothelial growth factor
VGF: Non acronymic, a neurotrophin
VIP: Vasoactive intestinal peptide
WAT: White adipose tissue
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